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Abstract 
This thesis describes the diastereoselective synthesis of a wide range of α-functionalised 
acyclic sulfoximines via lithiation-trapping methodology. The diastereoselective 
synthesis of some tetrasubstituted sulfoximines is also presented. 
Chapter 2.1 describes the synthesis of a range of N-TBDPS acyclic sulfoximines A 
bearing different aliphatic and aromatic substituents at sulfur. A range of lithiation-
trappings with different electrophiles is presented in Chapter 2.2. N-TBDPS acyclic 
sulfoximines A generally showed high diastereoselectivity and yields of B, particularly 
when the sulfoximine was substituted with a bulky group (R1 = t-butyl and adamantyl). 
Across most examples, the anti-diastereomer anti-B was produced as the major product 
and a model for this is proposed. Benzylic sulfoximines A (R2 = Ph) (Chapter 2.2.3) were 
also explored and exhibited different and unpredictable diastereoselectivity. 
 
The synthesis of tetrasubstituted sulfoximines D by lithiation-trapping is presented in 
Chapter 2.3 using t-Bu-substituted sulfoximines C. High yields and diastereoselectivity 
were obtained for some examples and the same outcome was observed with benzaldehyde 
when employing either diastereomeric starting sulfoximine. The best results were 
obtained when small, reactive electrophiles were used, presumably due to the sterically 
demanding substrate. It was not possible to assign the stereochemistry of the major 
diastereomers. 
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1. Introduction 
  Introduction to Sulfoximines 
In the last few years, sulfoximines have been a focus of interest in synthetic chemistry 
due to their applications in the pharmaceutical1 and agrochemical2 industries. As a result, 
attention in this interesting functional group is continuously expanding. Sulfoximines 
share similarities with the related sulfone and sulfoxide functionalities and are 
isoelectronic with sulfones (Figure 1.1).1 The synthesis and reactions of sulfones and 
sulfoxides are far more explored than sulfoximines and therefore research efforts 
regarding the synthesis and functionalisation of sulfoximines is a current focus. 
 
Figure 1.1 Structure of the sulfoxide, sulfone and sulfoximine 
The structural differences between the sulfoximine and sulfone units consist of the 
presence of a nitrogen atom replacing one of the oxygen atoms of the sulfone, which leads 
to unique physicochemical properties. Sulfoximines demonstrate a desirable spectrum of 
properties including high stability, a hydrophilic core and the ability to undergo hydrogen 
bonding.1 Furthermore, they demonstrate better ‘drug-like’ features over their 
corresponding sulfone analogues by being more polar and readily soluble in water which 
is likely to be due to the solvation of the sulfoximine.3 These factors collectively showcase 
the potential of sulfoximines as viable candidates for drug discovery. 
As sulfoximines have beneficial ‘drug-like’ properties and good bioactivity, they have 
been employed in various pharmaceuticals over recent years. This is best illustrated by 
enantiopure nanomolar pan-CDK inhibitor BAY 100394 (Figure 1.2), developed by 
Bayer, currently undergoing clinical trials.4 BAY 100394 was investigated following the 
failure and termination of sulfonamide ZK 304709 (Figure 1.2) during phase 1 clinical 
trials due to poor thermodynamic solubility in water (8 mg L-1 at a pH of 7.4) and low 
lipophilicity.5 Sulfoximine-containing BAY 100394 allowed Bayer to overcome these 
issues by having much higher solubility in water (182 mg L-1). The use of the sulfoximine 
pharmacophore within BAY 100394 has sparked and directed further attention towards 
utilising this unit within other drug discovery programmes at Bayer.1 Another example is 
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AZD6738 (Figure 1.2), developed by AstraZeneca, an enantiopure ATR kinase inhibitor 
which has shown potential as an anticancer treatment. AZD6738 is currently undergoing 
clinical trials and has provided promising results in terms of its effectiveness against 
gastric cancer cells.6 
 
Figure 1.2 Sulfoximine-containing pharmaceutical candidates 
An earlier example is racemic antiasthmatic drug candidate RU 31156 (Sudexanox) that 
has been selected to undergo clinical trials (Figure 1.3). Disodium chromoglycate 
(DSCG) is an effective asthma treatment but is not orally active. Therefore, xanthone-2-
carboxylic acid was selected as a template for an orally active antiasthmatic agent, as it 
displays activity similar to that of DSCG when dosed orally. This lead structure then 
enabled the development of Sudexanox through a series of structural modifications which 
showed an increase in potency and intravenous and oral activity when compared to 
DSCG.1,7 
 
Figure 1.3 Details of the lead optimisation of Sudexanox 
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The electron withdrawing nature of sulfoximines and the presence of the mildly basic 
amine group allows for further diversification via installation of a variety of substituents. 
N-H, or ‘free’, sulfoximines are often the focus of research, but alternative nitrogen 
substituents have also been investigated. Some common examples include alkyl (N-R), 
aryl (N-Ar), silyl (N-SiR3) and cyano (N-CN) substituents. The electronic properties of 
the group on nitrogen has a significant effect on the properties of the sulfoximine and 
therefore its applications. For example, electron donating substituents such as alkyl, aryl 
and silyl containing groups decrease the polarity of the sulfoximine. Conversely, 
functional groups with electronic withdrawing capabilities such as cyano and sulfonyl 
increase the polarity.8  
The installation of different groups at nitrogen allows for different applications of 
sulfoximines. For example, N-CN functionalised sulfoximines have shown potential to 
act as insecticides. Sulfoxaflor (Figure 1.4) was developed as an insecticidal compound 
that is effective against a range of sap-feeding insects.9 Sulfoxaflor is racemic and exists 
as a mixture of four stereoisomers, two of which are diastereomers.10 It was shown that 
the N-CN substituent was an important feature required for its activity when compared to 
the previously investigated N-nitro sulfoximine. Other related examples also describe the 
incorporation of the N-CN functionality further highlighting its necessity.11 Prior to the 
development of Sulfoxaflor, the sulfoximine scaffold had not been extensively 
investigated within the agrochemical industry.9  
 
Figure 1.4 The structure of Sulfoxaflor 
When the two carbon substituents attached to sulfur are not identical, the sulfoximine 
centre is stereogenic and applications in asymmetric synthesis as chiral ligands and 
auxiliaries have been described.12 For example, Pyne13 and co-workers have described 
the asymmetric synthesis of cyclopropanes and Harmata14 has reported the 
enantioselective synthesis of benzothiazines. Work by Johnson also showed the potential 
of chiral sulfoximines as reagents for the optical resolution of ketones.15 
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The enantioselective borane reduction of ketones to alcohols using β-
hydroxysulfoximines has been described by Bolm.16 Langner and Bolm have also 
investigated sulfoximines as chiral ligands and described their application in Cu-catalysed 
Mukaiyama-type aldol reactions.17 Bisulfoximines such as 1 have been used in 
asymmetric Pd-catalysed allylic alkylation reactions. For example, bisester 2 was formed 
in 94% ee, although the absolute stereochemistry was not established (Scheme 1.1).18 
Studies have also reported the use of sulfoximines as directing groups in various C-H 
activations, including the Rh-catalysed synthesis of 1,2-benzothiazines.19,20 
 
Scheme 1.1 
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  α-Functionalisation of Sulfoximines by Lithiation-Trapping 
It is possible to functionalise at the α-position of alkyl substituents of N-functionalised 
sulfoximines via deprotonation of the α-protons and subsequent trapping with an 
electrophile. The ease of such α-carbanion formation depends on the functionality 
attached to the amino group. Bordwell and co-workers experimentally measured the 
associated pKa values of the α-protons in sulfoximine, sulfone and sulfoxide functional 
groups. The phenyl methyl derivative of each sulfur-containing compound was used in 
these studies and the pKas of the methyl protons were measured (Figure 1.5). N-Me 
sulfoximine 3 was shown to have a pKa ~33 in DMSO at 25 °C. This was equal to the 
measured pKa of the corresponding sulfoxide 4 and higher than that of the corresponding 
sulfone 5 (pKa ~29) presumably due to the greater electron withdrawing ability of the 
sulfone functional group. Bordwell’s studies also highlighted the effect of the nitrogen 
substituent on the sulfoximine since the pKa of the N-Ts sulfoximine analogue 6 was 24.5. 
This is significantly lower than the N-Me sulfoximine 3 presumably due to the electron 
withdrawing ability of the tosyl functionality which is better at stabilising the resulting α-
carbanion.21 
 
Figure 1.5 pKas of sulfoximines, sulfones and sulfoxides 
Since the α-protons of sulfoximines generally have pKa values of ~23-33,8,21 strong bases 
such as n-BuLi and LDA are typically used for deprotonation. There has been significant 
research exploring the α-functionalisation of various acyclic sulfoximines using 
lithiation-trapping, where a range of N-substituents and electrophiles have been explored. 
This chapter will provide a selection of key examples of the lithiation-trapping of acyclic 
sulfoximines to demonstrate the scope and diastereoselectivity which is possible with this 
methodology. 
The reaction conditions used for the lithiation-trapping of acyclic sulfoximines usually 
consist of a deprotonation step using n-BuLi in THF at low temperatures, typically at −78 
°C. This is followed by addition of the electrophile under the same conditions. Often, the 
trapping step is performed at −78 °C but it is common for higher temperatures to be 
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used.22 Using these typical conditions, the lithiation-trapping of N-TBDPS sulfoximine 7 
with 1-bromo-2-bromomethylbenzene gave α-substituted sulfoximine 8 in 70% yield 
(Scheme 1.2).23 
 
Scheme 1.2  
The study also employed other alkylating agents and the electron rich 2-bromo-5-
methoxybenzyl bromide gave benzylated sulfoximine 9 in 72% yield (Scheme 1.3). 
Trapping with a secondary alkyl bromide such as 10 resulted in the formation of α-
alkylated products anti-11 and syn-11 due to the formation of an additional stereocentre 
at the β-position. In this example, a 67:33 mixture of anti-11 and syn-11 was obtained 
(isolated yields of 39% and 17% respectively). The diastereoselectivity presumably arises 
from the different rates of trapping of the lithiated sulfoximine with the chiral 
electrophile.23 
 
Scheme 1.3 
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The lithiation-trapping methodology has also been applied to the synthesis of some 
complex molecules such as sulfoximine-containing vitamin D analogues which were 
being studied as potential chemotherapy agents. Lithiation-trapping of N-TBDMS 
sulfoximine 12 with alkyl iodide 13 gave a 50:50 diastereomeric mixture of sulfoximines 
14 in 55% yield (Scheme 1.4). The HMPA was probably used to increase the reactivity 
of the lithiated sulfoximine in its reaction with the sterically hindered alkyl iodide. The 
lithiated sulfoximine was presumably used in excess to ensure consumption of the 
complex alkyl iodide.24 
 
Scheme 1.4 
Füger and Bolm have carried out lithiation-trappings with a range of allyl bromides, an 
example of which is shown in Scheme 1.5. It was reported that upon slow addition of the 
alkenyl bromide, double trapping at the α-position was observed to give disubstituted 
sulfoximine 17. This is presumably due to the ability of unreacted lithiated sulfoximine 
to deprotonate at the α-position of the trapped sulfoximine which will enable another 
trapping reaction. The double alkylation was minimised via either fast addition of an 
excess of the electrophile to the lithiated sulfoximine or slow transfer of the lithiated 
sulfoximine to the electrophile. The chosen method was not reported, but a 67% yield of 
N-H sulfoximine 16 was obtained over two steps, after removal of the N-TMS group using 
NH4Cl/MeOH (Scheme 1.5).
25 
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Scheme 1.5 
The lithiation-trapping of sulfoximines with carbonyl-containing compounds as 
electrophiles has also been investigated. A range of examples using ketones, aldehydes, 
CO2, esters, acid chlorides and Weinreb amides have been reported. For example, 
lithiation of N-Me sulfoximine 3 was carried out using n-BuLi in THF at −78 °C. 
Subsequent trapping with cycloalkanones of various ring sizes gave 83-97% yields of the 
corresponding alcohols (Scheme 1.6).26 In related work, N-Me sulfoximine 3 was 
deprotonated using n-BuLi at −5 °C and then an acyclic ketone was added at −78 °C. This 
gave sulfoximine 18 in good yield (80%) but, unfortunately, the diastereoselectivity was 
not commented on in this study (Scheme 1.6).27 
 
Scheme 1.6 
Lithiation of N-TBDPS sulfoximine 19 and trapping with i-PrCHO gave a 93:7 mixture 
of diastereomeric alcohols syn-20 and anti-20 in 74% yield (Scheme 1.7).28 Trapping with 
linear or aryl aldehydes provided similar diastereoselectivity to branched aldehydes. 
Furthermore, the use of sterically smaller N-silyl substituents led to lower 
diastereoselectivity.29 Lithiation of the corresponding N-Ts sulfoximine 6 and trapping 
with i-PrCHO gave an 87:13 mixture of diastereomeric alcohols 21 in 70% yield although 
the relative stereochemistry was not assigned.30 
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Scheme 1.7 
To rationalise the preferred formation of syn-alcohols such as syn-20 from the lithiation 
of N-TBDPS sulfoximine 19 and trapping with aldehydes, two chair-like transition states 
were proposed (Figure 1.6). In each one, the sulfoximine and aldehyde oxygens would be 
chelated to the lithium. When the aldehyde substituent is pseudo-axial, severe 1,3-diaxial-
like interactions with the bulky N-TBDPS group would occur. Hence, the major products 
would arise from the transition state with the more favourable pseudo-equatorial 
orientation.28 No explanation for the diastereoselectivity of the lithiation-trappings of N-
Ts sulfoximine 6 with aldehydes was provided although it is conceivable that it proceeds 
via a similar transition state. 
 
Figure 1.6 Transition states for trapping a lithiated sulfoximine with aldehydes 
Esters and chloroformates have also been used as electrophiles in related lithiation-
trappings. One example is the lithiation of N-Me sulfoximine 3 using LDA and 
subsequent trapping with ethyl isobutyrate, followed by heating at reflux for 12-35 h to 
give ketone 22 in 69% (Scheme 1.8).31 In a related example, the lithiation-trapping of N-
benzoyl sulfoximine 23 was performed with ethyl chloroformate enabling the installation 
of an ester functionality. This was carried out using LiTMP (generated from n-BuLi and 
tetramethylpiperidine) for the lithiation and subsequent trapping gave ester 24 in a high 
yield (89%) (Scheme 1.8).32 In both examples, two equivalents of base were employed 
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presumably due to the acidity of the α-proton present in both the ketone and ester 
products. 
 
Scheme 1.8 
Weinreb amides can also be used as electrophiles to install a ketone functionality into the 
product of the lithiation-trapping process. For example, lithiation of N-TBDPS 
sulfoximine 19 and trapping with Weinreb amide 25 gave ketone 26 in 84% yield 
(Scheme 1.9). The ketone product results from a nucleophilic addition to the carbonyl 
functionality. A substitution reaction displacing the bromide could also be expected to 
give the α-alkylated product, but this was not observed.33 
 
Scheme 1.9 
Carboxylic acids can also be accessed via lithiation-trapping reactions with gaseous CO2. 
For example, N-tolyl sulfoximine 27 underwent lithiation and trapping with CO2 to give 
carboxylic acid 28 in 79% yield (Scheme 1.10). Changing the phenyl substituent to a 
mesitylene or pyridyl substituent gave respective yields of 42% and 61%.34 Epoxides can 
also be used as electrophiles. Hwang reported the lithiation of N-TMS sulfoximine 15 
using n-BuLi and trapping with gaseous ethylene oxide to give alcohol 29 in 75% yield 
(Scheme 1.10).22 
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Scheme 1.10 
It is also possible to install an enone functionality into the lithiation-trapping product. For 
example, the lithiation of N-Ts sulfoximine 6 and trapping with β-sulfonyl-enone 30 gave 
enone 31 in 83% yield (Scheme 1.11).35 Presumably, conjugate addition of the lithiated 
sulfoximine to the Michael acceptor takes place to give intermediate 32, followed by 
elimination of the benzenesulfinate group. 
 
Scheme 1.11 
Lithiation-trapping can also lead to diastereomeric products if the starting sulfoximine 
has a CH2R substituent. For example, lithiation of N-Ts sulfoximines 33, 34 and 35 and 
subsequent trapping with enones 36 and 37 gave Michael adducts 38-42 as reported by 
Pyne (Table 1.1). Lithiation of allylic sulfoximine 33 and trapping with enone 36 gave a 
93:7 mixture of diastereomeric ketones syn,anti-38 and 38 of unidentified 
stereochemistry in 90% yield (Entry 1). Similarly, trapping with enone 37 provided a 94:6 
mixture in 69% yield (Entry 2). X-ray crystallography was used to determine the structure 
of the major diastereomeric ketone syn,anti-38, but that of the minor product was not 
reported. Lithiation of alkyl sulfoximine 34 and trapping with enone 36 gave a 98:2 
mixture of diastereomeric ketones syn,anti-40 and 40 in 68% yield (Entry 3). Similarly, 
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trapping with enone 37 gave a 96:4 mixture of syn,anti-41 and 41 in 62% yield (Entry 4). 
Benzylic sulfoximine 35 yielded a 99:1 mixture of diastereomeric ketones syn,anti-42 
and 42 in 72% yield after lithiation and trapping with enone 36 (Entry 5). Preferential 
lithiation was observed at the benzylic position due to the increased stability of the 
resulting carbanion via delocalisation into the phenyl group. X-ray diffraction was also 
used to assign the relative stereochemistry of the major diastereomeric ketones syn,anti-
40 and syn,anti-42.13 
Table 1.1 Lithiation-trapping of N-Ts sulfoximines 33, 34 and 35 with various enones  
 
Entry R1 R2 Starting 
material 
R3 R4 Electrophile dr Product/% 
1 Ph CH=CH2 33 Ph Ph 36 93:7 38, 90 
2 Ph CH=CH2 33 Me Ph 37 94:6 39, 69 
3 Ph n-Pr 34 Ph Ph 36 98:2 40, 68 
4 Ph n-Pr 34 Me Ph 37 96:4 41, 62 
5 Me Ph 35 Ph Ph 36 99:1 42, 72 
 
To explain the observed syn,anti-stereochemistry of the major product, a transition state 
structure was proposed (Figure 1.7). The transition state describes the orientation of the 
R2 and bulky Ts substituents of the lithiated sulfoximine as anti. The approach of the 
electrophile then takes place from the top face of the lithiated sulfoximine, and subsequent 
chelation of the sulfoximine nitrogen and oxygen atoms as well as the enone oxygen by 
lithium occurs. R4 and the sulfonimidoyl are depicted in an anti-orientation to minimise 
steric hindrance.  
Chapter One: Introduction 
 
13 
 
 
Figure 1.7 Proposed transition state for the lithiation-trapping of N-Ts sulfoximines 33, 
34 and 35 with enones 36 and 37 
Pyne also described the addition of both ketones and imines to lithiated N-TBDPS 
sulfoximines to yield the corresponding alcohol and amine products.36,37 For example, N-
TBDPS sulfoximine 43 was lithiated and trapped with benzaldehyde giving a 48:26:10:16 
mixture of diastereomeric alcohols syn,syn-44, anti,anti-44, anti,syn-44 and syn,anti-44 
in a 95% yield (Scheme 1.12). When benzaldehyde was precomplexed with boron 
trifluoride-diethyl ether prior to its addition to the lithiated sulfoximine, better 
diastereoselectivity (67:28:1:4 dr) was obtained. Trapping with imine 45 gave a 60% 
yield of a 79:21 mixture of diastereomeric amines syn,anti-46 and 46. Precomplexing the 
imine with boron trifluoride-diethyl ether provided a higher diastereoselectivity (95:5) 
and high yield (86%). Lithiation-trappings of the analogous N-TBDMS sulfoximines 
were shown to give lower diastereoselectivity. 
 
Scheme 1.12 
The observed stereochemistry for the major diastereomeric alcohol syn,syn-44 was 
explained by the transition state model shown in Figure 1.8. The benzylic position was 
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depicted as close to planar, and the phenyl substituent was shown as anti to the bulky 
TBDPS group. The aldehyde would then add to the top face to minimise steric hindrance 
in which the aldehyde substituent is orientated anti to the phenyl substituent. It was 
speculated that the minor diastereomeric alcohols anti,syn-44 and syn,anti-44 could arise 
from a chelated chair transition state. The yield of these diastereomers decreased when 
benzaldehyde was precomplexed with boron trifluoride-diethyl ether, supporting this 
theory. A similar transition state was proposed for the formation of major diastereomeric 
amine syn,anti-46, where the approach of imine 45 was dictated by unfavourable 
interactions between the N-Ph and sulfoximine Ph substituents. An alternative model for 
amine syn,anti-46 was presented by Pyne in the literature initially,36 however this was 
updated later in a review.37 This thesis discusses the model and subsequent 
stereochemistry reported in the review. The resulting stereochemistry of alcohol syn,syn-
44 and amine syn,anti-46 differed at the β-position. However, the stereochemistry at the 
α-position was consistent with that obtained for major diastereomeric N-Ts sulfoximines 
syn,syn-38-42 in a related example (see Table 1.1). 
 
Figure 1.8 Proposed transition states for the addition of benzaldehyde and imine 45 to 
the lithiated N-TBDPS sulfoximine 
Zhang investigated the lithiation of N-Ts α-fluoro sulfoximine 47 and subsequent trapping 
with MeI which formed a single diastereomeric sulfoximine 48 (Scheme 1.13).38 The 
fluorination of N-Ts sulfoximine 49 was also carried out via lithiation-trapping with NFSI 
to give fluorinated sulfoximine 48 in 69% but, unfortunately, the diastereoselectivity was 
not reported in this case.39 
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Scheme 1.13 
In a related example, the lithiation-trapping of N-Ts sulfoximine 50 with MeI gave a 
mixture of diastereomeric alcohols 51 in 55% yield (Scheme 1.14). Two equivalents of 
n-BuLi were required due to the presence of the hydroxyl group. Unfortunately, no 
explanation of the diastereoselectivity or assignment of stereochemistry was provided.35 
Gais and Mahajan carried out the lithiation-trapping of N-Me sulfoximine 52 with allyl 
bromide to give the α-functionalised product as a 77:23 mixture of diastereomeric 
sulfoximines 53 in 80% yield. Similarly, no comment was made regarding the 
stereochemistry in this example.40 
 
Scheme 1.14 
In a similar example, N-Me sulfoximine 54 was lithiated and trapped with MeI which 
gave an 83:17 mixture of diastereomeric sulfoximines syn,syn,anti,anti-55 and 
anti,anti,anti,anti-55 (Scheme 1.15). Two equivalents of n-BuLi were employed to ensure 
the production of the dilithiated sulfoximine. Purification afforded syn,syn,anti,anti-55 in 
75% yield and a mixture of anti,anti,anti,anti-55 and starting material 54.41 
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Scheme 1.15 
The stereochemistry of syn,syn,anti,anti-55 was assigned by X-ray crystallography. By 
analysis of the 1H NMR spectrum and NOE experiments, it was determined that the 
adopted structure of the lithiated sulfoximine in solution was similar to that in the solid-
state. Therefore, to explain the stereochemical outcome, a transition state structure was 
proposed where the phenyl sulfoximine substituent adopted a pseudoaxial orientation 
(Figure 1.9). The diastereoselectivity is thought to arise from the sterically demanding i-
Pr substituent encouraging a preferential electrophilic attack from the opposing face. 
 
Figure 1.9 Proposed transition state for the lithiation-trapping of N-Me sulfoximine 54 
Lithiation of N-Me sulfoximine 56 and trapping with tosylate 57 gave sulfoximine 58 in 
68% yield and a high dr (>98%) (Scheme 1.16). Trapping of the same lithiated 
sulfoximine with ditosylate 59 gave cyclised sulfoximine 60 in 75% and >98% dr. An 
excess of n-BuLi was presumably employed due to the acidic NH proton within the 
starting sulfoximine and the high diastereoselectivity was controlled by the bulky α-
substituent within this starting sulfoximine.42 
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Scheme 1.16 
To summarise, the lithiation-trapping reactions of a range of acyclic sulfoximines have 
been well explored and established, with the examples described in this chapter 
employing a range of substrates, electrophiles and N-substituents. Some 
diastereoselective lithiation-trappings have been carried out and, in many of these 
examples, the starting sulfoximine contains at least one additional stereogenic centre, 
which will no doubt influence the diastereoselectivity. Zhang and Pyne have reported 
three highly diastereoselective reactions (see Table 1.1 and Scheme 1.12), but only a few 
electrophiles and substrates were employed. In addition, Pyne has proposed different 
transition state models to explain the diastereoselectivity of these reactions (see Figures 
1.7 and 1.8). 
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  α-Functionalisation of Sulfoximines by Lithiation-Trapping – 
Previous Work within the Group 
Previous work on the α-functionalisation of N-functionalised sulfoximines via lithiation-
trapping has been performed in our group43 and has inspired many of the project aims 
detailed in this thesis. The 5-membered and 6-membered cyclic sulfoximines were chosen 
due to limited associated research. N-TBDPS sulfoximines were selected due to their 
frequency in similar studies,23,24,28,36,37 but other N-functionalised sulfoximines were 
investigated including those containing N-Boc, N-CN and N-Me groups.  
It was found that N-TBPDS functionalised 5- and 6-membered cyclic sulfoximines 61 
and 62 exhibited high yields and diastereoselectivity from lithiation-trappings with a 
range of electrophiles. Two examples, each trapping with benzophenone, are shown in 
Scheme 1.17. n-BuLi was used to deprotonate sulfoximines 61 and 62 in THF at −78 °C 
for 20 min. Then, benzophenone was added and reacted for 1 h to yield the α-
functionalised sulfoximines cis-63 (66%) and cis-64 (59%) (Scheme 1.17). These 
experimental conditions used were adapted from various literature procedures23,33,36 and 
were employed for most lithiation-trappings of sulfoximines within the group.  
 
Scheme 1.17 
The associated stereochemistry of cis-63 and cis-64 was assigned using X-ray 
crystallography, where the new α-substituent was shown to be cis to the sulfoximine 
oxygen. The proposed model for the high diastereoselectivity is shown in Figure 1.10. It 
is believed that the bulky TBDPS group blocks one face from electrophilic attack of the 
sp2 hybridised carbanion and, as a result, the newly formed α-substituent forms cis to the 
sulfoximine oxygen atom. 
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Figure 1.10 Proposed model for electrophilic trapping of cyclic sulfoximines 
Lithiation-trapping of 5-membered sulfoximine 61 with benzyl bromide gave benzyl 
sulfoximine cis-65 in 65% yield and disubstituted sulfoximine cis,cis-66 in 13% yield.44 
The analogous reaction with 6-membered sulfoximine 62 provided cis-67 in only 31% 
yield. This was because a significant amount (33%) of double-trapped sulfoximine 
cis,cis-68 was formed (Scheme 1.18). 
 
Scheme 1.18 
These double-trapped products are proposed to be a result of the slow trapping process 
with alkyl halides, therefore allowing a second deprotonation and trapping. An example 
of the proposed mechanism is shown in Scheme 1.19 for the lithiation-trapping of 
sulfoximine 62. It is thought that initially the reaction proceeds as expected to give mono-
trapped sulfoximine cis-67. Sulfoximine cis-67 can then be deprotonated at the other, less 
sterically hindered, α-position by residual lithiated sulfoximine 69. Finally, lithiated 
monosubstituted sulfoximine cis-70 can react with another molecule of benzyl bromide 
to yield disubstituted sulfoximine cis,cis-68. A similar effect was reported by Füger and 
Bolm (see Scheme 1.5), where disubstitution took place at the α-position with an alkenyl 
bromide.25 
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Scheme 1.19 
Benzaldehyde was employed as the electrophile in some examples. For example, 
lithiation-trapping of 5-membered N-TBDPS sulfoximine 61 gave full stereocontrol at 
the α-position and an 85:15 dr corresponding to the β-position (Scheme 1.20). Both 
diastereomeric alcohols were separated in good yields (66% for cis,anti-71 and 10% for 
cis,syn-71). Lithiation-trapping of 6-membered N-TBDPS sulfoximine 62 gave cis,anti-
72 and cis,syn-72 (isolated as an 85:15 mixture in 73% yield).  
 
Scheme 1.20 
Weinreb amides were used as the electrophile to install a ketone functionality. Examples 
included the lithiation-trappings of N-TBDPS sulfoximines 61 and 62 with Weinreb 
amide 73 to give the corresponding diastereomeric ketones 74 and 75, both in a 75:25 dr 
(Scheme 1.21). The low diastereoselectivity was unexpected and repeats of the reaction 
with 5-membered sulfoximine 61 gave varying diastereomeric ratios (55:45 dr and 65:35 
dr). This was rationalised by proposing that during the work-up and/or the 
chromatographic purification, epimerisation occurred via enolisation due to the acidity of 
the α-proton in the ketone products.  
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Scheme 1.21 
In some cases, it was shown that further functionalisation of the lithiation-trapping 
products could be carried out on the less sterically hindered α-position to afford 
disubstituted sulfoximines. For example, lithiation of α-methyl functionalised 
sulfoximines cis-76 and cis-77 and trapping with benzophenone gave disubstituted 
sulfoximines cis,cis-78 and cis,cis-79 in yields of 71% and 81% (Scheme 1.22). 
 
Scheme 1.22 
As part of the study, some other N-functionalised sulfoximines were investigated 
including those with N-Boc, N-Me and N-CN groups attached. The results with N-Me and 
N-CN sulfoximines were less successful. Some examples of lithiation-trappings of cyclic 
N-Boc sulfoximines 80 and 81 are summarised in Table 1.2. Lithiation of N-Boc 
sulfoximines 80 and 81, followed by trapping with benzophenone gave single 
diastereomeric alcohols cis-82 and cis-83 respectively (isolated in 71% and 75% yields) 
(Entries 1 and 2). Lithiation-trappings with benzyl bromide gave 85:15 and 65:35 
mixtures of diastereomeric alcohols cis-84 and trans-84 (isolated in 85% yield) and 85a 
and 85b (isolated in 45% yield) (Entries 3 and 4). This diastereoselectivity with benzyl 
bromide was lower than that observed for analogous N-TBDPS sulfoximines cis-65 and 
cis-67 (≥95:5).  
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Table 1.2 Synthesis of α-functionalised N-Boc sulfoximines 
 
Entry n Starting material Electrophile dr Product/% 
1 1 80 Ph2CO ≥95:5 cis-82, 71 
2 2 81 Ph2CO ≥95:5 cis-83, 75 
3 1 80 Benzyl bromide 85:15 cis-84, trans-84, 85a 
4 2 81 Benzyl bromide 75:25 85a, 85b, 45b 
a Isolated as an 85:15 mixture of cis-84 and trans-84. b Isolated as a 75:25 mixture of 
diastereomers. 
Two N-TBDPS acyclic sulfoximines (86 and 87) were also lithiated and trapped with 
benzophenone to give alcohols 88 and 89 in 73% and 70% yields respectively (Scheme 
1.23). Lithiation-trapping of N-TBDPS diethyl sulfoximine 86 gave a single 
diastereomer, whereas N-TBDPS phenyl ethyl sulfoximine 87 gave an 85:15 dr, although 
the minor diastereomer was not isolated during column chromatography. The 
stereochemistry of these products was not determined.  
 
Scheme 1.23 
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  Project Outline 
Over recent years, sulfoximines have received increased attention as potential medicinal 
and pesticidal compounds. Therefore, it is important to develop effective and selective 
methodology for the installation of the sulfoximine unit and its subsequent 
functionalisation. Novel methodology for the diastereoselective α-functionalisation via 
lithiation-trapping of some cyclic sulfoximines has been developed previously within our 
group.43 It was planned that this project would focus on the diastereoselective lithiation-
trappings of acyclic sulfoximines 90, to give the corresponding α-substituted products 91, 
via reactions that have received limited attention previously. It was decided that a range 
of acyclic sulfoximines and electrophiles would be used and their effect on the yield and 
diastereoselectivity would be investigated (Scheme 1.24). Previous work within the group 
had shown that N-TBDPS cyclic sulfoximines provided high diastereoselectivity, and, 
therefore, N-TBDPS acyclic sulfoximines would be the main focus of this work. It was 
also planned that some other nitrogen substituents would be investigated including N-
TBDMS and N-Boc groups. The results of these investigations are presented in Chapters 
2.1 and 2.2.  
 
Scheme 1.24 
It was thought that some of the α-functionalised sulfoximines 91 could provide a scaffold 
for the synthesis of some tetrasubstituted sulfoximines. Therefore, we planned to further 
functionalise α-functionalised sulfoximines 92 to give tetrasubstituted products 93 using 
similar lithiation-trapping conditions (Scheme 1.25). This would be carried out with a 
range of electrophiles to investigate the yield and diastereoselectivity. The results of these 
studies are presented in Chapter 2.3.  
 
Scheme 1.25
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2. Results and Discussion 
  Synthesis of Sulfoximines 
To enable the planned lithiation-trapping investigations, it was necessary to synthesise 
several acyclic sulfoximines. The majority of examples contained the N-TBDPS group 
but one N-Boc and N-TBDMS example were also included. For these syntheses, based 
on the route used previously in the group for the synthesis of cyclic sulfoximines, a two-
step approach was chosen (Scheme 2.1). The first of these two steps, as reported Luisi, 
Bull and co-workers,45,46 is a one-pot synthesis of NH sulfoximines 95 from the 
corresponding sulfides 94. Following this, the desired nitrogen protecting group would 
be installed. 
 
Scheme 2.1 
In 2017, Luisi, Bull and co-workers reported a convenient method for the synthesis of 
NH sulfoximines from sulfides.46 This methodology presents much milder experimental 
conditions and better safety aspects, by avoiding metal-containing or explosive reagents, 
e.g. azides, than the previous methods.47-49 The conditions utilise PIDA (2.5 eq.) as the 
oxidising agent and ammonium carbamate (2.0 eq.) as the source of ammonia. Three 
representative examples are shown in Scheme 2.2. Methanol was found to be a better 
solvent than toluene and acetonitrile, giving the shortest reaction time (3 h) whilst also 
maintaining good yields. Subsequently, Reboul et al. carried out mechanistic studies on 
this reaction and they proposed several mechanistic pathways proceeding via an 
iodonitrene species.50 
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Scheme 2.2 
As a starting point, the synthesis of N-TBDPS diethyl sulfoximine 86 was performed 
using this two-step approach. Treatment of diethyl sulfide 96 with PIDA (2.5 eq.) and 
ammonium carbamate (2.0 eq.) in methanol at rt for 3 h gave NH sulfoximine 97 in 92% 
yield after purification (Scheme 2.3). 1H NMR spectroscopy showed the expected signals 
of the ethyl substituents alongside a 1H broad singlet at δH 2.42 indicating the presence 
of the newly formed NH group. NH sulfoximine 97 was reported in the literature and the 
data obtained matched the NMR spectroscopic data reported.51 Using a literature 
procedure,52 subsequent treatment with TBDPSCl (1.25 eq.) and imidazole (2.0 eq.) in 
DMF initially at 0 °C and then at 90 °C for 48 h, followed by column chromatography, 
gave N-TBDPS sulfoximine 86 in 80% yield (Scheme 2.3). The incorporation of the 
TBDPS group was confirmed by 1H NMR spectroscopy, in which a 9H singlet was 
observed at δH 1.07. 
 
Scheme 2.3 
A series of N-TBDPS sulfoximines were then produced using this methodology (Scheme 
2.4, yields reported for each step). The range of examples illustrates the broad scope of 
this methodology, where different alkyl and aryl containing substrates are tolerated. For 
the TBDPS protection, the literature method reports the addition of TBDPSCl to the 
reaction mixture at 0 °C and sulfoximines 87, 19, 104 and 105 were synthesised using 
these conditions. To investigate whether the cooling step was required, the synthesis of 
sulfoximines 104 and 105 was repeated with the addition of all reagents at rt, giving 
higher yields (91% and 76%) than previously (46% and 73% respectively). N-TBDPS 
sulfoximines 106 and 107 were therefore synthesised using these modified conditions.  
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Scheme 2.4 
The yields in Scheme 2.4 were variable and substrate-dependent. For some sulfoximines, 
low yields arose due to difficult separation of the product from either TBDPSCl or 
TBDPSOH. To try to combat this, TBDPSCl was used as the limiting reagent (0.9 eq.) 
and, as previously discussed, added to the reaction mixture at rt, in the synthesis of N-
TBDPS sulfoximines 110 and 43 (Scheme 2.5). However, this did not significantly 
improve the purification in these cases and unreacted TBSPSCl or TBDPSOH was still 
observed in the 1H NMR spectra of the crude products.  
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Scheme 2.5 
NH sulfoximines 98, 99, 101 and 109 were known and the NMR spectroscopic data 
matched those reported in the literature.50,53 1H and 13C NMR spectroscopic data of N-
TBDPS sulfoximine 19 were also consistent to those reported in the literature.54 N-
TBDPS sulfoximine 43 was synthesised by Pyne, but no spectroscopic data was 
provided.37 All of the other NH and N-TBDPS sulfoximines had not been reported 
previously (see Schemes 2.4 and 2.5).  
For sulfoximines 106, 107 and 110, the sulfides required to synthesise the desired N-
TBDPS sulfoximines were not commercially available and, therefore, they were prepared 
from their corresponding thiols. Sulfides 113 and 114 were synthesised using a literature 
procedure employing KOH, ethyl bromide and Aliquat 336® as a phase transfer catalyst. 
High yields were obtained (Scheme 2.6).55 For sulfide 113, the 1H and 13C NMR 
spectroscopic data were reported in the literature56 and for sulfide 114, the 1H NMR data 
was provided.57 In both cases, the obtained spectroscopic data was consistent to the 
literature data. Sulfide 116 was prepared using a similar approach from the literature.58 t-
Butyl thiol 115 was treated with KOH and benzyl bromide followed by heating at reflux 
for 16 h to give sulfide 116 in 99% yield (Scheme 2.6). The 1H NMR spectroscopic data 
of sulfide 116 matched that reported in the literature.58,59  
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Scheme 2.6 
In some cases, the required sulfide was not commercially available and the best approach 
was to synthesise the desired starting sulfoximine via functionalisation of an existing N-
TBDPS sulfoximine using lithiation-trapping. This was performed for the synthesis of 
sulfoximines 117, 118 and 119. Sulfoximines 19 and 105 were initially treated with n-
BuLi (1.1 eq.) in THF at −78 °C followed by the addition of either methyl iodide or benzyl 
bromide and stirred for 1 h. This delivered yields of 82–93% (Scheme 2.7). 
 
Scheme 2.7 
Previous results within the group suggested that the TBDPS group offers good control on 
the diastereomeric outcome. However, compounds with two other protecting groups (N-
Boc and N-TBDMS) were also synthesised for comparison. Sulfoximine 97 was treated 
with KOtBu and then Boc2O, using a literature procedure,
60 to give N-Boc sulfoximine 
120 in low yield (14%) (Scheme 2.8). A repeat provided a consistently low yield (12%) 
indicating that further optimisation is necessary.  
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Scheme 2.8 
A TBDMS group was installed onto sulfoximine 98 in an attempt to improve the yields 
obtained when synthesising N-TBDPS sulfoximines from some aromatic sulfides. Two 
reactions were employed from the literature for acyclic sulfoximines.24,61 Reaction of NH 
sulfoximine 98 with TBDMSCl in pyridine or in DMF with added imidazole, both at rt 
for 12 h, gave N-TBDMS sulfoximine 121 in the same high (87%) yield (Scheme 2.9). 
These yields improved on the analogous reactions for N-TBDPS installation (see Scheme 
2.4) and required milder reaction conditions and shorter reaction times.  
 
Scheme 2.9 
To summarise, a range of NH sulfoximines were synthesised from their corresponding 
sulfides using a convenient one-pot procedure. A series of N-functionalised sulfoximines 
were then prepared with N-TBDPS, N-TBDMS and N-Boc groups. When the desired 
sulfide was commercially unavailable, the corresponding thiol was employed in its 
synthesis, or alternatively, the N-TBDPS sulfoximine was functionalised at the α-position 
via lithiation-trapping with n-BuLi and an electrophile. 
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  Lithiation-Trapping of Sulfoximines 
Following the synthesis of a range of acyclic N-TBDPS sulfoximines and some examples 
of N-TBDMS and N-Boc sulfoximines, a variety of lithiation-trapping reactions were then 
carried out to yield the α-functionalised products. A range of electrophiles would be 
explored for these lithiation-trapping reactions and the impact on the associated yields 
and diastereoselectivity would be investigated. 
2.2.1 Lithiation and Trapping of Sulfoximines with Carbonyl-Containing 
Electrophiles 
Initially, the lithiation-trapping of N-TBDPS diethyl sulfoximine 86 was explored using 
benzophenone as the electrophile, as this had previously been performed within the group. 
The selected methodology was therefore carried out as per the previous work in the group 
(see Chapter 1.3). N-TBDPS diethyl sulfoximine 86 was initially treated with n-BuLi in 
THF at ‒78 °C for 20 min, and then trapped with benzophenone to give α-functionalised 
N-TBDPS sulfoximine anti-88 in a high yield (71%) following purification by column 
chromatography (Scheme 2.10). The result agrees with previous work,43 where anti-88 
was obtained in a similar yield (73%) (see Scheme 1.23). 
 
Scheme 2.10 
The 1H NMR spectra of both the crude and purified product demonstrated that only one 
diastereomer was produced since only one set of signals was observed. The 1H signal at 
δH 4.20 (q, J = 7.0 Hz) was assigned to the α-proton next to the newly installed alcohol 
unit and exhibited a much higher chemical shift than the two diastereotopic α-protons at 
δH 2.19 (dq, J = 14.0, 7.0 Hz) and δH 1.69 (dq, J = 14.0, 7.0 Hz) (Figure 2.1). The 1H 
singlet at 6.31 was assigned to the OH environment. These spectra and subsequent 
analysis were consistent with those obtained from the previous work in the group.43 The 
stereochemistry of N-TBDPS sulfoximine anti-88 was assigned by an independent 
synthesis from a compound of known stereochemistry (vide infra). 
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Figure 2.1 1H NMR spectroscopic data for N-TBDPS diethyl sulfoximine 88 
Due to this high observed diastereoselectivity and yield, other N-TBDPS acyclic 
sulfoximines were investigated to explore the scope of this methodology (Table 2.1). 
Lithiation of t-Bu-substituted sulfoximines 118 and 119 and trapping with benzophenone 
provided single diastereomeric alcohols anti-122 and anti-123 in 92% and 87% yields 
respectively (Entries 1 and 2). A similar outcome was obtained with adamantyl ethyl 
sulfoximine 107 which gave alcohol anti-124 in 76% yield (Entry 3). Phenyl-substituted 
sulfoximines 87 and 117 and i-Pr-substituted sulfoximine 104 all gave a crude product 
which contained an 85:15 mixture of anti and syn-alcohols (Entries 4-6). The major 
phenyl-substituted sulfoximine anti-89 was isolated in 58% yield and the minor product 
was not isolated, whereas anti-125 and syn-125 were isolated in 91% yield as an 85:15 
mixture (Entries 4 and 5). The major and minor i-Pr-substituted sulfoximines anti-126 
and syn-126 were isolated in 80% and 3% yields respectively (Entry 6). A 65:35 mixture 
of diastereomeric alcohols anti-127 and syn-127 (isolated in 64% and 20% as an 80:20 
mixture of benzophenone and syn-127) were obtained from the analogous reaction of o-
tolyl-substituted sulfoximine 106 (Entry 7). Both syn-126 and syn-127 were isolated in 
low yields as they were difficult to separate from 1,1-diphenylmethanol (a side-product 
from lithiation-trappings with benzophenone). 
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Table 2.1 Lithiation-trapping of different sulfoximines with benzophenone 
 
Entry R1 R2 Starting 
material 
anti:syna Major (%)b Minor (%)b 
1 t-Bu Me 118 >98:2 anti-122, 92 - 
2 t-Bu Bn 119 >98:2 anti-123, 87 - 
3 Ad Me 107 >98:2 anti-124, 76c - 
4 Ph Me 87 85:15 anti-89, 58 syn-89d 
5 Ph Bn 117 85:15 anti-125, 77e syn-125, 14e 
6 i-Pr Me 104 85:15 anti-126, 80 syn-126, 3f 
7 o-tol Me 106 65:35 anti-127, 64 syn-127, 20f,g 
a Ratio determined by 1H NMR spectroscopy of the crude product. b Yield after 
purification by chromatography. c Isolated as an inseparable 95:5 mixture of anti-124 and 
starting sulfoximine 107. d The minor diastereomer was not isolated. e Isolated as an 
inseparable 85:15 mixture (by 1H NMR spectroscopy). f Yield after two purifications by 
chromatography. g Isolated as an inseparable 80:20 mixture of benzophenone and syn-
127 (by 1H NMR spectroscopy). 
For these lithiation-trapping results, the 1H NMR spectra of the crude products were used 
to determine the ratio of diastereomeric alcohols. In particular, the signal corresponding 
to the α-CH environment adjacent to the newly formed α-substituent was the most useful. 
In the case of isolated alcohols anti-127 and syn-127, broad singlets were observed for 
the α-CH and α-methyl positions. We suspected that this was due to slow rotation around 
the S-Ar bond resulting in atropisomers. Upon changing the solvent from CDCl3 to d6-
DMSO for anti-127, a 1H NMR spectrum was obtained which presented signals δH 4.70 
(q, J = 7.0 Hz) and δH 1.44 (d, J = 7.0 Hz) for the SCH and SCHMe environments 
respectively. For syn-127, changing the solvent to d6-DMSO and additionally heating to 
80 °C gave signals at δH 4.90 (q, J = 7.0 Hz) and δH 1.43 (d, J = 7.0 Hz) for the SCH and 
SCHMe protons. 
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The stereochemistry of t-Bu-substituted alcohol anti-123 was determined using X-ray 
crystallography (Figure 2.2). Due to the proximity of the sulfoximine oxygen atom and 
the hydroxyl group, it is likely that a 6-membered ring hydrogen bonding interaction is 
present. The stereochemistry of i-Pr alcohol anti-126 was also assigned using X-ray 
crystallography (Figure 2.2). Similarly, a hydrogen bond interaction is indicated by the 
positions of the sulfoximine oxygen and the OH substituent. Both X-ray structures show 
that the major products had anti configuration. Therefore, each of the major 
diastereomeric alcohols resulting from lithiation and trapping with benzophenone shown 
in Table 2.1 was assigned as anti by analogy. Furthermore, this assigned stereochemistry 
is consistent with that of alcohol anti-88 generated from the lithiation-trapping of diethyl 
sulfoximine 86 with benzophenone. 
 
 
Figure 2.2 X-ray crystal structures of N-TBDPS sulfoximines anti-123 and anti-126 
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To explore the effects of other N-functionalised sulfoximines, N-Boc sulfoximine 120 
was also lithiated and trapped with benzophenone. This gave a 55:45 mixture of 
diastereomeric alcohols anti-128 and syn-128 (isolated in 44% and 24% yields 
respectively) (Scheme 2.11). The diastereoselectivity of this reaction was significantly 
lower than the analogous reaction of N-TBDPS sulfoximine 86 (see Scheme 2.10). 
Alcohols anti-128 and syn-128 showed α-CH signals at δH 4.66 (q, J = 7.5 Hz) and δH 
4.34 (q, J = 7.5 Hz) respectively. In this case, crystals of the minor diastereomeric alcohol 
syn-128 were grown and the structure was identified by X-ray crystallography (Figure 
2.3). 
 
Scheme 2.11 
 
Figure 2.3 X-ray crystal structure of N-Boc sulfoximine syn-128 
With N-Boc sulfoximine anti-128 of known stereochemistry in hand, we converted it into 
the corresponding N-TBDPS sulfoximine using a method from previous work in the 
group.43 This would allow us to assign the stereochemistry of N-TBDPS sulfoximine anti-
88. Thus, the Boc group in N-Boc sulfoximine anti-128 was removed using TFA in 
CH2Cl2 (rt, 24 h). This produced the NH sulfoximine anti-129 in 30% yield (Scheme 
2.12). Subsequent treatment with TBDPSCl and imidazole under the standard TBDPS 
protection conditions gave traces of the corresponding N-TBDPS sulfoximine anti-88. 
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Due to the small scale, and anti-88 being isolated with an unknown by-product, the yield 
was not calculated. However, all key 1H NMR spectroscopic signals required for 
comparison were present and identified, allowing the stereochemistry to be assigned. 
 
Scheme 2.12 
As the TBDMS installation was shown to be easier than with TBDPS (see Scheme 2.9), 
the lithiation-trapping of an N-TBDMS sulfoximine was explored. N-TBDMS 
sulfoximine 121 was lithiated and trapped with benzophenone to give an 80:20 mixture 
of diastereomeric alcohols anti-130 and syn-130 (isolated in yields of 66% and 17% 
respectively) (Scheme 2.13). The 1H NMR spectrum of the crude product showed two 
overlapping signals at δH 4.31 (q, J = 7.5 Hz) and δH 4.24 (q, J = 7.5 Hz) for the α-CH 
environment of each diastereomeric alcohol. The resulting diastereoselectivity was 
slightly lower than that of the analogous lithiation-trapping of N-TBDPS sulfoximine 87, 
where an 85:15 dr of diastereomeric alcohols 89 was obtained.  
 
Scheme 2.13 
It was hoped that removal of the TBDMS substituent would generate a solid from which 
crystals could be grown, and the stereochemistry could be assigned. Using a procedure 
previously performed within the group, N-TBDMS sulfoximine anti-130 was treated with 
TBAF in THF (48 h, rt)43 (Scheme 2.14). However, the desired NH sulfoximine anti-131 
was not formed and, instead, a 91% yield of NH sulfoximine 98 was isolated. It is believed 
that the NH sulfoximine originates from a mechanism which we have termed as a ‘retro-
aldol’-type. After deprotection of the TBDMS group, anti-132 can rearrange to produce 
the NH sulfoximine 98 and benzophenone (Scheme 2.14). As this approach was 
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unsuccessful, the stereochemistry of both diastereomeric alcohols anti-130 and syn-130 
was assigned by analogy with the N-TBDPS examples. 
 
Scheme 2.14 
Due to the high yields and diastereoselectivity observed for the lithiation-trappings with 
N-TBDPS sulfoximines, other electrophiles were explored. Acetone was selected as an 
alternative symmetrical ketone and lithiation-trapping was performed for several selected 
substrates (Scheme 2.15). t-Bu-substituted sulfoximines 118 and 119 gave single 
diastereomeric alcohols anti-133 and anti-134 respectively in 50% and 72% yields. This 
high diastereoselectivity was comparable with the related lithiation-trappings with 
benzophenone (>98:2 dr) (see Table 2.1). The analogous reaction using diethyl 
sulfoximine 86 provided an 80:20 mixture of diastereomeric alcohols anti-135 and syn-
135 (isolated in 82% yield as an 85:15 mixture). This was a lower diastereoselectivity 
than with benzophenone (>98:2 dr). i-Pr-substituted sulfoximine 104 gave an 80:20 
mixture of diastereomeric alcohols anti-136 and syn-136. These were isolated as 95:5 
mixture of alcohols 136 (as an 80:20 mixture of anti and syn in 49% yield) and starting 
sulfoximine 86, This diastereoselectivity was slightly lower than the related reaction with 
benzophenone (85:15 dr). 
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Scheme 2.15 
Analysis of the 1H NMR spectrum of each crude product was used to determine the 
diastereoselectivity. For t-Bu alcohols anti-133 and anti-134 and ethyl diastereomeric 
alcohols anti-135 and syn-135, the signal corresponding to the α-CH position was the 
most useful. For i-Pr alcohols 136, the signals corresponding to the α-CH of each 
diastereomer were not resolved. Therefore, the signals at δH 2.88 and δH 2.81 (septet, J = 
8.0 Hz) corresponding to the SCHMe2 position were used to determine the 
diastereoselectivity.  
The stereochemistry of alcohol anti-133 was assigned via a conversion into N-4-
bromobenozyl sulfoximine anti-138, using a procedure adapted from the literature,62 and 
subsequent analysis by X-ray crystallography (Scheme 2.16). N-TBDPS sulfoximine 
anti-133 was treated with TBAF in THF (rt, 48 h) to yield the corresponding NH 
sulfoximine anti-137 in 80% yield. Of note, there were no issues in this case with a ‘retro-
aldol’-type reaction. Attempts to grow crystals of NH sulfoximine anti-137 were 
unsuccessful. To try to obtain a crystalline compound, NH sulfoximine anti-137 was 
treated with Et3N and 4-bromobenzoyl chloride in CH2Cl2 (0 °C, 1 h then rt, 64 h) to yield 
a 70:30 mixture of 4-bromobenzoic acid and N-4-bromobenzoyl sulfoximine anti-138 in 
26% yield. The observed benzoic acid would be generated by hydrolysis of 4-
bromobenzoyl chloride. Aromatic signals for 4-bromobenzoic acid in the 1H NMR 
spectrum at δH 7.99 (d, J = 8.5 Hz) and δH 7.68 (d, J = 8.5 Hz) were consistent with those 
in the literature.63 The corresponding aromatic signals in the 13C NMR spectrum were 
also observed as well as a signal at δC 161.6 which was assigned to the COOH. 
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Scheme 2.16 
Suitable crystals of anti-138 were grown and the stereochemistry was assigned using X-
ray crystallography (Figure 2.4). The X-ray structure showed a hydrogen bond interaction 
between the carbonyl oxygen and the hydroxyl group. This assigned relative 
stereochemistry is consistent with that shown previously in this chapter.  
 
Figure 2.4 X-ray crystal structure of sulfoximine anti-138 
In order to assign the stereochemistry of alcohol anti-134, TBDPS removal was 
attempted. TBAF was reacted with alcohol anti-134 in THF at rt for 48 h (Scheme 2.17). 
However, the 1H NMR spectrum of the crude product showed no formation of NH 
sulfoximine anti-139 and no product was isolated during purification. The 
stereochemistry of anti-134 was therefore assigned by analogy with related alcohol anti-
133. Similarly, for alcohols 135 and 136, the stereochemistry of the major diastereomeric 
alcohols was also assigned as anti by analogy. 
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Scheme 2.17 
Previous work in the group had used Weinreb amides to install a ketone into the 
sulfoximine product. Using a literature procedure,64 Weinreb amide 141 was prepared in 
64% yield from N,O-dimethylhydroxylamine, Et3N and nicotinoyl hydrochloride 140 in 
CH2Cl2 (0 °C to rt, 2 h) (Scheme 2.18). 
 
Scheme 2.18 
Three examples of trapping with Weinreb amides are shown in Scheme 2.19. The 1H 
NMR spectrum of the crude products of ketones 142, 143 and 145, particularly the signals 
for the α-CH position, were used to determine the diastereoselectivity in each case. 
Lithiation of t-Bu-substituted sulfoximine 118 and trapping with Weinreb amide 73 
yielded a 97:3 mixture of ketones anti-142 and syn-142 (isolated in 87% yield as a 96:4 
mixture). In contrast, the analogous reaction with diethyl sulfoximine 86 showed poor 
diastereoselectivity, and a 55:45 mixture of ketones syn-143 and anti-143 was obtained. 
After chromatography, 52% of syn-143, 9% of a 93:7 mixture and 32% of a 75:25 mixture 
of anti-143 and syn-143 were isolated. Thus, a total of 61% of syn-143 and 32% of anti-
143 were produced. The amount of syn-143 obtained was higher than that present in the 
1H NMR spectrum of the crude product. To account for this, we suggest that epimerisation 
had occurred during purification. This likely occurred via an enolisation process due to 
the acidity of the α-proton when adjacent to both the ketone and sulfoximine groups. 
Trapping lithiated 86 with Weinreb amide 144 gave ketones syn-145 and anti-145 as a 
65:35 mixture. After chromatography, a 70:30 mixture of syn-145 and anti-145 was 
isolated in 66% yield. In order to try to separate the diastereomers, a second purification 
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by chromatography was attempted. This gave a 90:10 mixture of syn-145 and anti-145 
obtained in 22% yield. 
 
Scheme 2.19 
The stereochemistry of ketone syn-143 was assigned using X-ray crystallography (Figure 
2.5). In the 1H NMR spectrum of the crude product, signals appeared at δH 4.36 (q, J = 
7.5 Hz) and δH 1.52 (d, J = 7.5 Hz) for the α-CH and CHMe environments of syn-143. 
For anti-143, these signals were present at δH 4.85 and δH 1.66 respectively. In addition, 
the RF value for syn-143 was higher than for anti-143. To assign the stereochemistry of 
ketones 142 and 145, 1H NMR spectroscopic data and RF values were compared. The 
trends seen with ketones anti-143 and syn-143 allowed the anti and syn stereochemistry 
of ketones 142 and 145 to be tentatively assigned.  
It is surprising that the three reactions with Weinreb amides (Scheme 2.19) gave very 
different outcomes. One was highly anti-selective and one was syn-selective. Both this 
work and previous work in the group (see Scheme 1.21) have suggested that epimerisation 
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may occur during the synthesis or purification of the ketone-containing products. As a 
result, the diastereoselectivity with Weinreb amide trappings is often different to that with 
other electrophiles. This is because it is difficult to quantify how much epimerisation will 
occur in each example. However, even when variable diastereoselectivity was observed 
as in these three reactions, it was still possible to isolate ketones in high dr and good 
yields. 
 
Figure 2.5 X-ray crystal structure of N-TBDPS sulfoximine syn-143 
Lithiation of sulfoximine 86 and trapping with benzaldehyde gave a 50:35:15 mixture of 
three diastereomeric alcohols anti,anti-146, syn,syn-146 and anti,syn-146. After 
chromatography, alcohols anti,anti-146 and syn,syn-146 were isolated in 80% yield as a 
60:40 mixture and anti,syn-146 was isolated in 7% yield (Scheme 2.20). The 60:40 ratio 
of alcohols anti,anti-146 and syn,syn-146 was determined using signals at δH 3.20 
(quintet, J = 7.0 Hz) and δH 3.02 (q, J = 7.0 Hz) for the α-CH position. For alcohol 
anti,syn-146, a signal at δH 2.91 (qd, J = 7.5, 1.0 Hz) was assigned to the α-CH position. 
The relatively low diastereoselectivity (65:35 dr) at the α-position was surprising. 
However, when trapping with aldehydes, the preferred formation of a 1,3-syn relationship 
between the oxygen atoms of the sulfoximine and hydroxyl groups has been observed in 
related compounds (see Scheme 1.7). In our example, the 1,3-selectivity is 85:15 dr. We 
suggest that the impact of the preference for 1,3-syn selectivity lowers the overall α-
diastereoselectivity compared to benzophenone (see Scheme 2.10). 
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Scheme 2.20 
To assign the stereochemistry of alcohols 146, ketone syn-143 of known stereochemistry 
was reduced using L-Selectride®.65 L-Selectride® was selected as a sterically hindered 
reducing agent which we expected to proceed under Felkin-Ahn control and so could be 
used to predict the stereochemistry. Reaction of ketone syn-143 with L-Selectride® in 
THF at −78 °C gave a single diastereomer of an alcohol in 85% yield, which was assigned 
as syn,anti-146 (Scheme 2.21). The Felkin-Ahn model for the L-Selectride® reduction of 
ketone syn-143 is shown in Figure 2.6; the bulky sulfoximine group is expected to sit 
perpendicular to the ketone functionality and the hindered hydride will attack the carbonyl 
group on the least sterically hindered face. This model would predict syn,anti-146 as the 
major product. 
 
Scheme 2.21 
 
Figure 2.6 Felkin-Ahn model for the L-Selectride® reduction of syn-143 
In an attempt to favour chelation control and therefore the formation of alcohol syn,syn-
146, Red-Al® was employed as a reducing agent. Use of Red-Al® has been shown to 
give high levels of chelation control in the reduction of α-alkoxy ketones.66 Reaction of 
ketone syn-143 with Red-Al® in CH2Cl2 at 0 °C produced alcohols syn,anti-146 and 
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syn,syn-146 as an 80:20 mixture (isolated as an 85:15 mixture in 49% yield) (Scheme 
2.22). Unfortunately, alcohol syn,anti-146 was still the major product indicating that 
Felkin-Ahn reduction remained the main pathway.  
 
Scheme 2.22 
By comparing the 1H NMR spectra of the purified alcohol syn,anti-146 and the lithiation-
trapping products (see Scheme 2.20), it was shown that syn,anti-146 was not formed in 
the initial lithiation-trapping reaction. When comparing the 1H NMR spectra of the 85:15 
mixture of syn,anti-146 and syn,syn-146, it was determined that syn,syn-146 was the 
minor diastereomeric alcohol in the 60:40 mixture. The two remaining alcohols therefore 
had anti-α-stereochemistry. Lithiation-trapping reactions with aldehydes have been 
previously shown to favour the 1,3-syn configuration between the sulfoximine oxygen 
and hydroxyl substituents (see Scheme 1.7).28 Therefore, we assumed that the major 
alcohol would exhibit this 1,3-syn configuration and it was therefore assigned as anti,anti-
146. The minor alcohol was assigned as anti,syn-146. 
Trapping with imines had previously been investigated by Pyne.36,37 Therefore, t-Bu-
substituted sulfoximine 118 was lithiated and trapped with imine 45 to give a 40:30:20:10 
mixture of amines 147a, 147b, 147c and 147d in a total yield of 79% (Scheme 2.23). In 
a similar way to the lithiation and trapping of diethyl sulfoximine 86 with benzaldehyde 
(see Scheme 2.20), a lower diastereoselectivity was achieved compared to the 
electrophiles discussed in this chapter. Pyne had also investigated precomplexing the 
imine with boron trifluoride-diethyl ether prior to trapping.36,37 When the analogous 
reaction with the precomplexed imine was performed, a 30:35:10:25 mixture of amines 
147a, 147b, 147c and 147d was produced in a 62% yield. The diastereoselectivity was 
determined in each case using the signals corresponding to the CHNH environment for 
each diastereomer in the 1H NMR spectrum of the crude product. The CHNH signals were 
chosen, due to overlapping of the α-CH signals. The stereochemistry of amines 147 was 
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not determined. With or without boron trifluoride-etherate present, poor 
diastereoselectivity was observed. 
 
Scheme 2.23 
Most of the acyclic N-TBDPS sulfoximines presented in this chapter have displayed high 
anti-α-diastereoselectivity in lithiation-trapping reactions with a range of electrophiles. 
To explain this, we propose the models shown in Figure 2.7. For the formation of the 
anti-diastereomer (pathway A), we suggest that the α-carbanion is sp2 hybridised and that 
the R1 and R2 substituents are in an antiperiplanar orientation to minimise unfavourable 
steric interactions. Electrophilic trapping then occurs on the face opposite to the bulky 
TBDPS group to give the observed anti-configured products. The formation of the syn 
product is proposed to occur via pathway B, where the α-R2 and α-H substituents are in 
opposite positions. Pathway B would be especially disfavoured when R1 is a sterically 
demanding substituent. This is supported by the high diastereoselectivity observed for the 
bulky Ad-substituted and t-Bu-substituted sulfoximines. 
 
Figure 2.7 Proposed models for electrophilic trapping of acyclic sulfoximines 
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In conclusion, a range of α-substituted products have been synthesised from t-Bu and Ad-
substituted sulfoximines 118, 119 and 107 in high diastereoselectivity. The 
diastereoselectivity has generally been slightly lower for Et, i-Pr and Ph-substituted 
sulfoximines 86, 104, 87 and 117. Alternative nitrogen protecting groups (TBDMS and 
Boc) have been explored briefly and have resulted in high and low diastereoselectivity 
respectively. Products with anti-α-stereochemistry are the major diastereomers across 
most examples. This differs to the syn-α-stereochemistry reported by Pyne in trapping 
methyl benzyl sulfoximine 43 with aldehydes and imines (see Chapter 1.3). This 
difference is explored further in Chapter 2.2.3.  
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2.2.2 Lithiation and Trapping of Sulfoximines with Alkyl Halides and Silyl 
Chlorides 
To further explore the scope of the lithiation-trapping methodology, benzyl bromide, 
methyl iodide, ethyl iodide, deuterated methanol and trimethylsilyl chloride were 
investigated as electrophiles. The reactions of four sulfoximines with benzyl bromide 
were studied first and the results are shown in Scheme 2.24. Lithiation of adamantyl-
substituted sulfoximine 107 and trapping with benzyl bromide provided anti-148 in 69% 
yield. The analogous reaction of t-Bu-substituted sulfoximine 118 gave an inseparable 
97:3 mixture of sulfoximines anti-149 and syn-149 in 96% yield. Lithiation-trapping of 
i-Pr-substituted sulfoximine 104 resulted in a 70:30 mixture of anti-150 and syn-150 in 
94% yield. The reaction of Ph-substituted sulfoximine 87 gave a 60:40 mixture of anti-
151 and syn-151 in 84% yield. The reactions of adamantyl and t-Bu-substituted 
sulfoximines provided high diastereoselectivity, whereas those of i-Pr and Ph-substituted 
sulfoximines were lower. These trends were consistent with the results discussed in the 
previous chapter. 
 
Scheme 2.24 
The signals in the 1H NMR spectra for the crude products were used to measure the 
diastereoselectivity for each reaction. In each spectrum, the signals corresponding to the 
α-CH environment for each diastereomer were not resolved and so the signals 
corresponding to the diastereotopic CH2 position were used to determine the 
diastereoselectivity. For example, from the 1H NMR spectrum of the crude product, anti-
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150 presented a signal at δH 2.31 (dd, J = 13.0, 11.0 Hz) for the CHPh environment and 
syn-150 showed a signal at δH 2.44 (dd, J = 13.0, 11.0 Hz). 
The stereochemistry of anti-148 was assigned by its conversion into N-4-bromobenzoyl 
sulfoximine anti-153 and subsequent X-ray analysis. N-TBDPS sulfoximine anti-148 was 
treated with TBAF to give NH sulfoximine anti-152 in 93% yield. Then, reaction of anti-
152 with 4-bromobenzoyl chloride and Et3N produced anti-153 in 84% yield (Scheme 
2.25). X-ray crystallography was then used to establish its stereochemistry (Figure 2.8). 
The stereochemistry of the related major diastereomeric sulfoximines anti-149, anti-150 
and anti-151 was assigned by analogy. 
 
Scheme 2.25 
 
Figure 2.8 X-ray crystal structure of N-4-bromobenzoyl sulfoximine anti-153 
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Trapping with benzyl bromide was also explored with diethyl sulfoximine 86. In this case, 
an unquantifiable mixture of monosubstituted diastereomeric sulfoximines anti-154 and 
syn-154 and disubstituted sulfoximine 155 (unknown mixture of diastereomers) was 
obtained. After chromatography, monosubstituted sulfoximines anti-154 and syn-154 
were isolated as a 75:25 mixture in 45% yield and disubstituted sulfoximines 155 were 
obtained as an unknown mixture of diastereomers in 26% yield (Scheme 2.26).  
 
Scheme 2.26 
The 1H NMR spectrum for the purified mixture of anti-154 and syn-154 was used to 
determine the diastereoselectivity, specifically the signals corresponding to the benzylic 
CH2 protons. The formation of a disubstituted product was identified by mass 
spectrometry. The structure of this disubstituted sulfoximine could not be deduced using 
the 1H NMR spectrum as the key signals were overlapped. The 13C NMR spectrum, 
however, showed no evidence of disubstitution occurring at the same α-carbon position. 
There were no signals corresponding to either the Et substituent or the quaternary α-CH. 
Figure 2.9 shows that four sets of signals for each of the Me, CH2 and SCH environments 
were present in the 13C NMR spectrum, which indicates that all three possible 
diastereomers of disubstituted sulfoximine 155 were formed (two of which are meso 
compounds).  
 
Figure 2.9 13C NMR spectroscopic data for disubstituted sulfoximine 155 
To explain the formation of disubstituted sulfoximine 155, a mechanistic proposal is 
summarised in Scheme 2.27. We propose that, initially, deprotonation of sulfoximine 86 
takes place followed by trapping with benzyl bromide to yield monosubstituted 
sulfoximine 154 of unknown stereochemistry. If this trapping process is relatively slow 
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then enough lithiated sulfoximine 156 may still be present to deprotonate at the other, less 
sterically hindered α-position of 154. This would produce monosubstituted lithiated 
sulfoximine 157 and starting material 86. Finally, 157 can undergo a second trapping 
reaction with benzyl bromide to produce disubstituted sulfoximine 155. Another possible 
pathway for disubstitution is via dianion formation and has been proposed within the 
literature.67 However, when sulfoximine 86 was lithiated and trapped with other 
electrophiles (see Chapter 2.2.1), no disubstitution was observed and so we disfavour this 
explanation. Furthermore, the 1H NMR spectrum for the crude product shows evidence 
of some leftover starting sulfoximine 86 which supports the proposal of its regeneration 
during the formation of disubstituted sulfoximine 155.  
 
Scheme 2.27 
The stereochemistry of the major and minor diastereomeric monosubstituted 
sulfoximines anti-154 and syn-154 has been assigned by analogy with the other benzyl 
bromide trappings (see Scheme 2.24). However, in this case, the assignment should be 
viewed as tentative since it is not possible to quantify the amount of each diastereomer 
that has contributed to the formation of disubstituted sulfoximine 155. 
In order to selectively access the syn-diastereomers, we planned to reverse the order in 
which the α-substituents would be installed onto the sulfoximine. For example, lithiation 
of t-Bu-substituted sulfoximine 119 and subsequent trapping with methyl iodide gave a 
98:2 mixture of sulfoximines syn-149 and anti-149 (isolated as a 98:2 mixture in 96% 
yield) (Scheme 2.28). Lithiation-trapping of Ph-substituted sulfoximine 117 with methyl 
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iodide provided a 65:35 mixture of syn-151 and anti-151, which were isolated as a 65:35 
mixture in 71% yield. Both of these reactions gave similar diastereoselectivity to those in 
Scheme 2.24 but, as expected, the syn diastereomer was the major product. 
 
Scheme 2.28 
Figure 2.10 compares the signal corresponding to the CHPh proton for syn-149 and anti-
149 in their associated 1H NMR spectra. Each diastereomer was synthesised as the major 
product from the two decribed approaches.  
         
Figure 2.10 The CHPh signal in the 1H NMR spectra for syn-149 and anti-149 
Lithiation of t-Bu-substituted sulfoximine 119 and trapping with ethyl iodide gave a 97:3 
mixture of diastereomeric sulfoximines anti-158 and syn-158 (isolated as a 97:3 mixture 
in 47% yield) (Scheme 2.29). From the 1H NMR spectrum of the crude product, the 
signals corresponding to the CH2 protons were used to determine the diastereoselectivity. 
The stereochemistry of anti-158 was assigned by analogy with the other alkylations. 
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Scheme 2.29 
Lithiation-trapping of t-Bu-substituted sulfoximine 118 with deuterated methanol 
provided a 60:40 mixture of deuterated sulfoximines 118-d in 91% yield (Scheme 2.30). 
The diastereoselectivity was determined using the 1H NMR spectrum of the crude 
product, specifically the signals corresponding to the α-CH position. The 
diastereoselectivity was significantly lower than the lithiation-trappings of t-Bu-
substituted sulfoximines with other electrophiles. To explain this, one possibility is that 
the alkoxide generated during deuteration could epimerise the product to change the 
diastereomeric ratio. Alternatively, it could be that deuteration is simply much less 
diastereoselective than trappings with other electrophiles.  
 
Scheme 2.30 
For comparison, we also explored TMSCl trapping. Thus, lithiation of t-Bu-substituted 
sulfoximine 119 and subsequent trapping with TMSCl gave α-silylated sulfoximine anti-
159 in 90% yield (Scheme 2.31). The analogous reaction of diethyl sulfoximine 86 
provided a 67:33 mixture of monosubstituted sulfoximines anti-160 and syn-160 (as an 
80:20 mixture of diastereomers) and disubstituted sulfoximine 161. An 80:20 mixture of 
sulfoximines anti-160 and syn-160 was isolated in 59% yield and disubstituted 
sulfoximine 161 was recovered in 24% yield (Scheme 2.31). The stereochemistry for both 
anti-159 and anti-160 was assigned by analogy.  
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Scheme 2.31 
Mass spectrometry indicated the formation of a disubstituted sulfoximine and evidence 
that both silyl groups were on the same carbon came from the 1H and 13C NMR spectra. 
A 3H singlet was observed in the 1H NMR spectrum at δH 1.39 corresponding to the α-
methyl substituent, which suggested that the adjacent α-carbon must be quaternary and 
therefore disubstituted. This quaternary α-carbon was present in the 13C NMR spectrum 
at δC 51.3. 
In order to explain the double silylation, a mechanism similar to that used to rationalise 
the formation of dibenzylated sulfoximine 155 can be proposed (see Scheme 2.27). 
However, to form dibenzylated sulfoximine 155, the benzylations occurred on different 
carbons. With disilylated sulfoximine 161, the double silylation on the same carbon can 
be explained by the α-anion stabilising effect of silicon. Presumably, lithiation of 
sulfoximine 86 and subsequent trapping with TMSCl would take place to give silylated 
sulfoximine 162 and subsequently monosubstituted sulfoximine 160 (Scheme 2.32). 
Another carbanion adjacent to silicon would then result from deprotonation of the α-
proton by the remaining lithiated sulfoximine 156. This is favourable due to the ability of 
silicon to stabilise the α-carbanion via silicon’s empty σ* antibonding orbital. Trapping 
of lithiated sulfoximine 163 would then give disubstituted sulfoximine 161. The 
stereochemistry of anti-160 and syn-160 is also assigned tentatively due to the formation 
of disubstituted sulfoximine 161. 
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Scheme 2.32 
To conclude, t-Bu-substituted and adamantyl-substituted sulfoximines 118, 119 and 107 
provided high diastereoselectivity when lithiated and trapped with alkyl halides and silyl 
chlorides. This diastereoselectivity was lower when Ph, i-Pr and Et-substituted 
sulfoximines 87, 117, 104 and 86 were employed. These trends are consistent with those 
identified for the same sulfoximines with carbonyl-containing electrophiles (see Chapter 
2.2.1). These results suggest that the model presented in Figure 2.7 can explain the 
diastereoselectivity in the lithiation-trappings of sulfoximine with alkyl halides.  
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2.2.3 Lithiation and Trapping of Benzylic Sulfoximines 
The results in the literature that are most similar to the examples described in the previous 
two chapters were reported by Pyne et al.36,37 Pyne investigated the lithiation of N-TBDPS 
protected methyl benzyl sulfoximine 43 and trapping with aldehydes and imines. Two 
representative examples are shown in Scheme 2.33.36,37 Trapping with benzaldehyde gave 
alcohols syn,syn-44, anti,anti-44, anti,syn-44 and syn,anti-44 as a 48:26:10:16 mixture, 
i.e. a 64:36 syn:anti ratio at the α-position. Use of imine 45 provided a 79:21 mixture of 
amine syn,anti-46 and another unidentified diastereomer of 46. Models were presented 
which rationalised the formation of the major diastereomer in each case, both of which 
had syn relative stereochemistry between the sulfoximine oxygen and α-phenyl 
substituent (see Figure 1.8). In contrast, the major products that we had obtained from the 
results presented in Chapters 2.2.1 and 2.2.2 were consistently anti at the α-position. The 
reason for the difference could be because sulfoximine 43 produces a benzylic lithiated 
sulfoximine or it could be due to the electrophile used. To probe this, we decided to carry 
out some lithiation-trappings with sulfoximine 43 and its t-Bu analogue 110 (Figure 2.11). 
 
Scheme 2.33 
 
Figure 2.11 The structures of benzylic sulfoximines 43 and 110 
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We began with sulfoximine 43 and repeated the reactions initially carried out by Pyne.37 
In our hands, lithiation of Me-substituted sulfoximine 43 and trapping with benzaldehyde 
gave a 70:25:5 mixture of alcohols 44a, 44b and 44c (Scheme 2.34). A 95:5 mixture of 
sulfoximines 44a and 44c was isolated in 40% yield and sulfoximine 44b was isolated in 
13% yield. The signals at δH 6.07 (dd, J = 2.0, 2.0 Hz), δH 5.78 (d, J = 9.5 Hz) and δH 5.64 
(dd, J = 9.5, 1.0 Hz) in the 1H NMR spectrum of the crude product were assigned to the 
CHOH positions of 44b, 44a and 44c respectively. These signals were used to determine 
the diastereoselectivity as they were better resolved than those for the α-CH environment. 
However, the stereochemistry was not assigned since Pyne’s data is not available for 
comparison, and unfortunately, we were not able to reproduce Pyne’s results.  
 
Scheme 2.34 
Lithiation of sulfoximine 43 and trapping with imine 45 provided a 50:35:10:5 mixture 
of diastereomeric amines 46a, 46b, 46c and 46d (Scheme 2.35). Amine 46b was isolated 
in 8% yield whereas 46a, 46c and 46d were isolated as an 80:15:5 mixture in 38% yield. 
When imine 45 was precomplexed with boron trifluoride-diethyl ether prior to trapping, 
Pyne obtained a 95:5 mixture of amines 46 (see Scheme 1.12). When we attempted the 
boron trifluoride-diethyl ether reduction, a 15:20:50:15 mixture of amines 46a, 46b, 46c 
and 46d was obtained. The diastereoselectivity of these reactions was determined using 
the 1H NMR spectra of the crude products. The signals corresponding to the SMe 
environment were the most useful, as these were the best resolved. The singlets at δH 2.20, 
δH 2.27, δH 2.32 and δH 2.38 were assigned to amines 46a, 46b, 46c and 46d respectively. 
Even though the stereochemistry has not been assigned, the ratio of diastereomeric 
products 46a-d from imine 45 were not in line with those reported by Pyne. 
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Scheme 2.35 
Disappointingly, we were unable to reproduce Pyne’s reactions of lithiated sulfoximine 
43 with benzaldehyde and imine 45. It is not clear to as why our ratios were so different 
to Pyne’s. Nevertheless, two other electrophiles were investigated in order to explore the 
α-diastereoselectivity. Lithiation and trapping using benzophenone did not give any of 
the desired alcohol 164 (Scheme 2.36). After purification, the starting sulfoximine 43 was 
isolated in 36% yield together with alcohol 165, which was obtained as a 70:30 mixture 
with TBDPSOH (calculated by 1H NMR spectroscopy). Comparison of a literature 1H 
NMR spectrum of TBDPSOH provided evidence of the impurity in this case.68 The 
formation of sulfoximine 165 was shown by mass spectrometry and 1H and 13C NMR 
spectroscopy of the purified product. The 1H NMR spectrum showed 1H, 1H and 2H 
signals at δH 3.74 (d, J = 14.5 Hz, 1H, SCHPh), δH 3.66 (d, J = 14.5 Hz, 1H, SCHPh) and 
δH 3.42 (s, 2H, SCH2COH), corresponding to the two CH2 environments. The 
corresponding signals were also observed in the 13C NMR spectrum. To explain the lack 
of formation of 164, we speculate that the trapping reaction is reversible via a ‘retro-
aldol’-type process. In this case, the retro-process could occur because of the stability of 
the benzylic anion that is generated. Furthermore, since product 165 has been 
functionalised on the less acidic methyl position, it is possible that the reversibility of the 
trapping allows anion equilibration to occur.  
 
Scheme 2.36 
Lithiation of Me-substituted sulfoximine 43 and trapping with methyl iodide provided an 
85:15 mixture of monosubstituted sulfoximine 166 (as a 90:10 mixture of syn-166 and 
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anti-166) and disubstituted sulfoximine 167 (as a 60:40 mixture of unknown 
diastereomers 167a and 167b) (Scheme 2.37). Sulfoximines syn-166 and 167b were 
isolated in 74% yield (as a 94:6 mixture). Disubstituted sulfoximine 167a was obtained 
in 8% yield and monosubstituted anti-166 was isolated in 10% yield. 
 
Scheme 2.37 
The 1H NMR spectrum of the crude product was used to determine the 
diastereoselectivity. For diastereomeric sulfoximines syn-166 and anti-166, the signals 
corresponding to the SMe environment were the most useful. The presence of 
disubstituted sulfoximines 167 were indicated by the signals at δH 1.04 (t, J = 7.0 Hz) and 
δH 1.02 (t, J = 7.0 Hz) for the SCH2Me position in the 1H NMR spectra of the purified 
products. The diastereoselectivity was identified by the signals in the 1H NMR spectra of 
the crude product at δH 1.72 (d, J = 7.5 Hz) and δH 1.68 (d, J = 7.5 Hz) which were 
assigned to the SCHMe environment. Mass spectrometry was also used to establish the 
formation of the disubstituted product. The stereochemistry of the minor monosubstituted 
product, anti-166, was assigned using X-ray crystallography (Figure 2.12). The relative 
stereochemistry of major monosubstituted sulfoximine, syn-166, has an α-
stereochemistry that is the same as Pyne observed with imine 45 (see Scheme 2.33) but 
opposite to that from our results (see Chapters 2.2.1 and 2.2.2). 
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Figure 2.12 X-ray crystal structure of N-TBDPS sulfoximine anti-166 
To explain the formation of disubstituted sulfoximine 167, a similar mechanism is 
proposed to the related trapping of diethyl sulfoximine 86 with benzyl bromide (see 
Scheme 2.27). It is likely that lithiation would initially take place at the benzylic position 
to give 166 after methylation. As the trapping process with alkyl halides is believed to be 
slow, this could allow a second lithiation and trapping at the methyl position, leading to 
the disubstituted sulfoximine 167 (Scheme 2.38).  
 
Scheme 2.38 
With limited information obtained with methyl benzyl sulfoximine 43 so far, we decided 
to investigate t-Bu-substituted benzylic sulfoximine 110. This was because of the high 
diastereoselectivity exhibited by structurally similar t-Bu-substituted alkyl sulfoximines 
118 and 119. As an initial test, t-Bu-substituted sulfoximine 110 was lithiated and trapped 
with deuterated methanol (Scheme 2.39). This gave deuterated sulfoximine 110-d as a 
65:35 mixture of diastereomers in 99% yield. 
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Scheme 2.39 
Next, lithiation and trapping with benzaldehyde was explored. This gave an 85:15 mixture 
of diastereomeric alcohols anti,anti-170 and syn,syn-170 which were isolated in 
respective yields of 77% and 6% (Scheme 2.40). The α-SCH signals in the 1H NMR 
spectra of the crude product were used to determine the diastereoselectivity. The 
stereochemistry of sulfoximines anti,anti-170 and syn,syn-170 were assigned using X-ray 
crystallography (Figure 2.13). For anti,anti-170, the proximity of the hydroxyl substituent 
and the sulfoximine oxygen indicated a hydrogen bonding interaction. The relative α-
stereochemistry of major alcohol anti,anti-170 is anti which is different to that observed 
by Pyne (see Scheme 2.33) but consistent with that observed in our examples shown in 
the previous chapters.  
 
Scheme 2.40 
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Figure 2.13 X-ray crystal structures of N-TBDPS sulfoximines anti,anti-170 and 
syn,syn-170 
Lithiation of t-Bu-substituted sulfoximine 110 and trapping with benzophenone did not 
give any of the desired alcohol 171. This is a similar outcome to that obtained with methyl 
benzyl sulfoximine 43 (see Scheme 2.36). Trapping with imine 45 was also unsuccessful 
and gave none of the desired product 172 (Scheme 2.41).  
 
Scheme 2.41 
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In contrast, trapping with methyl iodide was more successful. The reaction gave a 50:50 
mixture of diastereomeric sulfoximines 173 (Scheme 2.42). After purification, 173a was 
isolated in 47% yield and a 96:4 mixture of 173b and 173a were isolated in 41% yield. 
The signals for the α-CH position within the 1H NMR spectrum of the crude product were 
used to determine the diastereoselectivity. Compared to the benzaldehyde trapping, the 
low diastereoselectivity with methyl iodide was surprising. We suggest that slow trapping 
allows equilibration between lithiated 110 and the product which would impact on the 
ratio of diastereomeric products. 
 
Scheme 2.42 
To summarise, the reactions of benzylic sulfoximines 43 and 110 in this chapter have 
shown variable diastereoselectivity with a range of electrophiles. This is surprising as the 
related reactions of alkyl sulfoximines were consistently anti-diastereoselective (see 
Chapters 2.2.1 and 2.2.2). However, anti-diastereoselectivity was observed in one 
example: the lithiation-trapping of t-Bu-substituted sulfoximine 110 with benzaldehyde. 
In this reaction, an 85:15 mixture of anti,anti-170 and syn,syn-170 were obtained and the 
major product had the anti-α-stereochemistry.  
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  Synthesis of Tetrasubstituted Sulfoximines  
The lithiation-trappings of t-Bu-substituted N-TBDPS sulfoximines 118 and 119 
provided a high yielding and diastereoselective approach for the α-functionalisation of 
sulfoximines using a range of electrophiles. Due to the success of this work, it was 
decided that some of these α-functionalised products could provide a means of 
diastereoselectively synthesising tetrasubstituted sulfoximines using a second lithiation-
trapping reaction. t-Bu-substituted sulfoximine syn-149 was selected as a candidate for 
this work as it had no protons that would be more acidic than those at the α-position. The 
plan was to employ conditions similar to those that were used previously, utilising n-BuLi 
for deprotonation followed by trapping with an electrophile to give sulfoximines 174 
(Scheme 2.43). 
 
Scheme 2.43 
There were two key factors to consider. First, due to the extra steric hindrance, both the 
lithiation and the electrophile trapping steps may be slower. Second, it was unclear 
whether the second lithiation-trapping would be diastereoselective. To investigate 
whether complete lithiation of the starting sulfoximine would occur, syn-149 was lithiated 
and trapped with deuterated methanol. This gave an 85:15 mixture of deuterated 
diastereomeric sulfoximines syn-149-d and anti-149-d in 89% yield (Scheme 2.44). This 
high diastereoselectivity was very promising. 
 
Scheme 2.44 
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Analysis of the 1H NMR spectrum of the crude product showed that complete lithiation 
of starting sulfoximine syn-149 had occurred after 20 min at −78 °C. The stereochemistry 
of the major deuterated product syn-149-d was assigned as syn. The 1H NMR spectrum 
of 149-d allowed the stereochemistry to be determined by analogy with protonated 
sulfoximine syn-149. Protonated syn-149 presented 1H NMR spectroscopic signals at δH 
2.30 (dd, J = 13.5, 12.0 Hz) and δH 0.96 (d, J = 7.0 Hz) for one of the diastereotopic SCH2 
protons and the SCHMe environments respectively. In contrast, protonated sulfoximine 
anti-149 exhibited these signals at δH 1.80 (dd, J = 13.5, 12.0 Hz) and δH 1.04 (d, J = 7.0 
Hz). The chemical shifts of the analogous signals for deuterated sulfoximines syn-149-d 
(δH 2.30 and δH 0.96) and anti-149-d (δH 1.85 and δH 1.08), showed that syn-149-d was 
the major diastereomer.  
Next, a protonation reaction was carried out to confirm this stereochemical assignment. 
Sulfoximine syn-149 was lithiated and trapped with an excess of saturated ammonium 
chloride solution. This gave syn-149 and anti-149 as a 90:10 mixture in 47% yield 
(Scheme 2.45), thus supporting the assignment of stereochemistry for deuterated 
sulfoximine syn-149-d. 
 
Scheme 2.45 
We then decided to explore the lithiation-trapping reactions of disubstituted sulfoximine 
syn-149 with various electrophiles. Initially, lithiation of syn-149 and subsequent trapping 
with benzophenone was attempted using the standard conditions of n-BuLi in THF at −78 
°C for 20 min followed by trapping for 1 h at −78 °C. This resulted in no formation of 
alcohol 175. A 65:35 mixture of diastereomeric starting sulfoximines syn-149 and anti-
149 was isolated (Scheme 2.46). As the lithiation step had previously been shown to be 
successful, we suspected that the trapping step was the problem. With this in mind, the 
reaction mixture for the electrophilic trapping was left overnight and allowed to warm to 
rt. However, this also gave no evidence of product formation and only a 65:35 mixture of 
syn-149 and anti-149 was isolated (Scheme 2.46).  
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Scheme 2.46 
Trapping with Weinreb amide 73 was also unsuccessful and provided none of the desired 
ketone 176 after a trapping duration of 2 h at −78 °C (Scheme 2.47). The fluorination38 
of syn-149 was also attempted by trapping with NFSI but this reaction gave no desired 
fluorinated sulfoximine 177 (by 1H and 19F NMR spectroscopy). Allowing the reaction 
mixture to warm to rt over a period of 12 h during the trapping step showed no change in 
the 1H NMR spectrum of the crude product. Analysis of the 1H NMR spectrum of the 
crude product in each case indicated the formation of 65:35 mixture of starting 
sulfoximines syn-149 and anti-149. 
 
Scheme 2.47 
To explore whether trapping with less sterically demanding electrophiles was possible, 
methyl iodide was selected. To our delight, trapping with methyl iodide afforded 
sulfoximine 178 and starting sulfoximines syn-149 and anti-149 as an 80:17:3 mixture 
(calculated yield of 80% for sulfoximine 178 by 1H NMR spectroscopy) (Scheme 2.48). 
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Ethyl iodide was then employed as an alternative electrophile that would allow us to 
explore the diastereoselectivity. Trapping with ethyl iodide provided a 75:25 mixture of 
diastereomeric sulfoximines 179. A 90:10 mixture of 179 and starting material anti-149 
were then isolated after two attempts at separation (calculated yield of 28% by 1H NMR 
spectroscopy). 
 
Scheme 2.48 
1H NMR spectroscopy was used to determine that the ethylation of sulfoximine syn-149 
was successful. For sulfoximines 179, signals at δH 0.73 (dd, J = 9.5, 7.5 Hz), δH 0.72 (dd, 
J = 9.5, 7.5 Hz), δH 1.59–1.52 (m), δH 1.85–1.76 (m) and δH 2.2–2.93 (m) were assigned 
to the CH2Me and CHMe environments which showed the installation of the ethyl 
substituent. The signals at δH 3.10 and δH 3.16 corresponding to the CHPh environment 
were used to determine the diastereoselectivity. The stereochemistry of sulfoximines 179 
could not be assigned in this case. 
Finally, benzaldehyde was investigated and this gave the best result. Lithiation and 
trapping of syn-149 with benzaldehyde gave alcohol 180 as a 95:5 mixture of 
diastereomers 180a and 180b from which single diastereomeric sulfoximine 180a was 
isolated in 67% yield after chromatography (Scheme 2.49). Successful trapping with 
benzaldehyde was presumably due to its increased electrophilicity when compared to the 
other carbonyl-containing electrophiles employed (benzophenone and Weinreb amide 
73). In the 1H NMR spectrum of the crude product, the signals at δH 5.61 and δH 6.54 
were assigned to the CHOH and CHOH environments of alcohol 180a, which showed the 
incorporation of the newly formed alcohol unit. Signals were observed at δH 5.30 (d, J = 
7.0 Hz) and δH 6.16 (d, J = 7.0 Hz) for the minor diastereomer 180b. 
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Scheme 2.49 
Due to the poor crystallinity of sulfoximine 180a, X-ray crystallography could not be 
used to assign the stereochemistry. In an attempt to produce a crystalline compound, 
TBDPS removal was explored. Thus, N-TBDPS sulfoximine 180a was treated with 
TBAF in THF (rt, 64 h) which gave a complex mixture and none of the desired NH 
sulfoximine 181 was formed (Scheme 2.50). In a similar system, we observed 
deprotection taking place followed by a ‘retro-aldol’ type process (see Scheme 2.14). We 
therefore suspect that sulfoximine 180a may have undergone a similar process under the 
basic conditions. To overcome this, a procedure for TBDPS removal under acidic 
conditions was employed. Reaction of N-TBDPS sulfoximine 180a with HCl (generated 
in situ from AcCl and dry MeOH) gave none of the desired product.69 The use of TBAF 
with AcOH has also been described for the silyl deprotection of base-sensitive 
compounds.70 Therefore, in a final attempt, sulfoximine 180a was treated with AcOH and 
TBAF in THF (rt, 96 h) but the formation of the NH sulfoximine 181 was not observed. 
 
Scheme 2.50 
As an alternative approach to obtaining a more crystalline compound, we tried to 
functionalise at the hydroxy group without removing the TBDPS group. Sulfoximine 
180a was treated with Et3N and 4-bromobenzoyl chloride in CH2Cl2 (rt, 96 h). This gave 
none of the desired ester 182 and only starting sulfoximine 180a (Scheme 2.51). A similar 
procedure, adapted from the literature, 71 which employed catalytic DMAP, was then also 
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attempted. Unfortunately, only the starting sulfoximine 180a was observed in the 1H 
NMR spectrum of the crude product. 
 
Scheme 2.51 
The lithiation-trapping of syn-149 with benzaldehyde was highly diastereoselective. We 
therefore wondered if employing the opposite diastereomeric starting sulfoximine would 
lead to the same or a different outcome. Lithiation of anti-149 and subsequent trapping 
with benzaldehyde provided a 95:5 mixture of diastereomeric alcohols 180a and 180b 
(Scheme 2.52). After purification, a 90:10 mixture of 180a and starting sulfoximine anti-
149 were isolated, with a calculated yield of 68% for 180a (by 1H NMR spectroscopy). 
This was essentially the same result as that achieved from the reaction of starting 
sulfoximine syn-149 with benzaldehyde (see Scheme 2.49). These results imply that the 
reactions of syn-149 and anti-149 proceed via the same pathway and therefore share a 
common intermediate. We suspect that the lithiated intermediate species would contain a 
sp2 hybridised α-carbon. This may be similar to the previously proposed model for the 
lithiation-trappings discussed in Chapters 2.2.1 and 2.2.2 (see Figure 2.7). However, as 
the stereochemistry could not be assigned for the reactions of syn-149 and anti-149 with 
benzaldehyde, a model for the transition state cannot currently be proposed. 
 
Scheme 2.52 
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To summarise, three tetrasubstituted sulfoximines have been successfully synthesised via 
lithiation of sulfoximine syn-149 and subsequent trapping with methyl iodide, ethyl 
iodide and benzaldehyde. Trapping with benzaldehyde provided a highly 
diastereoselective reaction, and the same mixture of diastereomers could be obtained from 
either diastereomeric starting sulfoximine, syn-149 or anti-149. Unfortunately, the 
stereochemistry could only be assigned for deuterated sulfoximines 149-d, and further 
work is therefore required for the stereochemical assignment of the other examples. 
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3. Conclusions and Future Work 
To conclude, we have synthesised a wide range of α-functionalised acyclic sulfoximines 
via lithiation-trapping methodology. N-TBDPS adamantyl and t-Bu-substituted 
sulfoximines have displayed high diastereoselectivity consistently across a range of 
carbonyl-containing and alkyl halide electrophiles. Some other functionalised N-TBDPS 
acyclic sulfoximines have also demonstrated good diastereoselectivity, including Ph, i-
Pr, o-tol and Et-substituted sulfoximines. These reactions consistently give the anti-
configured product as the major diastereomer and we have proposed a model which 
rationalises this. In contrast, when benzylic sulfoximines were employed, varied 
diastereoselectivity was observed. Examples of some of the most diastereoselective and 
high yielding results are presented in Figure 3.1. It was also discovered that, by changing 
the order of the installation of the α-substituents, the opposite diastereomer could be 
obtained. An example of this is shown by t-Bu-substituted sulfoximines anti-149 and syn-
149 (Figure 3.1). 
 
Figure 3.1 Products of highly diastereoselective lithiation-trapping reactions of N-
TBDPS sulfoximines 
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Even in cases where a lower diastereoselectivity was observed, the anti-products could 
still be obtained in good yields after chromatography. Examples of this are shown in 
Figure 3.2. Some alternative functionalities on nitrogen were also explored including N-
TBDMS and N-Boc which gave high and low diastereoselectivity respectively. 
Chromatography, however, enabled the isolation of both diastereomers and the major 
anti-configured products could therefore still be obtained in good yields (Figure 3.2). 
 
Figure 3.2 N-TBDPS, N-TBDMS and N-Boc lithiation-trapping products 
Using the lithiation-trapping methodology, some tetrasubstituted acyclic sulfoximines 
were also successfully prepared. Lithiation and trapping of t-Bu-substituted sulfoximine 
149 with deuterated methanol, alkyl halides and benzaldehyde afforded the corresponding 
products in moderate to high yields and diastereoselectivity (Figure 3.3). Furthermore, it 
was found that the same diastereomeric outcome was obtained when either diastereomeric 
starting sulfoximine, syn-149 or anti-149, was employed. 
 
Figure 3.3 N-TBDPS tetrasubstituted lithiation-trapping products 
Future work will involve completing the stereochemical assignments of some α-
functionalised products. This will focus especially on the assignment of the 
stereochemistry of the tetrasubstituted sulfoximines which would allow a model for the 
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lithiation-trapping to be proposed. As we have been unable to grow crystals of alcohol 
180a suitable for X-ray crystallography, an alternative approach could be to employ other 
electrophiles in the synthesis, such as different aldehydes. These derivatives of 
sulfoximine 180a may be more suitable for crystallisation. 
Future work will also focus on the arylation of some acyclic sulfoximines using Negishi 
cross-coupling72 (Scheme 3.1). This will employ n-BuLi as the base, followed by 
transmetallation with ZnCl2. Then, the desired aryl bromide, Pd(OAc)2 and X-Phos will 
be used to give the α-functionalised sulfoximine 184. N-TBDPS acyclic sulfoximines 183 
will be initially investigated and we expect that the bulky TBDPS substituent will offer 
high diastereoselectivity and preferentially give the anti-configured products. Other N-
functionalised sulfoximines could also be explored in these reactions. 
 
Scheme 3.1 
Long term future plans may involve the enantioselective synthesis of α-functionalised 
sulfoximines using a chiral ligand such as sparteine52 and related diamines. An example 
approach could involve the kinetic resolution of a racemic mixture of sulfoximine 119 in 
which a single enantiomer 185 could be isolated (Scheme 3.2). 
 
Scheme 3.2 
 
 
Chapter Four: Experimental 
 
72 
 
4. Experimental 
  General Information 
All-non aqueous reactions were carried out under oxygen−free Ar using flame-dried 
glassware. THF was freshly distilled from sodium and benzophenone. Alkyllithiums were 
titrated against N-benzylbenzamide before use.73 Acetone, methyl iodide, ethyl iodide and 
benzaldehyde were distilled over CaH2 before use. Benzophenone, benzyl bromide, 
TMSCl, Weinreb amide 73, Weinreb amide 144, CD3OD, NFSI and N-
benzylideneaniline were used without further purification. Brine refers to a saturated 
solution. Water is distilled water.  
 
Flash column chromatography was carried out using Fluka Chemie GmbH silica (220-
440 mesh). Thin layer chromatography was carried out using commercially available 
Merck F254 aluminium backed silica plates. Proton (400 MHz) and carbon (100.6 MHz) 
NMR spectra were recorded on a Jeol ECX-400 instrument using an internal deuterium 
lock. For samples recorded in CDCl3, chemical shifts are quoted in parts per million 
relative to CHCl3 (δH 7.26) and CDCl3 (δC 77.0, central line of triplet). For samples 
recorded in d6-DMSO, chemical shifts are quoted in parts per million relative to DMSO 
(δH 2.50, central line of quintet) and d6-DMSO (δC 39.5, central line of septet). For 
samples recorded in d6-acetone, chemical shifts are quoted in parts per million relative to 
acetone (δH 2.05, central line of quintet) and d6-acetone (δC 29.8, central line of septet). 
Carbon NMR spectra were recorded with broad band proton decoupling and assigned 
using DEPT experiments. Coupling constants (J) are quoted in Hertz. Melting points were 
carried out on a Gallenkamp melting point apparatus. Infrared spectra were recorded on 
an ATI Mattson Genesis FT-IR spectrometer. Electrospray high and low resonance mass 
spectra were recorded at room temperature on a Bruker Daltronics microOTOF 
spectrometer.  
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  General Procedures 
General Procedure A: Synthesis of N-H sulfoximines 
A solution of the sulfide (20.0 mmol, 1.0 eq.), (diacetoxyiodo)benzene (16.11 g, 50.0 
mmol, 2.5 eq) and ammonium carbamate (3.12 g, 20.0 mmol, 2.0 eq.) in MeOH (40 mL) 
was stirred at rt for 3 h. The solvent was evaporated under reduced pressure to give the 
crude product.  
 
General Procedure B: Synthesis of N-TBDPS sulfoximines from N-H sulfoximines 
TBDPSCl (12.5 mmol, 1.25 eq. or 9.0 mmol, 0.9 eq.) was added dropwise to a stirred 
solution of the N-H sulfoximine (10.0 mmol, 1.0 eq.) and imidazole (20.0 mmol, 2.0 eq.) 
in DMF (3 mL) under Ar at 0 °C or rt. The resulting solution was stirred and heated at 90 
°C for 48 h. The solution was allowed to cool to rt and then water (5 mL) was added to 
the solution. The two layers were separated and the aqueous layer was extracted with 
Et2O (3 × 20 mL). The combined organic layers were washed with brine (5 × 60 mL), 
dried (MgSO4) and evaporated under reduced pressure to give the crude product.  
 
General Procedure C: Lithiation-trapping of acyclic sulfoximines  
n-BuLi (1.5–2.5 M solution in hexanes, 1.1 eq.) was added dropwise to a stirred solution 
of the sulfoximine (0.5 mmol, 1.0 eq.) in THF (5 mL) at ‒78 °C under Ar. The resulting 
solution was stirred at ‒78 °C for 20 min. Then, the electrophile (1.0 mmol, 2.0 eq. or 
0.65 mmol, 1.3 eq.) (as a solution in THF for benzophenone, NFSI and N-
benzylideneanailine) was added dropwise. The resulting solution was stirred at the 
desired temperature for the desired duration and then allowed to warm to rt. Then, water 
(5 mL) was added and the two layers were separated. The aqueous layer was extracted 
with CH2Cl2 (3 × 20 mL). The combined organic layers were dried (MgSO4) and 
evaporated under reduced pressure to give the crude product.  
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  Experimental Procedures and Characterisation Data 
Diethyl(imino)-λ⁶-sulfanone 97 
 
Using general procedure A, diethyl sulfide 96 (2.16 mL, 20.0 mmol, 1.0 eq.), 
(diacetoxyiodo)benzene (16.11 g, 50.0 mmol, 2.5 eq.) and ammonium carbamate (3.12 g, 
40.0 mmol, 2.0 eq.) in MeOH (40 mL) gave the crude product. Purification by flash 
column chromatography on silica with EtOAc and then 9:1 EtOAc-MeOH as eluent gave 
sulfoximine 97 (2.22 g, 92%) as a yellow oil, RF (9:1 EtOAc-MeOH) 0.13; IR (ATR) 
3401 (NH), 3260 (NH), 2981, 2943, 1666, 1457, 1414, 1186, 1103, 972, 781, 717, 495 
cm−1; 1H NMR (400 MHz, CDCl3) δ 3.03 (q, J = 7.5 Hz, 4H, SCH2), 2.41 (s, 1H, NH), 
1.38 (t, J = 7.5 Hz, 6H, SCH2Me); 
13C NMR (100.6 MHz, CDCl3) δ 48.3 (SCH2), 7.1 
(SCH2Me); MS (ESI) m/z 122 (M + H)
+; HRMS (ESI) m/z calcd for C4H11NOS (M + H)
+ 
122.0634, found 122.0630 (+3.8 ppm error). Spectroscopic data are consistent with those 
reported in the literature.51 
Lab book reference: AH-1-28 
  
[(tert-Butyldiphenylsilyl)imino]diethyl-λ⁶-sulfanone 86 
 
Using general procedure B, TBDPSCl (2.75 mL, 10.58 mmol, 1.25 eq.), sulfoximine 97 
(1.02 g, 8.46 mmol, 1.0 eq.) and imidazole (1.15 g, 16.9 mmol, 2.0 eq.) in DMF (3 mL) 
added at 0 °C gave the crude product. Purification by flash column chromatography on 
silica with 9:1 hexane-EtOAc as eluent gave N-TBDPS sulfoximine 86 (2.42 g, 80%) as 
a clear oil, RF (6:4 hexane-EtOAc) 0.42; IR (ATR) 3069, 2931, 2855, 1427, 1311, 1281, 
1263, 1148, 1107, 821, 783, 738, 701, 625, 615, 589, 502 cm−1; 1H NMR (400 MHz, 
CDCl3) δ 7.77–7.74 (m, 4H, Ph), 7.40–7.32 (m, 6H, Ph), 2.89–2.74 (m, 4H, SCH2), 1.24 
(t, J = 7.5 Hz, 6H, SCH2Me), 1.07 (s, 9H, CMe3); 
13C NMR (100.6 MHz, CDCl3) δ 136.9 
(ipso-Ph), 135.7 (Ph), 129.1 (Ph), 127.5 (Ph), 49.7 (SCH2), 27.3 (CMe3), 19.5 (CMe3), 
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7.9 (SCH2Me); MS (ESI) m/z 360 (M + H)
+; HRMS (ESI) m/z calcd for C20H29NOSSi (M 
+ H)+ 360.1812, found 360.1808 (+0.9 ppm error). 
Lab book reference: AH-1-21 
 
Ethyl(imino)phenyl-λ⁶-sulfanone 98 
 
Using general procedure A, ethyl phenyl sulfide 186 (0.41 mL, 3.0 mmol, 1.0 eq.), 
(diacetoxyiodo)benzene (2.42 g, 7.5 mmol, 2.5 eq.) and ammonium carbamate (468 mg, 
6.0 mmol, 2.0 eq.) in MeOH (6 mL) gave the crude product. Purification by flash column 
chromatography on silica with EtOAc and then 9:1 EtOAc-MeOH as eluent gave 
sulfoximine 98 (295 mg, 58%) as a yellow oil, RF (9:1 EtOAc-MeOH) 0.49; IR (ATR) 
3268 (NH), 3063, 2938, 2878, 1446, 1209, 1096, 971, 761, 690, 568, 510 cm−1; 1H NMR 
(400 MHz, CDCl3) δ 7.96 (d, J = 7.5 Hz, 2H, Ph), 7.61 (t, J = 7.5 Hz, 1H, Ph), 7.54 (dd, 
J = 7.5, 7.5 Hz, 2H, Ph), 3.17 (q, J = 7.5 Hz, 2H, SCH2), 2.91 (br s, 1H, NH), 1.25 (t, J = 
7.5 Hz, 3H, SCH2Me); 
13C NMR (100.6 MHz, CDCl3) δ 141.4 (ipso-Ph), 133.2 (Ph), 
129.3 (Ph), 128.7 (Ph), 51.9 (SCH2), 8.0 (SCH2Me); MS (ESI) m/z 170 (M + H)
+; HRMS 
(ESI) m/z calcd for C8H11NOS (M + H)
+ 170.0634, found 170.0633 (+0.9 ppm error). 
Spectroscopic data are consistent with those reported in the literature.50 
Lab book reference: AH-1-29 
 
Imino(methyl)phenyl-λ⁶-sulfanone 99 
 
Using general procedure A, methyl phenyl sulfide 187 (0.35 mL, 3.0 mmol, 1.0 eq.), 
(diacetoxyiodo)benzene (2.42 g, 7.5 mmol, 2.5 eq.) and ammonium carbamate (468 mg, 
6.0 mmol, 2.0 eq.) in MeOH (6 mL) gave the crude product. Purification by flash column 
chromatography on silica with EtOAc and then 9:1 EtOAc-MeOH as eluent gave 
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sulfoximine 99 (145 mg, 31%) as a yellow oil, RF (9:1 EtOAc-MeOH) 0.40; IR (ATR) 
3266 (NH), 3063, 2928, 1446, 1218, 1098, 1010, 994, 742, 689, 524, 506 cm−1; 1H NMR 
(400 MHz, CDCl3) δ 8.01 (d, J = 7.5 Hz, 2H, Ph), 7.61 (t, J = 7.5 Hz, 1H, Ph), 7.55 (dd, 
J = 7.5, 7.5 Hz, 2H, Ph), 3.11 (s, 3H, SMe), 2.96 (br s, 1H, NH); 13C NMR (100.6 MHz, 
CDCl3) δ 143.5 (ipso-Ph), 133.2 (Ph), 129.4 (Ph), 127.8 (Ph), 46.2 (SMe); MS (ESI) m/z 
156 (M + H)+; HRMS (ESI) m/z calcd for C7H9NOS (M + H)
+ 156.0478, found 156.0473 
(+2.9 ppm error). Spectroscopic data are consistent with those reported in the literature.50 
Lab book reference: AH-1-31 
 
Ethyl(imino)isopropyl-λ⁶-sulfanone 100 
 
Using general procedure A, isopropyl ethyl sulfide 188 (0.64 mL, 5.0 mmol, 1.0 eq.), 
(diacetoxyiodo)benzene (4.03 g, 12.5 mmol, 2.5 eq.) and ammonium carbamate (781 mg, 
10.0 mmol, 2.0 eq.) in MeOH (10 mL) gave the crude product. Purification by flash 
column chromatography on silica with EtOAc and then 9:1 EtOAc-MeOH as eluent gave 
sulfoximine 100 (574 mg, 85%) as a yellow oil, RF (9:1 EtOAc-MeOH) 0.19; IR (ATR) 
3269 (NH), 2981, 2941, 1647, 1460, 1193, 995, 713 cm−1; 1H NMR (400 MHz, CDCl3) 
δ 3.17 (septet, J = 7.5 Hz, 1H, SCH), 3.01 (q, J = 7.5 Hz, 2H, SCH2), 2.57 (br s, 1H, NH), 
1.41–1.33 (m, 9H, SCH2Me, SCHMe2); 13C NMR (100.6 MHz, CDCl3) δ 53.7 (SCH), 
45.5 (SCH2), 16.1 (SCHMe), 15.4 (SCHMe), 6.5 (SCH2Me); MS (ESI) m/z 136 (M + H)
+; 
HRMS (ESI) m/z calcd for C5H13NOS (M + H)
+ 136.0791, found 136.0791 (−0.1 ppm 
error). 
Lab book reference: AH-1-32 
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tert-Butyl(imino)methyl-λ⁶-sulfanone 101 
 
Using general procedure A, tert-butyl methyl sulfide 189 (2.21 mL, 17.5 mmol, 1.0 eq.), 
(diacetoxyiodo)benzene (14.09 g, 43.75 mmol, 2.5 eq.) and ammonium carbamate (2.73 
g, 35.0 mmol, 2.0 eq.) in MeOH (40 mL) gave the crude product. Purification by flash 
column chromatography on silica with EtOAc and then 9:1 EtOAc-MeOH as eluent gave 
sulfoximine 101 (1.99 g, 84%) as a yellow oil, RF (9:1 EtOAc-MeOH) 0.26; IR (ATR) 
3413 (NH), 3270 (NH), 2977, 2939, 1667, 1369, 1197, 1004, 941, 752, 588, 482 cm−1; 
1H NMR (400 MHz, CDCl3) δ 2.86 (s, 3H, SMe), 2.24 (br s, 1H, NH), 1.43 (s, 9H, CMe3); 
13C NMR (100.6 MHz, CDCl3) δ 60.3 (CMe3), 36.1 (SMe), 24.0 (CMe3); MS (ESI) m/z 
136 (M + H)+; HRMS (ESI) m/z calcd for C5H13NOS (M + H)
+ 136.0791, found 136.0789 
(+1.0 ppm error). Spectroscopic data are consistent with those reported in the literature.50 
Lab book reference: AH-1-30 
 
Ethyl(imino)(2-methylphenyl)-λ⁶-sulfanone 102 
 
Using general procedure A, 2-(ethylsulfanyl)-1-methylbenzene 113 (2.81 g, 18.4 mmol, 
1.0 eq.), (diacetoxyiodo)benzene (14.82 g, 46.0 mmol, 2.5 eq.) and ammonium carbamate 
(2.87 g, 36.8 mmol, 2.0 eq.) in MeOH (40 mL) gave the crude product. Purification by 
flash column chromatography on silica with EtOAc and then 9:1 EtOAc-MeOH as eluent 
gave sulfoximine 102 (3.06 g, 91%) as a yellow oil, RF (9:1 EtOAc-MeOH) 0.42; IR 
(ATR) 3271 (NH), 2978, 2938, 1456, 1210, 1072, 970, 804, 764, 718, 515, 474 cm−1; 1H 
NMR (400 MHz, CDCl3) δ 8.05 (d, J = 7.5 Hz, 1H, Ar), 7.48 (dd, J = 7.5, 7.5 Hz, 1H, 
Ar), 7.38–7.29 (m, 2H, Ar), 4.69 (br s, NH), 3.24 (q, J = 7.5 Hz, 2H, SCH2), 2.73 (s, 3H, 
ArMe), 1.25 (td, J = 7.5, 2.0 Hz, 3H, SCH2Me); 
13C NMR (100.6 MHz, CDCl3) δ 139.4 
(ipso-Ar), 138.1 (ipso-Ar), 133.2 (Ar), 133.1 (Ar), 130.8 (Ar), 126.7 (Ar), 50.1 (SCH2), 
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21.0 (ArMe), 7.7 (SCH2Me); MS (ESI) m/z 184 (M + H)
+; HRMS (ESI) m/z calcd for 
C9H13NOS (M + H)
+ 184.0791, found 184.0792 (−1.0 ppm error). 
Lab book reference: AH-1-58 
 
Adamantan-1-yl(ethyl)imino-λ⁶-sulfanone 103 
 
Using general procedure A, adamantyl ethyl sulfide 114 (2.42 g, 12.7 mmol, 1.0 eq.), 
(diacetoxyiodo)benzene (10.23 g, 31.75 mmol, 2.5 eq.) and ammonium carbamate (1.98 
g, 25.4 mmol, 2.0 eq.) in MeOH (30 mL) gave the crude product. Purification by flash 
column chromatography on silica with EtOAc and then 9:1 EtOAc-MeOH as eluent gave 
sulfoximine 103 (2.21 g, 77%) as a yellow oil, RF (9:1 EtOAc-MeOH) 0.39; IR (ATR) 
3275 (NH), 2908, 2851, 1453, 1198, 976, 957, 704, 575 cm−1; 1H NMR (400 MHz, 
CDCl3) δ 3.00–2.85 (m, 2H, SCH2), 2.24–2.14 (m, 3H, CH), 2.08–1.97 (m, 6H, CH2), 
1.92–1.79 (m, 1H, NH), 1.79–1.66 (m, 6H, CH2), 1.41 (t, J = 7.5 Hz, 3H, SCH2Me); 13C 
NMR (100.6 MHz, CDCl3) δ 61.5 (SC), 40.2 (SCH2), 36.5 (CH2), 36.0 (CH2), 35.2 (CH2), 
28.7 (CH), 28.6 (CH), 5.4 (SCH2Me); MS (ESI) m/z 228 (M + H)
+; HRMS (ESI) m/z 
calcd for C12H21NOS (M + H)
+ 228.1417, found 228.1416 (+0.4 ppm error). 
Lab book reference: AH-1-82 
 
(tert-Butyldiphenylsilyl)[ethyl(oxo)phenyl-λ⁶-sulfanylidene]amine 87 
 
Using general procedure B, TBDPSCl (4.83 mL, 18.56 mmol, 1.25 eq.), sulfoximine 98 
(2.51 g, 14.84 mmol, 1.0 eq.) and imidazole (2.02 g, 29.68 mmol, 2.0 eq.) in DMF (6 mL) 
added at 0 °C gave the crude product. Purification by flash column chromatography on 
silica with 95:5 hexane-EtOAc as eluent gave impure sulfoximine 87 (6.261 g). Further 
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purification by flash column chromatography on silica with 80:20 hexane-Et2O gave N-
TPDPS sulfoximine 87 (963 mg, 16%) as a colourless oil, RF (6:4 hexane-EtOAc) 0.56; 
IR (ATR) 3069, 2931, 2855, 1427, 1323, 1295, 1152, 1107, 908, 732, 701, 689, 497 cm−1; 
1H NMR (400 MHz, CDCl3) δ 7.84 (dd, J = 7.5, 1.5 Hz, 2H, Ph), 7.77–7.68 (m, 4H, Ph), 
7.49 (tt, J = 7.5, 1.5 Hz, 1H, Ph), 7.44–7.26 (m, 8H, Ph), 3.01 (dq, J = 14.0, 7.5 Hz, 1H, 
SCH), 2.91 (dq, J = 14.0, 7.5 Hz, 1H, SCH), 1.12–1.05 (m, 12H, CMe3, SCH2Me); 13C 
NMR (100.6 MHz, CDCl3) δ 142.2 (ipso-Ph), 136.7 (ipso-Ph), 136.6 (ipso-Ph), 135.8 
(Ph), 135.7 (Ph), 132.3 (Ph), 129.1 (Ph), 129.0 (Ph), 128.8 (Ph), 128.0 (Ph), 127.5 (Ph), 
127.4 (Ph), 54.8 (SCH2), 27.3 (CMe3), 19.6 (CMe3), 8.5 (SCH2Me); MS (ESI) m/z 408 
(M + H)+; HRMS (ESI) m/z calcd for C29H29NOSSi (M + H)
+ 408.1812, found 408.1807 
(+1.2 ppm error).  
Lab book reference: AH-1-7 
 
(tert-Butyldiphenylsilyl)[methyl(oxo)phenyl-λ⁶-sulfanylidene]amine 19 
 
Using general procedure B, TBDPSCl (3.67 mL, 14.13 mmol, 1.25 eq.), sulfoximine 99 
(1.75 g, 11.3 mmol, 1.0 eq.) and imidazole (1.54 g, 22.6 mmol, 2.0 eq.) in DMF (4 mL) 
added at 0 °C gave the crude product. Purification by flash column chromatography on 
silica with 9:1 hexane-Et2O as eluent gave N-TBDPS sulfoximine 19 (987 mg, 22%) as a 
white solid, mp 58–60 °C; RF (8:2 hexane-Et2O) 0.25, IR (ATR) 3068, 2930, 2856, 1427, 
1326, 1295, 1165, 1108, 956, 821, 742, 702, 650, 600, 498 cm−1; 1H NMR (400 MHz, 
CDCl3) δ 7.94 (d, J = 8.0 Hz, 2H, Ph), 7.77 (d, J = 8.0 Hz, 2H, Ph), 7.71 (d, J = 7.5 Hz, 
2H, Ph), 7.51 (t, J = 7.5 Hz, 1H, Ph), 7.45 (t, J = 8.0 Hz, 2H, Ph), 7.40–7.27 (m, 6H, Ph), 
2.86 (s, 3H, SMe), 1.10 (s, 9H, CMe3); 
13C NMR (100.6 MHz, CDCl3) δ 144.6 (ipso-Ph), 
136.5 (ipso-Ph), 136.4 (ipso-Ph), 135.8 (Ph), 135.7 (Ph), 132.3 (Ph), 129.2 (Ph), 129.1 
(Ph), 129.0 (Ph), 127.6 (Ph), 127.5 (Ph), 127.1 (Ph), 49.1 (SMe), 27.3 (CMe3), 19.5 
(CMe3); MS (ESI) m/z 394 (M + H)
+; HRMS (ESI) m/z calcd for C32H27NOSSi (M + H)
+ 
394.1656, found 394.1655 (−0.2 ppm error). Spectroscopic data are consistent with those 
reported in the literature.54 
Chapter Four: Experimental 
 
80 
 
Lab book reference: AH-1-12 
 
[(tert-Butyldiphenylsilyl)imino](ethyl)isopropyl-λ⁶-sulfanone 104 
 
Using general procedure B, TBDPSCl (6.27 mL, 24.1 mmol, 1.25 eq.), sulfoximine 100 
(2.60 g, 19.28 mmol, 1.0 eq.) and imidazole (2.63 g, 38.56 mmol, 2.0 eq.) in DMF (6 mL) 
added at 0 °C gave the crude product. Purification by flash column chromatography on 
silica with 9:1 hexane-Et2O as eluent gave N-TBDPS sulfoximine 104 (3.33 g, 46%) as a 
colourless oil, RF (8:2 hexane-Et2O) 0.15; IR (ATR) 3069, 2931, 2855, 1427, 1309, 1143, 
1107, 821, 734, 701, 612, 503 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.79–7.70 (m, 4H, 
Ph), 7.40–7.29 (m, 6H, Ph), 3.05 (septet, J = 7.0 Hz, 1H, SCH), 2.81–2.66 (m, 2H, SCH2), 
1.32 (d, J = 7.0 Hz, 3H, SCHMe), 1.29 (d, J = 7.0 Hz, 3H, SCHMe), 1.13 (t, J = 7.5 Hz, 
3H, SCH2Me), 1.06 (s, 9H, CMe3); 
13C NMR (100.6 MHz, CDCl3) δ 137.1 (ipso-Ph), 
136.9 (ipso-Ph), 135.82 (Ph), 135.75 (Ph), 129.0 (Ph), 127.5 (Ph), 54.3 (SCH2), 47.3 
(SCH), 27.4 (CMe3), 19.6 (CMe3), 16.7 (SCHMe), 15.4 (SCHMe), 7.6 (SCH2Me) (two 
Ph resonances not resolved); MS (ESI) m/z 374 (M + H)+; HRMS (ESI) m/z calcd for 
C21H31NOSSi (M + H)
+ 374.1968, found 374.1971 (−0.8 ppm error).  
Lab book reference: AH-1-9 
 
Using general procedure B, TBDPSCl (1.14 mL, 4.38 mmol, 1.25 eq.), sulfoximine 100 
(473 mg, 3.5 mmol, 1.0 eq.) and imidazole (477 mg, 7.0 mmol, 2.0 eq.) in DMF (3 mL) 
added at rt gave the crude product. Purification by flash column chromatography on silica 
with 85:15 hexane-Et2O as eluent gave N-TBDPS sulfoximine 104 (1.19 g, 91%) as a 
colourless oil. 
Lab book reference: AH-1-39 
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tert-Butyl[(tert-butyldiphenylsilyl)imino]methyl-λ⁶-sulfanone 105 
 
Using general procedure B, TBDPSCl (4.63 mL, 17.79 mmol, 1.25 eq.), sulfoximine 101 
(1.92 g, 14.23 mmol, 1.0 eq.) and imidazole (1.94 g, 28.46 mmol, 2.0 eq.) in DMF (6 mL) 
added at 0 °C gave the crude product. Purification by flash column chromatography on 
silica with 9:1 hexane-Et2O as eluent gave N-TBDPS sulfoximine 105 (3.90 g, 73%) as a 
white solid, mp 74–76 °C; RF (8:2 hexane-Et2O) 0.13, IR (ATR) 3069, 2958, 2930, 2855, 
1427, 1315, 1294, 1137, 1108, 953, 821, 741, 722, 701, 671, 604, 507 cm−1; 1H NMR 
(400 MHz, CDCl3) δ 7.77 (dd, J = 8.0, 2.0 Hz, 2H, Ph), 7.72 (dd, J = 8.0, 2.0 Hz, 2H, 
Ph), 7.41–7.30 (m, 6H, Ph), 2.45 (s, 3H, SMe), 1.43 (s, 9H, SCMe3), 1.07 (s, 9H, SiCMe3); 
13C NMR (100.6 MHz, CDCl3) δ 136.1 (ipso-Ph), 136.7 (ipso-Ph), 135.9 (Ph), 135.8 (Ph), 
129.12 (Ph), 129.08 (Ph), 127.5 (Ph), 60.6 (SCMe3), 37.6 (SMe), 27.3 (SiCMe3), 23.9 
(SCMe3), 19.6 (SiCMe3) (one Ph resonance not resolved); MS (ESI) m/z 374 (M + H)
+; 
HRMS (ESI) m/z calcd for C21H31NOSSi (M + H)
+ 374.1968, found 374.1966 (+0.6 ppm 
error). 
Lab book reference: AH-1-23 
 
Using general procedure B, TBDPSCl (3.74 mL, 14.38 mmol, 1.25 eq.), sulfoximine 101 
(1.55 g, 11.5 mmol, 1.0 eq.) and imidazole (1.57 g, 23.0 mmol, 2.0 eq.) in DMF (5 mL) 
added at rt gave the crude product. Purification by flash column chromatography on silica 
with 9:1 hexane-Et2O as eluent gave N-TBDPS sulfoximine 105 (3.28 g, 76%) as a white 
solid. 
Lab book reference: AH-2-12  
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(tert-Butyldiphenylsilyl)[ethyl(2-methylphenyl)oxo-λ⁶-sulfanylidene]amine 106 
 
Using general procedure B, TBDPSCl (5.33 mL, 20.5 mmol, 1.25 eq.), sulfoximine 102 
(3.00 g, 16.4 mmol, 1.0 eq.) and imidazole (2.23 g, 32.8 mmol, 2.0 eq.) in DMF (6 mL) 
added at rt gave the crude product. Purification by flash column chromatography on silica 
with 95:5 hexane-Et2O as eluent gave impure sulfoximine 106. Further purification by 
flash column chromatography on silica with 90:7:3 hexane-CH2Cl2-acetone as eluent 
gave impure sulfoximine 106. Further purification by flash column chromatography on 
silica with 50:50 hexane-CH2Cl2 gave N-TPDPS sulfoximine 106 (903 mg, 13%) as a 
colourless oil, RF (9:1 CH2Cl2-hexane) 0.37; IR (ATR) 3069, 2931, 2855, 1427, 1305, 
1156, 1107, 821, 741, 701, 601, 500 cm−1; 1H NMR (400 MHz, CDCl3) δ 8.02 (dd, J = 
7.5, 1.0 Hz, 1H, Ar), 7.74 (dd, J = 7.5, 1.0 Hz, 2H, Ar), 7.68 (dd, J = 7.5, 1.0 Hz, 2H, Ar), 
7.39–7.20 (m, 8H, Ar), 7.18 (d, J = 7.5 Hz, 1H, Ar), 3.12 (dq, J = 14.0, 7.5 Hz, 1H, SCH), 
3.00 (dq, J = 14.0, 7.5 Hz, 1H, SCH), 2.62 (s, 3H, ArMe), 1.12–1.04 (m, 12H, CMe3, 
SCH2Me); 
13C NMR (100.6 MHz, CDCl3) δ 140.1 (ipso-Ar), 137.2 (ipso-Ar), 136.7 (ipso-
Ar), 136.6 (ipso-Ar), 135.8 (Ar), 135.7 (Ar), 132.7 (Ar), 132.3 (Ar), 130.4 (Ar), 129.0 
(Ar), 127.39 (Ar), 127.35 (Ar), 126.2 (Ar), 53.4 (SCH2), 27.4 (CMe3), 20.8 (ArMe), 19.6 
(CMe3), 8.2 (SCH2Me) (one Ar resonance not resolved); MS (ESI) m/z 422 (M + H)
+; 
HRMS (ESI) m/z calcd for C25H31NOSSi (M + H)
+ 422.1968, found 422.1974 (−1.4 ppm 
error).  
Lab book reference: AH-1-59 
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[Adamantan-1-yl(ethyl)oxo-λ⁶-sulfanylidene](tert-butyldiphenylsilyl)amine 107 
 
Using general procedure B, TBDPSCl (3.15 mL, 12.1 mmol, 1.25 eq.), sulfoximine 103 
(2.20 g, 9.68 mmol, 1.0 eq.) and imidazole (1.32 g, 19.36 mmol, 2.0 eq.) in DMF (4 mL) 
added at 0 °C gave the crude product. Purification by flash column chromatography on 
silica with 95:5 hexane-Et2O as eluent gave impure 107. Further purification by flash 
column chromatography on silica with 8:2 and then 1:1 hexane-CH2Cl2 as eluent gave N-
TBDPS sulfoximine 107 (445 mg, 10%) as a clear oil, RF (1:1 hexane-CH2Cl2) 0.25; IR 
(ATR) 2910, 2853, 1427, 1325, 1301, 1252, 1155, 1107, 821, 734, 702, 634, 598, 504 
cm−1; 1H NMR (400 MHz, CDCl3) δ 7.82–7.78 (m, 2H, Ph), 7.78–7.74 (m, 2H, Ph), 7.40–
7.31 (m, 6H, Ph), 2.80 (dq, J = 14.0, 7.0 Hz, 1H, SCH), 2.70 (dq, J = 14.0, 7.0 Hz, 1H, 
SCH), 2.16–2.09 (m, 3H, CH), 2.06–1.99 (m, 6H, CH), 1.74–1.66 (m, 3H, CH), 1.66–
1.59 (m, 3H, CH), 1.06 (s, 9H, CMe3), 0.97 (t, J = 7.0 Hz, 3H, SCH2Me); 
13C NMR (100.6 
MHz, CDCl3) δ 137.3 (ipso-Ph), 137.1 (ipso-Ph), 135.9 (Ph), 135.8 (Ph), 128.9 (Ph), 
127.4 (Ph), 127.3 (Ph), 62.6 (SC), 43.0 (SCH2), 36.1 (CH2), 35.5 (CH2), 28.7 (CH), 27.4 
(CMe3), 19.8 (CMe3), 6.6 (SCH2Me) (one Ph resonance not resolved); MS (ESI) m/z 466 
(M + H)+; HRMS (ESI) m/z calcd for C28H39NOSSi (M + H)
+ 466.2594, found 466.2591 
(+0.7 ppm error). 
Lab book reference: AH-1-83 
 
Benzyl(tert-butyl)imino-λ⁶-sulfanone 108 
 
Using general procedure A, tert-butyl benzyl sulfide 118 (3.58 g, 19.85 mmol, 1.0 eq.), 
(diacetoxyiodo)benzene (15.99 g, 49.65 mmol, 2.5 eq.) and ammonium carbamate (3.10 
g, 39.7 mmol, 2.0 eq.) in MeOH (40 mL) gave the crude product. Purification by flash 
column chromatography on silica with 50:50 hexane-EtOAc and then EtOAc as eluent 
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gave sulfoximine 108 (1.75 g, 42%) as a white solid, mp 118–120 °C; RF (EtOAc) 0.32, 
IR (ATR) 3316 (NH), 2974, 1213, 1136, 1099, 963, 767, 702, 518, 472 cm−1; 1H NMR 
(400 MHz, CDCl3) δ 7.42–7.37 (m, 5H, Ph), 4.30 (d, J = 12.0 Hz, 1H, SCH), 4.06 (d, J = 
12.0 Hz, 1H, SCH2), 2.37 (s, 1H, NH), 1.54 (s, 9H, SCMe3); 
13C NMR (100.6 MHz, 
CDCl3) δ 131.7 (Ph), 128.94 (Ph), 128.90 (Ph), 127.5 (ipso-Ph), 59.9 (SCMe3), 54.7 
(SCH2), 24.3 (SCMe3); MS (ESI) m/z 234 (M + Na)
+; HRMS (ESI) m/z calcd for 
C11H17NOS (M + Na)
+ 234.0923, found 234.0920 (+1.2 ppm error). 
Lab book reference: AH-1-89 
 
Benzyl(imino)methyl-λ⁶-sulfanone 109 
 
Using general procedure A, methyl benzyl sulfide 190 (2.72 mL, 20.0 mmol, 1.0 eq.), 
(diacetoxyiodo)benzene (16.11 g, 50.0 mmol, 2.5 eq.) and ammonium carbamate (3.12 g, 
40.0 mmol, 2.0 eq.) in MeOH (40 mL) gave the crude product. Purification by flash 
column chromatography on silica with EtOAc and then 9:1 EtOAc-MeOH as eluent gave 
sulfoximine 109 (1.15 g, 34%) as a pale orange solid, mp 74–76 °C (lit.,53 mp 82–84 °C); 
RF (9:1 EtOAc-MeOH) 0.31, IR (ATR) 3270 (NH), 2927, 1671, 1456, 1216, 1019, 782, 
701, 499 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.45–7.36 (m, 5H, Ph), 4.40 (d, J = 13.0 
Hz, 1H, SCH), 4.26 (d, J = 13.0 Hz, 1H, SCH), 2.93 (s, 3H, SMe), 2.06 (br s, 1H, NH); 
13C NMR (100.6 MHz, CDCl3) δ 130.9 (Ph), 129.23 (Ph), 129.15 (Ph), 128.5 (ipso-Ph), 
64.1 (SCH2), 41.5 (SMe); MS (ESI) m/z 192 (M + Na)
+; HRMS (ESI) m/z calcd for 
C8H11NOS (M + Na)
+ 192.0454, found 192.0456 (−1.4 ppm error). Spectroscopic data 
are consistent with those reported in the literature.53 
Lab book reference: AH-2-4 
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Benzyl(tert-butyl)[(tert-butyldiphenylsilyl)imino]-λ⁶-sulfanone 110 
 
Using general procedure B, TBDPSCl (1.94 mL, 7.45 mmol, 0.9 eq.), sulfoximine 108 
(1.75 g, 8.28 mmol, 1.0 eq.) and imidazole (1.13 g, 16.56 mmol, 2.0 eq.) in DMF (3 mL) 
added at rt gave the crude product. Purification by flash column chromatography on silica 
with 9:1 hexane-EtOAc as eluent gave N-TBDPS sulfoximine 110 (1.93 g, 52%) as a 
clear oil, RF (9:1 hexane-EtOAc) 0.37; IR (ATR) 3069, 2930, 2855, 1427, 1300, 1150, 
1123, 1108, 821, 799, 502 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.68 (dd, J = 7.0, 3.0 Hz, 
2H, Ph), 7.62 (dd, J = 7.0, 3.0 Hz, 2H, Ph), 7.37–7.27 (m, 6H, Ph), 7.24–7.13 (m, 5H, 
Ph), 4.17 (d, J = 14.0 Hz, 1H, SCH), 3.98 (d, J = 14.0 Hz, 1H, SCH), 1.31 (s, 9H, SCMe3), 
0.96 (s, 9H, CMe3); 
13C NMR (100.6 MHz, CDCl3) δ 137.1 (ipso-Ph), 136.7 (ipso-Ph), 
135.9 (Ph), 135.8 (Ph), 131.4 (Ph), 129.7 (ipso-Ph), 128.87 (Ph), 128.85 (Ph), 128.4 (Ph), 
128.2 (Ph), 127.31 (Ph), 127.29 (Ph), 63.1 (SCMe3), 57.6 (SCH2), 27.3 (SiCMe3), 24.6 
(SCMe3), 19.6 (SiCMe3) (three Ph resonances not resolved); MS (ESI) m/z 450 (M + H)
+; 
HRMS (ESI) m/z calcd for C27H35NOSSi (M + H)
+ 450.2281, found 450.2270 (+2.6 ppm 
error). 
Lab book reference: AH-1-90 
 
Benzyl[(tert-butyldiphenylsilyl)imino]methyl-λ⁶-sulfanone 43 
 
Using general procedure B, TBDPSCl (1.58 mL, 6.09 mmol, 0.9 eq.), sulfoximine 109 
(1.15 g, 6.77 mmol, 1.0 eq.) and imidazole (0.92 g, 13.54 mmol, 2.0 eq.) in DMF (3 mL) 
added at rt gave the crude product. Purification by flash column chromatography on silica 
with 95:5 and then 9:1 hexane-EtOAc as eluent gave N-TBDPS sulfoximine 43 (1.84 g, 
67%) as a white solid, mp 80–82 °C; RF (6:4 hexane-EtOAc) 0.24; IR (ATR) 3068, 2929, 
2855, 1427, 1319, 1297, 1123, 1140, 1108, 821, 700, 601, 500 cm−1; 1H NMR (400 MHz, 
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CDCl3) δ 7.66 (dd, J = 8.0, 2.0 Hz, 2H, Ph), 7.62 (dd, J = 8.0, 2.0 Hz, 2H, Ph), 7.39–7.28 
(m, 11H, Ph), 4.16 (d, J = 13.5 Hz, 1H, SCH), 4.10 (d, J = 13.5 Hz, 1H, SCH), 2.53 (s, 
3H, SMe), 1.03 (s, 9H, CMe3); 
13C NMR (100.6 MHz, CDCl3) δ 136.5 (ipso-Ph), 136.3 
(ipso-Ph), 135.8 (Ph), 135.7 (Ph), 131.0 (Ph), 130.3 (ipso-Ph), 129.21 (Ph), 129.17 (Ph), 
128.8 (Ph), 128.7 (Ph), 127.6 (Ph), 65.6 (SCH2), 43.1 (SMe), 27.2 (CMe3), 19.4 (CMe3) 
(one Ph resonance not resolved); MS (ESI) m/z 408 (M + H)+; HRMS (ESI) m/z calcd for 
C24H29NOSSi (M + H)
+ 408.1812, found 408.1806 (+1.5 ppm error). 
Lab book reference: AH-2-6 
 
1-(Ethylsulfanyl)-2-methylbenzene 113 
 
Bromoethane (1.64 mL, 22.0 mmol, 1.1 eq.) was added to a mixture of 2-thiocresol 111 
(2.36 mL, 20.0 mmol, 1.0 eq.), KOH (1.23 g, 22.0 mmol, 1.1 eq.) and Aliquat 336® (0.2 
g, 0.5 mmol, 0.02 eq.) in H2O (10 mL) at rt. The resulting mixture was stirred at rt for 2.5 
h. Then, saturated NH4Cl(aq) (5 mL) was added and the two layers were separated. The 
aqueous layer was extracted with CH2Cl2 (3 × 20 mL). The combined organic layers were 
dried (MgSO4) and evaporated under reduced pressure to give the crude product. 
Purification by flash column chromatography on silica with 98:2 and then 95:5 hexane-
Et2O as eluent gave sulfide 113 (2.82 g, 93%) as a colourless oil, RF (9:1 hexane-Et2O) 
0.59; IR (ATR) 3060, 2972, 2927, 1589, 1468, 1378, 1067, 1049, 741 cm−1; 1H NMR 
(400 MHz, CDCl3) δ 7.26 (dd, J = 7.5, 1.5 Hz, 1H, Ar), 7.19–7.13 (m, 2H, Ar), 7.08 (ddd, 
J = 7.5, 1.5, 1.5 Hz, 1H, Ar), 2.91 (q, J = 7.5 Hz, 2H, SCH2), 2.37 (s, 3H, ArMe), 1.32 (t, 
J = 7.5 Hz, 3H, SCH2Me); 
13C NMR (100.6 MHz, CDCl3) δ 137.3 (ipso-Ar), 136.2 (ipso-
Ar), 130.2 (Ar), 127.4 (Ar), 126.4 (Ar), 125.5 (Ar), 26.9 (SCH2), 20.4 (ArMe), 14.3 
(SCH2Me); MS (APCI) m/z 153 (M + H)
+; HRMS (APCI) m/z calcd for C9H12S (M + H)
+ 
153.0732, found 153.0736 (−2.5 ppm error). Spectroscopic data are consistent with those 
reported in the literature.55 
Lab book reference: AH-1-65 
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1-(Ethylsulfanyl)adamantane 114 
 
Bromoethane (1.3 mL, 17.38 mmol, 1.1 eq.) was added to a mixture of adamantane thiol 
112 (2.66 g, 15.8 mmol, 1.0 eq.), KOH (980 mg, 17.38 mmol, 1.1 eq.) and Aliquat 336® 
(0.17 g, 0.4 mmol, 0.02 eq.) in H2O (10 mL) at rt. The resulting mixture was stirred at rt 
for 1 h. Then, saturated NH4Cl(aq) (5 mL) was added and the two layers were separated. 
The aqueous layer was extracted with CH2Cl2 (3 × 20 mL). The combined organic layers 
were dried (MgSO4) and evaporated under reduced pressure to give the crude product. 
Purification by flash column chromatography on silica with 98:2 and then 95:5 hexane-
Et2O as eluent gave sulfide 114 (2.52 g, 81%) as a colourless oil, RF (9:1 hexane-Et2O) 
0.63; IR (ATR) 2902, 2848, 1448, 1342, 1301, 1252, 1067, 1044, 975 cm−1; 1H NMR 
(400 MHz, CDCl3) δ 2.56 (q, J = 7.5 Hz, 2H, SCH2), 1.99–2.06 (m, 6H, CH), 1.89–1.82 
(m, 3H, CH), 1.74–1.62 (m, 6H, CH), 1.22 (t, J = 7.5 Hz, 3H, SCH2Me); 13C NMR (100.6 
MHz, CDCl3) δ 44.2 (SC), 43.7 (CH2), 36.5 (CH2), 29.8 (CH), 19.7 (SCH2), 15.3 
(SCH2Me); MS (APCI) m/z 197 (M + H)
+; HRMS (APCI) m/z calcd for C12H20S (M + 
H)+ 197.1358, found 197.1355 (−1.6 ppm error). Spectroscopic data are consistent with 
those reported in the literature.56 
Lab book reference: AH-1-81 
 
[(tert-Butylsulfanyl)methyl]benzene 116 
 
Benzyl bromide (2.38 mL, 20.0 mmol, 1.0 eq.) was added to a stirred solution of tert-
butyl mercaptan 115 (2.25 mL, 20.0 mmol, 1.0 eq.) and KOH (1.23 g, 22.0 mmol, 1.1 
eq.) in 1:1 H2O-MeOH (10 mL). The resulting solution was stirred and heated at reflux 
for 16 h. The solution was then allowed to warm to rt. Then, saturated NH4Cl(aq) (5 mL) 
was added and the two layers were separated. The aqueous layer was extracted with 
CH2Cl2 (3 × 20 mL). The combined organic layers were dried (MgSO4) and evaporated 
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under reduced pressure to give the crude product. Purification by flash column 
chromatography on silica with 95:5 hexane-Et2O as eluent gave sulfide 116 (3.58 g, 99%) 
as a colourless oil, RF (9:1 hexane-Et2O) 0.57; IR (ATR) 3029, 2960, 1495, 1454, 1364, 
1167, 711, 695, 481 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.35 (d, J = 7.5 Hz, 2H, Ph), 
7.30 (dd, J = 7.5, 7.5 Hz, 2H, Ph), 7.22 (t, J = 7.5 Hz, 1H, Ph), 3.77 (s, 2H, SCH2), 1.36 
(s, 9H, SCMe3); 
13C NMR (100.6 MHz, CDCl3) δ 138.7 (ipso-Ph), 129.1 (Ph), 128.6 (Ph), 
126.9 (Ph), 43.0 (SCMe3), 33.6 (SCH2), 31.0 (SCMe3); MS (APCI) m/z 181 (M + H)
+; 
HRMS (APCI) m/z calcd for C11H16S (M + H)
+ 181.1045, found 181.1050 (−2.7 ppm 
error). Spectroscopic data are consistent with those reported in the literature.57,58 
Lab book reference: AH-1-88 
 
(tert-Butyldiphenylsilyl)[oxo(phenyl)(2-phenylethyl)-λ⁶-sulfanylidene]amine 117 
 
Using general procedure C, N-TBDPS sulfoximine 87 (680 mg, 1.72 mmol, 1.0 eq.), n-
BuLi (0.82 mL of a 2.3 M solution in hexanes, 1.89 mmol, 1.1 eq.) and benzyl bromide 
(0.41 mL, 3.44 mmol, 2.0 eq.) in THF (17 mL) at ‒78 °C for 1 h gave the crude product. 
Purification by flash column chromatography on silica with 95:5 hexane-EtOAc as eluent 
gave N-TBDPS sulfoximine 117 (682 mg, 82%) as a colourless oil, RF (8:2 hexane-
EtOAc) 0.38; IR (ATR) 2930, 2858, 1427, 1320, 1296, 1154, 1108, 821, 741, 700, 523, 
500 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.90 (d, J = 7.5, 2H, Ph), 7.72–7.80 (m, 4H, Ph), 
7.52 (t, J = 7.5 Hz, 1H, Ph), 7.47–7.40 (m, 2H, Ph), 7.40–7.27 (m, 6H, Ph), 7.21–7.11 (m, 
3H, Ph), 6.88 (d, J = 7.5 Hz, 2H, Ph), 3.31–3.12 (m, 2H, SCH2), 2.89–2.76 (m, 2H, 
CH2Ph), 1.11 (s, 9H, CMe3); 
13C NMR (100.6 MHz, CDCl3) δ 142.6 (ipso-Ph), 138.3 
(ipso-Ph), 136.51 (ipso-Ph), 136.47, (ipso-Ph), 135.8 (Ph), 135.7 (Ph), 132.4 (Ph), 129.2 
(Ph), 129.1 (Ph), 129.0 (Ph), 128.7 (Ph), 128.4 (Ph), 127.9 (Ph), 127.54 (Ph), 127.51 (Ph), 
126.7 (Ph), 61.6 (SCH2), 29.9 (SCH2CH2), 27.5 (CMe3), 19.4 (CMe3); MS (ESI) m/z 484 
[(M + H)+] HRMS (ESI) m/z calcd for C30H33NOSSi (M + H)
+ 484.2125, found 484.2124 
(+0.1 ppm error).  
Lab book reference: AH-1-14 
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tert-Butyl[(tert-butyldiphenylsilyl)imino]ethyl-λ⁶-sulfanone 118 
 
Using general procedure C, N-TBDPS sulfoximine 105 (2.70 g, 7.0 mmol, 1.0 eq.), n-
BuLi (5.13 mL of a 1.5 M solution in hexanes, 7.7 mmol, 1.1 eq.) and methyl iodide (0.87 
mL, 14.0 mmol, 2.0 eq.) in THF (70 mL) at ‒78 °C for 1 h gave the crude product. 
Purification by flash column chromatography on silica with 95:5 hexane-Et2O as eluent 
gave N-TBDPS sulfoximine 118 (2.52 g, 93%) as a white solid, mp 66–68 °C; RF (6:4 
hexane-Et2O) 0.34; IR (ATR) 3070, 2931, 2855, 1473, 1313, 1138, 1107, 821, 736, 701, 
610, 504 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.80 (dd, J = 7.5, 1.5 Hz, 2H, Ph), 7.74 
(dd, J = 7.5, 1.5 Hz, 2H, Ph), 7.40–7.30 (m, 6H, Ph), 2.92-2.71 (m, 2H, SCH2), 1.40 (s, 
9H, SCMe3), 1.05 (s, 9H, SiCMe3), 0.98 (t, J = 7.5 Hz, 3H, SCH2Me); 
13C NMR (100.6 
MHz, CDCl3) δ 137.2 (ipso-Ph), 136.9 (ipso-Ph), 136.0 (Ph), 135.8 (Ph), 129.0 (Ph), 
127.42 (Ph), 127.39 (Ph), 61.5 (SCMe3), 44.3 (SCH2), 27.4 (SiCMe3), 24.3 (SCMe3), 19.9 
(SiCMe3), 6.9 (SCH2Me) (one Ph resonance not resolved); MS (ESI) m/z 388 [(M + H)
+] 
HRMS (ESI) m/z calcd for C22H33NOSSi (M + H)
+ 388.2125, found 388.2120 (+1.2 ppm 
error).  
Lab book reference: AH-2-45 
 
tert-Butyl[(tert-butyldiphenylsilyl)imino](2-phenylethyl)-λ⁶-sulfanone 119 
 
Using general procedure C, N-TBDPS sulfoximine 105 (3.59 g, 9.6 mmol, 1.0 eq.), n-
BuLi (4.24 mL of a 2.5 M solution in hexanes, 10.6 mmol, 1.1 eq.) and benzyl bromide 
(2.28 mL, 19.2 mmol, 2.0 eq.) in THF (100 mL) at ‒78 °C for 1 h gave the crude product. 
Purification by flash column chromatography on silica with 95:5 hexane-Et2O as eluent 
gave N-TBDPS sulfoximine 119 (3.92 g, 88%) as a white solid, mp 88–90 °C; RF (8:2 
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hexane-Et2O) 0.43; IR (ATR) 3068, 2930, 2854, 1427, 1313, 1125, 1106, 820, 740, 698, 
600, 500 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.93 (dd, J = 7.5, 2.0 Hz, 2H, Ph), 7.86 
(dd, J = 7.5, 2.0 Hz, 2H, Ph), 7.48–7.34 (m, 6H, Ph), 7.22–7.11 (m, 3H, Ph), 6.72 (dd, J 
= 7.5, 2.0 Hz, 2H, Ph), 3.15 (ddd, J = 12.5, 12.5, 4.5 Hz, 1H, SCH), 2.96 (ddd, J = 12.5, 
12.5, 4.5 Hz, 1H, SCH), 2.81 (ddd, J = 12.5, 12.5, 4.5 Hz, 1H, CHPh), 2.61 (ddd, J = 
12.5, 12.5, 4.5 Hz, 1H, CHPh), 1.49 (s, 9H, SCMe3), 1.12 (s, 9H, CMe3); 
13C NMR (100.6 
MHz, CDCl3) δ 139.0 (ipso-Ph), 137.2 (ipso-Ph), 136.5 (ipso-Ph), 136.0 (Ph), 135.7 (Ph), 
129.12 (Ph), 129.09 (Ph), 128.6 (Ph), 128.5 (Ph), 127.64 (Ph), 127.55 (Ph), 126.5 (Ph), 
61.7 (SCMe3), 51.4 (SCH2), 28.1 (SCH2CH2), 27.3 (SiCMe3), 24.2 (SCMe3), 19.9 
(SiCMe3); MS (ESI) m/z 464 [(M + H)
+] HRMS (ESI) m/z calcd for C28H37NOSSi (M + 
H)+ 464.2438, found 464.2435 (−0.8 ppm error).  
Lab book reference: AH-1-60 
 
tert-Butyl N-[diethyl(oxo)-λ⁶-sulfanylidene]carbamate 120 
 
A solution of potassium tert-butoxide (1.26 g. 11.23 mmol, 1.3 eq.) in THF (23 mL) was 
added to a stirred solution of sulfoximine 97 (1.05 g, 8.64 mmol, 1.0 eq.) in THF (25 mL) 
at 0 °C under Ar. The resulting solution was stirred at 0 °C for 30 min. Then, a solution 
of Boc2O (3.77 g, 17.28 mmol, 2.0 eq.) in THF (40 mL) was added and the resulting 
solution was stirred at 0 °C for 1 h. The solution was allowed to warm to rt and stirred at 
rt for 30 h. Saturated NH4Cl(aq) (35 mL) was added and the two layers were separated. 
The aqueous layer was extracted with CH2Cl2 (3 × 30 mL). The combined organic layers 
were dried (MgSO4) and evaporated under reduced pressure to give the crude product. 
Purification by flash column chromatography on silica with 1:1 hexane-EtOAc and then 
1:4 hexane-EtOAc as eluent gave N-Boc sulfoximine 120 (274 mg, 14%) as a white solid, 
mp 54–56 °C; RF (1:4 hexane-EtOAc) 0.33, IR (ATR) 2978, 2941, 1659 (C=O), 1366, 
1273, 1252, 1207, 1161, 1069, 892, 866, 793 cm−1; 1H NMR (400 MHz, CDCl3) δ 3.36 
(q, J = 7.5 Hz, 4H, SCH2), 1.48 (s, 9H, CMe3), 1.42 (t, J = 7.5 Hz, 6H, SCH2Me); 
13C 
NMR (100.6 MHz, CDCl3) δ 158.8 (C=O), 80.4 (CMe3), 45.2 (SCH2), 28.3 (CMe3), 7.3 
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(SCH2Me); MS (ESI) m/z 222 (M + H)
+; HRMS (ESI) m/z calcd for C9H19NO3S (M + 
H)+ 222.1158, found 222.1156 (+1.0 ppm error). 
Lab book reference: AH-1-22 
 
(tert-Butyldimethylsilyl)[ethyl(oxo)phenyl-λ⁶-sulfanylidene]amine 121 
 
TBDMSCl (460 mg, 3.05 mmol, 1.2 eq.) was added to a stirred solution of sulfoximine 
98 (430 mg, 2.54 mmol, 1.0 eq.) in pyridine (5.1 mL) at rt under Ar. The resulting solution 
was stirred at rt for 12 h and then water (5 mL) was added to the solution. The two layers 
were separated and the aqueous layer was extracted with EtOAc (3 × 50 mL). The 
combined organic layers were washed with brine (20 mL), dried (MgSO4) and evaporated 
under reduced pressure to give the crude product. Purification by flash column 
chromatography on silica with 95:5 hexane-Et2O as eluent gave N-TBDMS sulfoximine 
121 (624 mg, 87%) as a colourless oil, RF (6:4 hexane-Et2O) 0.40; IR (ATR) 2953, 2927, 
2854, 1445, 1293, 1149, 1149, 829, 774, 720, 690, 534 cm−1; 1H NMR (400 MHz, CDCl3) 
δ 7.92–7.87 (m, 2H, Ph), 7.58–7.46 (m, 3H, Ph), 3.07–2.92 (m, 2H, SCH2), 1.18 (t, J = 
7.5 Hz, 3H, SCH2Me), 0.92 (s, 9H, CMe3), 0.04 (s, 3H, SiMe), 0.03 (s, 3H, SiMe); 
13C 
NMR (100.6 MHz, CDCl3) δ 143.2 (ipso-Ph), 132.3 (Ph), 128.9 (Ph), 128.0 (Ph), 54.8 
(SCH2), 26.2 (CMe3), 18.2 (CMe3), 8.2 (SCH2Me), −2.3 (SiMe2); MS (ESI) m/z 284 (M 
+ H)+; HRMS (ESI) m/z calcd for C14H25NOSSi (M + H)
+ 284.1499, found 284.1500 
(−0.6 ppm error).  
Lab book reference: AH-1-18 
 
TBDMSCl (722 mg, 4.79 mmol, 1.5 eq.) was added, in two portions, to a stirred solution 
of sulfoximine 98 (539 mg, 3.19 mmol, 1.0 eq.) and imidazole (652 mg, 9.57 mmol, 3.0 
eq.) in DMF (6.4 mL) at 0 °C under Ar. The resulting solution was stirred at rt for 12 h 
and then water (5 mL) was added to the solution. The two layers were separated and the 
aqueous layer was extracted with Et2O (3 × 50 mL). The combined organic layers were 
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washed with brine (20 mL), dried (MgSO4) and evaporated under reduced pressure to 
give the crude product. Purification by flash column chromatography on silica with 95:5 
hexane-EtOAc as eluent gave N-TBDMS sulfoximine 121 (789 mg, 87%) as a colourless 
oil. 
Lab book reference: AH-1-19 
 
[(tert-Butyldiphenylsilyl)imino](ethyl)(1-hydroxy-1,1-diphenylpropan-2-yl)-λ⁶-
sulfanone anti-88 
 
Using general procedure C, N-TBDPS sulfoximine 86 (180 mg, 0.5 mmol, 1.0 eq.), n-
BuLi (0.24 mL of a 2.3 M solution in hexanes, 0.55 mmol, 1.1 eq.) and benzophenone 
(0.25 mL of a 4 M solution in THF, 1.0 mmol, 2.0 eq.) in THF (5 mL) at ‒78 °C for 1 h 
gave the crude product which contained only alcohol anti-88 (by 1H NMR spectroscopy). 
Purification by flash column chromatography on silica with 95:5 hexane-EtOAc as eluent 
gave alcohol anti-88 (191 mg, 71%) as a white solid, mp 52–54 °C; RF (8:2 hexane-
EtOAc) 0.47; IR (ATR) 3386 (OH), 2931, 2856, 1450, 1427, 1311, 1138, 1109, 743, 702, 
504 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.73 (dd, J = 7.5, 1.0 Hz, 2H, Ph), 7.69–7.62 
(m, 4H, Ph), 7.58 (d, J = 7.5 Hz, 2H, Ph), 7.42–7.28 (m, 10H, Ph), 7.21–7.18 (m, 2H, Ph), 
6.31 (s, 1H, OH), 4.20 (q, J = 7.0 Hz, 1H, SCH(Me)COH), 2.19 (dq, J = 14.0, 7.0 Hz, 
1H, SCHMe), 1.69 (dq, J = 14.0, 7.0 Hz, 1H, SCHMe), 1.47 (d, J = 7.0 Hz, 3H, SCHMe), 
1.06 (s, 9H, CMe3), 0.93 (t, J = 7.0 Hz, 3H, SCH2Me); 
13C NMR (100.6 MHz, CDCl3) δ 
146.0 (ipso-Ph), 145.7 (ipso-Ph), 136.2 (ipso-Ph), 135.9 (ipso-Ph), 135.8 (Ph), 135.7 (Ph), 
129.34 (Ph), 129.31 (Ph), 128.5 (Ph), 128.3 (Ph), 127.64 (Ph), 127.55 (Ph), 127.3 (Ph), 
126.9 (Ph), 126.1 (Ph), 125.2 (Ph), 79.0 (COH), 63.0 (SCH), 51.8 (SCH2), 27.3 (CMe3), 
19.6 (CMe3), 11.7 (SCHMe), 8.9 (SCH2Me); MS (ESI) m/z 542 [(M + H)
+] HRMS (ESI) 
m/z calcd for C33H39NO2SSi (M + H)
+ 542.2544, found 542.2544 (‒0.1 ppm error). The 
stereochemistry of alcohol anti-88 was assigned by synthesis from N-Boc sulfoximine 
anti-128. 
Lab book reference: AH-1-2  
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Using general procedure B, TBDPSCl (0.03 mL, 0.09 mmol, 1.25 eq.), NH sulfoximine 
anti-129 (21 mg, 0.07 mmol, 1.0 eq.) and imidazole (10 mg, 0.14 mmol, 2.0 eq.) in DMF 
(1.0 mL) at rt gave the crude product. Purification by flash column chromatography on 
silica with 9:1 hexane-EtOAc as eluent gave impure N-TBDPS sulfoximine anti-88 (10 
mg, traces) as a white solid. 
Lab book reference: AH-2-39 
 
tert-Butyl[(tert-butyldiphenylsilyl)imino](1-hydroxy-1,1-diphenylpropan-2-yl)-λ⁶-
sulfanone anti-122 and syn-122 
 
Using general procedure C, N-TBDPS sulfoximine 118 (194 mg, 0.5 mmol, 1.0 eq.), n-
BuLi (0.24 mL of a 2.3 M solution in hexanes, 0.55 mmol, 1.1 eq.) and benzophenone 
(0.25 mL of a 4 M solution in THF, 1.0 mmol, 2.0 eq.) in THF (5 mL) at ‒78 °C for 1 h 
gave the crude product which contained a 95:5 mixture of alcohols anti-122 and syn-122 
(by 1H NMR spectroscopy). Purification by flash column chromatography on silica with 
95:5 hexane-Et2O as eluent gave alcohol anti-122 (262 mg, 92%) as a colourless oil, RF 
(8:2 hexane-Et2O) 0.31; IR (ATR) 3433 (OH), 3070, 2932, 2856, 1472, 1396, 1322, 1108, 
820, 769, 730, 701, 648, 604, 500 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.77 (dd, J = 7.5, 
5.0 Hz, 4H, Ph), 7.57 (dd, J = 7.5, 3.0 Hz, 2H, Ph), 7.44 (d, J = 7.5 Hz, 2H, Ph), 7.42–
7.29 (m, 8H, Ph), 7.28–7.23 (m, 1H, Ph), 7.22–7.18 (m, 3H, Ph), 5.41 (s, 1H, OH), 4.31 
(q, J = 7.5 Hz, 1H, SCH), 1.41 (d, J = 7.5 Hz, 3H, SCHMe), 1.25 (s, 9H, SCMe3), 1.11 
(s, 9H, SiCMe3); 
13C NMR (100.6 MHz, CDCl3) δ 147.0 (ipso-Ph), 143.8 (ipso-Ph), 136.7 
(ipso-Ph), 136.4 (ipso-Ph), 136.2 (Ph), 136.1 (Ph), 129.11 (Ph), 129.08 (Ph), 128.03 (Ph), 
127.96 (Ph). 127.9 (Ph), 127.4 (Ph), 127.2 (Ph), 127.1 (Ph), 126.7 (Ph), 81.3 (COH), 65.8 
(SCMe3), 63.6 (SCH), 27.6 (SiCMe3), 24.4 (SCMe3), 20.1 (SiCMe3), 17.7 (SCHMe) (one 
Ph resonance not resolved); MS (ESI) m/z 592 [(M + Na)+] HRMS (ESI) m/z calcd for 
C35H43NO2SSi (M + Na)
+ 592.2676, found 592.2673 (+0.5 ppm error). Alcohol syn-122 
was not isolated. Diagnostic signal for alcohol syn-122: 1H NMR (400 MHz, CDCl3) δ 
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3.40 (q, J = 7.5 Hz, 1H, SCH). The stereochemistry of anti-122 and syn-122 was assigned 
by analogy with related examples. 
Lab book reference: AH-1-41 
 
tert-Butyl[(tert-butyldiphenylsilyl)imino](1-hydroxy-1,1,3-triphenylpropan-2-yl)-λ⁶-
sulfanone anti-123 
 
Using general procedure C, N-TBDPS sulfoximine 119 (232 mg, 0.5 mmol, 1.0 eq.), n-
BuLi (0.25 mL of a 2.2 M solution in hexanes, 0.55 mmol, 1.1 eq.) and benzophenone 
(0.25 mL of a 4 M solution in THF, 1.0 mmol, 2.0 eq.) in THF (5 mL) at ‒78 °C for 1 h 
gave the crude product which contained only alcohol anti-123 (by 1H NMR 
spectroscopy). Purification by flash column chromatography on silica with 97:3 hexane-
Et2O as eluent gave alcohol anti-123 (281 mg, 87%) as a white solid, mp 140–142 °C; RF 
(8:2 hexane-Et2O) 0.31; IR (ATR) 3431 (OH), 3062, 2932, 2858, 1448, 1308, 1049, 1107, 
906, 820, 728, 700, 649, 606, 498 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.93 (dd, J = 7.5, 
2.0 Hz, 2H, Ph), 7.90 (dd, J = 7.5, 2.0 Hz, 2H, Ph), 7.68 (dd, J = 7.5, 2.0 Hz, 2H, Ph), 
7.55 (d, J = 7.5 Hz, 2H, Ph), 7.52–7.34 (m, 9H, Ph), 7.33–7.25 (m, 3H, Ph), 7.10–6.99 
(m, 3H, Ph), 6.37 (d, J = 7.5 Hz, 2H, Ph), 5.84 (s, 1H, OH), 4.19 (dd, J = 7.0, 2.0 Hz, 1H, 
SCH), 4.10 (dd, J = 15.5, 7.0 Hz, 1H, CHPh), 3.31 (dd, J = 15.5, 2.0 Hz, 1H, CHPh), 1.29 
(s, 9H, SCMe3), 1.03 (s, 9H, SiCMe3); 
13C NMR (100.6 MHz, CDCl3) δ 146.9 (ipso-Ph), 
143.5 (ipso-Ph), 140.2 (ipso-Ph), 136.7 (ipso-Ph), 136.6 (ipso-Ph), 136.4 (Ph), 129.3 (Ph), 
129.2 (Ph), 129.0 (Ph), 128.7 (Ph), 128.3 (Ph), 128.2 (Ph), 128.1 (Ph), 127.9 (Ph), 127.8 
(Ph), 127.5 (Ph), 127.4 (Ph), 126.8 (Ph), 126.3 (Ph), 126.1 (Ph), 83.4 (COH), 73.6 (SCH), 
65.9 (SCMe3), 34.9 (CH2Ph), 27.8 (SiCMe3), 24.3 (SCMe3), 20.2 (SiCMe3); MS (ESI) 
m/z 668 [(M + Na)+] HRMS (ESI) m/z calcd for C41H47NO2SSi (M + Na)
+ 668.2989, 
found 668.2991 (−0.4 ppm error). The stereochemistry of anti-123 was assigned by X-
ray crystallography. 
X-ray crystal structure determination of anti-123 
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C41H47NO2SSi, M = 645.94, triclinic, a = 10.8541(6), b = 12.9867(7), c = 13.7480(6) Å, 
β = 101.226(4)°, U = 1789.89(17) Å3, T = 110.00(10) K, space group P-1, Z = 2, μ(CuKα) 
= 1.390 mm-1, 11691 reflection measured, 6377 unique (Rint = 0.0334) which were used 
in calculation. The final R1 was 0.0441 (I≥2σ) and wR2 was 0.1253 (all data). 
Lab book reference: AH-1-54 
 
2-{Adamantan-1-yl[(tert-butyldiphenylsilyl)imino]oxo-λ⁶-sulfanyl}-1,1-
diphenylpropan-1-ol anti-124 
 
Using general procedure C, N-TBDPS sulfoximine 107 (212 mg, 0.5 mmol, 1.0 eq.), n-
BuLi (0.24 mL of a 2.3 M solution in hexanes, 0.55 mmol, 1.1 eq.) and benzophenone 
(0.25 mL of a 4 M solution in THF, 1.0 mmol, 2.0 eq.) in THF (5 mL) at ‒78 °C for 1 h 
gave the crude product which contained only alcohol anti-124 (by 1H NMR 
spectroscopy). Purification by flash column chromatography on silica with 1:1 hexane-
CH2Cl2 as eluent gave alcohol anti-124 (256 mg of a 95:5 mixture of anti-124 and starting 
sulfoximine 107 i.e. 247 mg (76%) of anti-124) as a white solid, mp 110–112 °C; RF 
(CH2Cl2) 0.51; IR (ATR) 3428 (OH), 2910, 2854, 1449, 1327, 1298, 1106, 820, 701, 500 
cm−1; 1H NMR (400 MHz, CDCl3) for anti-124 δ 7.77 (dd, J = 7.0, 1.5 Hz, 2H, Ph), 7.72 
(dd, J = 7.0, 1.5 Hz, 2H, Ph), 7.59 (dd, J = 7.0, 1.5 Hz, 2H, Ph), 7.42–7.29 (m, 11H, Ph), 
7.24–7.19 (m, 3H, Ph), 5.45 (s, 1H, OH), 4.24 (q, J = 7.5 Hz, 1H, SCH), 1.99–1.93 (m, 
3H, CH), 1.92–1.84 (m, 3H, CH), 1.79–1.71 (m, 3H, CH), 1.58–1.49 (m, 3H, CH), 1.39–
1.32 (m, 6H, SCHMe, CH), 1.09 (s, 9H, CMe3); 
13C NMR (100.6 MHz, CDCl3) for anti-
124 δ 137.3 (ipso-Ph), 136.7 (ipso-Ph), 136.3 (Ph), 136.2 (Ph), 134.9 (ipso-Ph), 129.8 
(ipso-Ph), 129.1 (Ph), 128.2 (Ph), 128.0 (Ph), 127.9 (Ph), 127.8 (Ph), 127.4 (Ph), 127.37 
(Ph), 127.3 (Ph), 127.1 (Ph), 126.9 (Ph), 81.3 (COH), 67.4 (SCH), 61.5 (SC), 35.7 (CH2), 
35.3 (CH2), 28.7 (CH), 27.7 (CMe3), 26.7 (CH), 20.1 (CMe3), 17.7 (SCHMe); MS (ESI) 
m/z 648 [(M + H)+] HRMS (ESI) m/z calcd for C41H49NO2SSi (M + H)
+ 648.3326, found 
648.3317 (+1.3 ppm error). The stereochemistry of anti-124 was assigned by analogy 
with related examples. 
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Lab book reference: AH-1-84  
 
2-{[(tert-Butyldiphenylsilyl)imino](oxo)phenyl-λ⁶-sulfanyl}-1,1-diphenylpropan-1-
ol anti-89 and syn-89 
 
Using general procedure C, N-TBDPS sulfoximine 87 (204 mg, 0.5 mmol, 1.0 eq.), n-
BuLi (0.24 mL of a 2.3 M solution in hexanes, 0.55 mmol, 1.1 eq.) and benzophenone 
(0.25 mL of a 4 M solution in THF, 1.0 mmol, 2.0 eq.) in THF (5 mL) at ‒78 °C for 1 h 
gave the crude product which contained an 85:15 mixture of alcohols anti-89 and syn-89 
(by 1H NMR spectroscopy). Purification by flash column chromatography on silica with 
95:5 hexane-Et2O gave alcohol anti-89 (170 mg, 58%) as a white solid, mp 154–156 °C; 
RF (9:1 hexane-Et2O) 0.15; IR (ATR) 3422 (OH), 3068, 2930, 2856, 1448, 1298, 1141, 
1109, 744, 703, 605, 567, 470 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.64 (d, J = 7.5 Hz, 
2H, Ph), 7.55 (d, J = 8.0 Hz, 2H, Ph), 7.47 (d, J = 8.0 Hz, 2H, Ph), 7.44–7.39 (m, 3H, Ph), 
7.33–7.23 (m, 6H, Ph), 7.22–7.06 (m, 5H, Ph), 7.06–6.95 (m, 5H, Ph), 6.38 (s, 1H, OH), 
4.47 (q, J = 7.0 Hz, 1H, SCH), 1.46 (d, J = 7.0 Hz, 3H, SCHMe), 1.04 (s, 9H, CMe3); 
13C 
NMR (100.6 MHz, CDCl3) δ 146.2 (ipso-Ph), 144.8 (ipso-Ph), 143.0 (ipso-Ph), 135.70 
(Ph), 135.68 (Ph), 135.6 (ipso-Ph), 135.1 (ipso-Ph), 131.4 (Ph), 129.0 (Ph), 128.9 (Ph), 
128.8 (Ph), 128.4 (Ph), 128.1 (Ph), 127.73 (Ph), 127.68 (Ph), 127.4 (Ph), 127.1 (Ph), 126.7 
(Ph), 126.2 (Ph), 124.9 (Ph), 79.2 (COH), 67.8 (SCH), 27.2 (CMe3), 19.4 (CMe3), 12.5 
(SCHMe); MS (ESI) m/z 590 (M + H)+; HRMS (ESI) m/z calcd for C37H39NO2SSi (M + 
H)+ 590.2544, found 590.2532 (+2.0 ppm error). Alcohol syn-89 was not isolated. 
Diagnostic signals for alcohol syn-89: 1H NMR (400 MHz, CDCl3) δ 4.43 (q, J = 7.0 Hz, 
1H, SCH), 1.46 (d, J = 7.0 Hz, 3H, SCHMe). The stereochemistry of anti-89 and syn-89 
was assigned by analogy with related examples. 
Lab book reference: AH-1-92 
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2-{[(tert-Butyldiphenylsilyl)imino](oxo)phenyl-λ⁶-sulfanyl}-1,1,3-triphenylpropan-
1-ol anti-125 and syn-125 
 
Using general procedure C, N-TBDPS sulfoximine 117 (175 mg, 0.36 mmol, 1.0 eq.), n-
BuLi (0.18 mL of a 2.2 M solution in hexanes, 0.4 mmol, 1.1 eq.) and benzophenone 
(0.25 mL of a 2.9 M solution in THF, 0.72 mmol, 2.0 eq.) in THF (5 mL) at ‒78 °C for 1 
h gave the crude product which contained an 85:15 mixture of diastereomeric alcohols 
anti-125 and syn-125 (by 1H NMR spectroscopy). Purification by flash column 
chromatography on silica with 95:5 hexane-Et2O as eluent gave an 85:15 mixture of 
diastereomeric alcohols anti-125 and syn-125 (217 mg, 91%) as a colourless oil, RF (8:2 
hexane-Et2O) 0.54; IR (ATR) 3411 (OH), 3067, 2930, 2856, 1806, 1493, 1448, 1259, 
1139, 1110, 1078, 821, 739, 701, 606, 497 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.74 (s, 
0.15H, COH), 7.66 (dd, J = 7.5, 2.0 Hz, 0.3 H, Ph), 7.55 (dd, J = 7.5, 2.0 Hz, 1.7H, Ph), 
7.52 (dd, J = 7.5, 2.0 Hz, 1.7H, Ph), 7.47 (dd, J = 7.5, 2.0 Hz, 0.3 H, Ph), 7.44–7.37 (m, 
3.5H, Ph), 7.35–7.29 (m, 1.5H, Ph), 7.29–7.19 (m, 4H, Ph), 7.19–7.03 (m, 10H, Ph), 6.99–
6.90 (m, 5H, Ph), 6.77 (dd, J = 7.5, 2.0 Hz, 1.7H, Ph), 6.68 (dd, J = 7.5, 2.0 Hz, 0.3H, 
Ph), 6.50 (s, 0.85H, OH), 4.81 (dd, J = 5.0, 1.0 Hz, 0.85H, SCH), 4.50 (dd, J = 5.0, 1.0 
Hz, 0.15H, SCH), 3.97 (dd, J = 16.0, 5.0 Hz, 0.85H, CHPh), 3.85 (dd, J = 16.0, 5.0 Hz, 
0.15H, CHPh), 3.25 (dd, J = 16.0, 1.0 Hz, 0.85H, CHPh), 3.19 (dd, J = 16.0, 1.0 Hz, 
0.15H, CHPh), 1.17 (s, 1.3H, CMe3), 1.05 (s, 7.7H, CMe3);
 13C NMR (100.6 MHz, 
CDCl3) δ 146.9 (ipso-Ph, syn-125), 145.2 (ipso-Ph, anti-125), 144.7 (ipso-Ph, syn-125), 
144.6 (ipso-Ph, anti-125), 143.89 (ipso-Ph, anti-125), 143.86 (ipso-Ph, syn-125), 140.7 
(ipso-Ph, anti-125), 140.6 (ipso-Ph, syn-125), 136.02 (Ph, syn-125), 135.95 (Ph, syn-125), 
135.7 (Ph, anti-125), 135.5 (ipso-Ph, anti-125), 135.09 (ipso-Ph, anti-125), 135.05 (ipso-
Ph, syn-125), 135.0 (ipso-Ph, syn-125), 131.4 (Ph, syn-125), 131.2 (Ph, anti-125), 129.2 
(Ph, syn-125), 129.1 (Ph, syn-125), 129.0 (Ph, anti-125), 128.8 (Ph, anti-125), 128.7 (Ph, 
syn-125), 128.24 (Ph, anti-125), 128.21 (Ph, anti-125), 128.20 (Ph, anti-125), 128.1 (Ph, 
anti-125), 128.0 (Ph, syn-125), 127.8 (Ph, syn-125), 127.7 (Ph, syn-125), 127.6 (Ph, anti-
125), 127.5 (Ph, anti-125), 127.4 (Ph, syn-125), 127.3 (Ph, anti-125), 127.2 (Ph, syn-125), 
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127.14 (Ph, syn-125), 127.06 (Ph, anti-125), 126.9 (Ph, anti-125), 126.63 (Ph, anti-125), 
126.58 (Ph, syn-125), 126.5 (Ph, syn-125), 126.2 (Ph, anti-125), 126.1 (Ph, syn-125), 
125.9 (Ph, syn-125), 125.8 (Ph, anti-125), 125.5 (Ph, anti-125), 80.4 (COH, anti-125), 
80.3 (COH, syn-125), 76.1 (SCH, syn-125), 75.0 (SCH, anti-125), 32.0 (CH2Ph, syn-125), 
31.6 (CH2Ph, anti-125), 27.5 (CMe3, syn-125), 27.3 (CMe3, anti-125), 19.5 (CMe3, syn-
125), 19.4 (CMe3, anti-125) (two syn-125 Ph and one anti-125 Ph resonance not 
resolved); MS (ESI) m/z 666 [(M + H)+] HRMS (ESI) m/z calcd for C43H43NO2SSi (M + 
H)+ 666.2857, found 666.2423 (+0.4 ppm error). The stereochemistry of anti-125 and 
syn-125 was assigned by analogy with related examples. 
Lab book reference: AH-1-42 
 
[(tert-Butyldiphenylsilyl)imino](1-hydroxy-1,1-diphenylpropan-2-yl)isopropyl-λ⁶-
sulfanone anti-126 and syn-126 
 
Using general procedure C, N-TBDPS sulfoximine 104 (187 mg, 0.5 mmol, 1.0 eq.), n-
BuLi (0.24 mL of a 2.3 M solution in hexanes, 0.55 mmol, 1.1 eq.) and benzophenone 
(0.25 mL of a 4 M solution in THF, 1.0 mmol, 2.0 eq.) in THF (5 mL) at ‒78 °C for 1 h 
gave the crude product which contained an 85:15 mixture of alcohols anti-126 and syn-
126 (by 1H NMR spectroscopy). Purification by flash column chromatography on silica 
with 97:3 hexane-EtOAc as eluent gave alcohol anti-126 (222 mg, 80%) as a white solid, 
mp 164–166 °C; RF (8:2 hexane-EtOAc) 0.47; IR (ATR) 3381 (OH), 3070, 2932, 2856, 
1449, 1318, 1257, 1181, 1107, 907, 730, 699, 611, 500 cm−1; 1H NMR (400 MHz, CDCl3) 
δ 7.84–7.71 (m, 4H, Ph), 7.59 (d, J = 7.0 Hz, 2H, Ph), 7.50 (dd, J = 7.0, 7.0 Hz, 2H, Ph), 
7.45–7.23 (m, 10H, Ph), 7.22–7.12 (m, 2H, Ph), 6.00 (s, 1H, OH), 4.23 (q, J = 7.0 Hz, 
1H, SCH(Me)COH), 1.84 (septet, J = 7.0 Hz, 1H, SCHMe2), 1.19 (d, J = 7.0 Hz, 3H, 
SCH(Me)COH), 1.11 (d, J = 7.0 Hz, 3H, SCHMe), 1.04 (s, 9H, CMe3), 0.88 (d, J = 7.0 
Hz, 3H, SCHMe); 13C NMR (100.6 MHz, CDCl3) δ 146.3 (ipso-Ph), 146.1 (ipso-Ph), 
136.22 (ipso-Ph), 136.20 (ipso-Ph), 135.9 (Ph), 135.7 (Ph), 129.23 (Ph), 129.17 (Ph), 
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128.38 (Ph), 128.36 (Ph), 127.51 (Ph), 127.5 (Ph), 127.2 (Ph), 126.8 (Ph), 126.0 (Ph), 
125.4 (Ph), 79.0 (COH), 63.3 (SCH(Me)COH), 57.1 (SCHMe2), 27.3 (CMe3), 19.9 
(CMe3), 17.9 (SCHMe), 14.4 (SCHMe), 12.0 (SCH(Me)COH); MS (ESI) m/z 556 [(M + 
H)+] HRMS (ESI) m/z calcd for C34H41NO2SSi (M + H)
+ 556.2700, found 556.2694 (+1.1 
ppm error) and impure alcohol syn-126 (25 mg) as a white solid. Further purification by 
flash column chromatography on silica with 6:4 and then 4:6 hexane-CH2Cl2 as eluent 
gave alcohol syn-126 (8 mg, 3%), as a white solid; mp 148–150 °C; RF (8:2 CH2Cl2-
hexane) 0.38; IR (ATR) 3246 (OH), 3071, 2932, 2857, 1450, 1427, 1277, 1236, 1140, 
1107, 701, 493 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.72 (dd, J = 8.5, 2.5 Hz, 2H, Ph), 
7.69 (dd, J = 8.5, 2.5 Hz, 2H, Ph), 7.62 (dd, J = 8.5, 1.0 Hz, 2H, Ph), 7.58 (dd, J = 8.5, 
1.0 Hz, 2H, Ph), 7.47–7.38 (m, 4H, Ph), 7.36–7.27 (m, 6H, Ph), 7.24–7.17 (m, 2H, Ph), 
7.15 (s, 1H, OH), 4.25 (q, J = 7.0 Hz, 1H, SCH(Me)COH), 1.69–1.58 (m, 4H, SCHMe, 
SCHMe), 1.11 (s, 9H, SiCMe3), 1.03 (d, J = 7.0 Hz, 3H, SCHMe), 0.55 (d, J = 7.0 Hz, 
3H, SCH(Me)COH); 13C NMR (100.6 MHz, CDCl3) δ 146.2 (ipso-Ph), 145.7 (ipso-Ph), 
136.14 (Ph), 136.10 (Ph), 135.9 (ipso-Ph), 129.3 (Ph), 129.2 (Ph), 128.4 (Ph), 128.3 (Ph), 
127.53 (Ph), 127.50 (Ph), 127.2 (Ph), 127.0 (Ph), 126.4 (Ph), 125.5 (Ph), 78.3 (COH), 
61.4 (SCH(Me)COH), 57.4 (SCHMe2), 27.4 (CMe3), 19.9 (CMe3), 18.3 (SCHMe), 15.0 
(SCHMe), 10.4 (SCH(Me)COH) (one ipso-Ph resonance not resolved); MS (ESI) m/z 556 
[(M + H)+] HRMS (ESI) m/z calcd for C34H41NO2SSi (M + H)
+ 556.2700, found 556.2704 
(−0.7 ppm error). The stereochemistry of anti-126 was assigned by X-ray crystallography. 
X-ray crystal structure determination of anti-126 
C34H41NO2SSi, M = 555.83, orthorhombic, a = 25.9296(3), b = 7.98537(10), c = 
29.7696(4) Å, β = 90°, U = 6164.02(13) Å3, T = 110.00(10) K, space group Pbcn, Z = 8, 
μ(CuKα) = 1.532 mm-1, 14050 reflection measured, 5506 unique (Rint = 0.0215) which 
were used in calculation. The final R1 was 0.0318 (I≥2σ) and wR2 was 0.0804 (all data). 
Lab book reference: AH-1-11 
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2-{[(tert-Butyldiphenylsilyl)imino](2-methylphenyl)oxo-λ⁶-sulfanyl}-1,1-
diphenylpropan-1-ol anti-127 and syn-127 
 
Using general procedure C, N-TBDPS sulfoximine 102 (211 mg, 0.5 mmol, 1.0 eq.), n-
BuLi (0.24 mL of a 2.3 M solution in hexanes, 0.55 mmol, 1.1 eq.) and benzophenone 
(0.25 mL of a 4 M solution in THF, 1.0 mmol, 2.0 eq.) in THF (5 mL) at ‒78 °C for 1 h 
gave the crude product which contained a 65:35 mixture of diastereomeric alcohols anti-
127 and syn-127 (by 1H NMR spectroscopy). Purification by flash column 
chromatography on silica with 95:5 hexane-Et2O as eluent gave alcohol anti-127 (193 
mg, 64%) as a white solid, mp 138–140 °C; RF (6:4 hexane-Et2O) 0.43; IR (ATR) 3249 
(OH), 3058, 2931, 2857, 1450, 1427, 1237, 1145, 1127, 1108, 907, 820, 729, 697, 645, 
605, 582, 494 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.65 (br s, 4H, Ar), 7.57-7.11 (m, 
14H, Ar, OH), 7.10-6.70 (m, 6H, Ar), 6.55 (br s, 1H, Ar), 4.35 (br q, J = 7.0 Hz, 1H, 
SCH), 2.70 (s, 3H, ArMe), 1.53 (br s, 3H, CHMe), 1.13 (s, 9H, CMe3); 
1H NMR (400 
MHz, d6-DMSO) δ 7.67 (d, J = 7.0 Hz, 2H, Ar), 7.61 (dd, J = 7.0, 1.5 Hz, 2H, Ar), 7.50 
(d, J = 7.0 Hz, 2H, Ar), 7.39–7.18 (m, 11H, Ar, OH), 7.16–7.06 (m, 3H, Ar), 6.84–6.67 
(m, 4H, Ar), 6.42 (t, J = 7.0 Hz, 1H, Ar), 4.70 (q, J = 7.0 Hz, 1H, SCH), 2.69 (s, 3H, 
ArMe), 1.44 (d, J = 7.0 Hz, 3H, CHMe), 1.06 (s, 9H, CMe3); 
13C NMR (100.6 MHz, 
CDCl3) δ 144.9 (ipso-Ar), 141.5 (ipso-Ar), 136.1 (Ar), 136.0 (Ar), 135.8 (ipso-Ar), 135.7 
(ipso-Ar), 135.1 (ipso-Ar), 135.0 (ipso-Ar), 132.0 (Ar), 131.7 (Ar), 130.4 (Ar), 129.2 
(Ar), 129.1 (Ar), 128.3 (Ar), 128.2 (Ar), 127.7 (Ar), 127.4 (Ar), 127.1 (Ar), 127.0 (Ar), 
126.9 (Ar), 126.1 (Ar), 125.9 (Ar), 79.2 (br, COH), 66.3 (br, SCH), 27.5 (CMe3), 21.2 
(ArMe), 19.5 (CMe3), 10.7 (br, SCHMe); MS (ESI) m/z 604 (M + H)
+; HRMS (ESI) m/z 
calcd for C38H41NO2SSi (M + H)
+ 604.2700, found 604.2683 (+2.8 ppm error) and impure 
alcohol syn-127. Further purification by flash column chromatography on silica with 1:1 
hexane-CH2Cl2 gave alcohol syn-127 (151 mg of an 80:20 mixture of benzophenone and 
syn-127 i.e. 60 mg (20%) of syn-127) as a white solid, RF (1:1 hexane-CH2Cl2) 0.31; IR 
(ATR) 3407 (OH), 2930, 2856, 1659, 1449, 1277, 1109, 700, 639, 605, 499 cm−1; 1H 
NMR (400 MHz, d6-DMSO, 80 °C) for syn-127 δ 7.69–7.60 (m, 2H, Ph), 7.58–7.51 (m, 
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2H, Ph), 7.44 (d, J = 7.5 Hz, 2H, Ar), 7.39–7.33 (m, 2H, Ar), 7.31 (d, J = 7.5 Hz, 1H, Ar), 
7.29–7.20 (m, 5H, Ar), 7.20–7.07 (m, 5H, Ar), 6.99 (d, J = 7.5 Hz, 1H, Ar), 6.87–6.81 
(m, 3H, Ar), 6.79 (t, J = 7.5 Hz, 1H, Ar), 5.94 (s, 1H, OH), 4.90 (q, J = 7.0 Hz, 1H, SCH), 
2.52 (s, 3H, ArMe), 1.43 (d, J = 7.0 Hz, 3H, CHMe), 0.94 (s, 9H, CMe3); 
13C NMR (100.6 
MHz, d6-DMSO) for syn-127 δ 150.7 (ipso-Ar), 147.4 (ipso-Ar), 145.3 (ipso-Ar), 135.8 
(Ar), 135.64 (Ar), 135.57 (Ar), 132.5 (Ar), 132.1 (Ar), 129.5 (Ar), 129.4 (Ar), 128.6 (Ar), 
127.8 (Ar), 127.7 (Ar), 127.6 (Ar), 126.9 (Ar), 126.7 (Ar), 126.0 (Ar), 125.7 (Ar), 125.2 
(Ar), 79.1 (COH), 27.4 (CMe3), 21.1 (ArMe), 19.6 (CMe3) (three ipso-Ar, one SCH and 
one SCHMe resonances not resolved); MS (ESI) m/z 604 (M + H)+; HRMS (ESI) m/z 
calcd for C38H41NO2SSi (M + H)
+ 604.2700, found 604.2700 (+0.0 ppm error). The 
stereochemistry of anti-127 and syn-127 was assigned by analogy with related examples. 
Lab book reference: AH-1-73 
 
tert-Butyl N-[ethyl(1-hydroxy-1,1-diphenylpropan-2-yl)oxo-λ⁶-
sulfanylidene]carbamate anti-128 and syn-128 
 
Using general procedure C, N-Boc sulfoximine 120 (111 mg, 0.5 mmol, 1.0 eq.), n-BuLi 
(0.24 mL of a 2.3 M solution in hexanes, 0.55 mmol, 1.1 eq.) and benzophenone (0.25 
mL of a 4 M solution in THF, 1.0 mmol, 2.0 eq.) in THF (5 mL) at ‒78 °C for 1 h gave 
the crude product which contained a 55:45 mixture of alcohols anti-128 and syn-128 (by 
1H NMR spectroscopy). Purification by flash column chromatography on silica with 95:5 
hexane-EtOAc as eluent gave alcohol syn-128 (48 mg, 24%) as a white solid, mp 164–
166 °C; RF (8:2 hexane-EtOAc) 0.23; IR (ATR) 3234 (OH), 2979, 1676 (C=O), 1450, 
1366, 1282, 1246, 1151, 1056, 860, 752, 705, 534 cm−1; 1H NMR (400 MHz, CDCl3) δ 
7.59 (d, J = 7.5 Hz, 2H, Ph), 7.52 (d, J = 7.5 Hz, 2H, Ph), 7.39–7.28 (m, 4H, Ph), 7.27–
7.19 (m, 2H, Ph), 7.04 (s, 1H, OH), 4.34 (q, J = 7.5 Hz, 1H, SCH(Me)COH), 3.58 (dq, J 
= 14.0, 7.5 Hz, 1H, SCHMe), 1.60 (d, J = 7.5 Hz, 3H, SCHMe), 1.53–1.42 (m, 10H, 
SCHMe, CMe3), 1.20 (t, J = 7.5 Hz, 3H, SCH2Me); 
13C NMR (100.6 MHz, CDCl3) δ 
158.0 (C=O), 144.9 (ipso-Ph), 128.7 (Ph), 128.6 (Ph), 127.8 (Ph), 127.4 (Ph), 126.2 (Ph), 
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125.2 (Ph), 80.6 (COH), 77.9 (CMe3), 61.4 (SCH), 46.4 (SCH2), 28.3 (CMe3), 9.6 
(SCHMe), 8.2 (SCH2Me) (one ipso-Ph resonance not resolved); MS (ESI) m/z 404 [(M + 
H)+] HRMS (ESI) m/z calcd for C22H29NO4S (M + H)
+ 404.1890, found 404.1884 (+1.6 
ppm error) and alcohol anti-128 (88 mg, 44%) as a white solid, mp 124–126 °C; RF (8:2 
hexane-EtOAc) 0.13; IR (ATR) 3282 (OH), 2980, 1651, 1450, 1367, 1292, 1248, 1151, 
1032, 907, 857, 771, 728, 703, 646, 535 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.63 (d, J 
= 7.5 Hz, 2H, Ph), 7.53 (d, J = 7.5 Hz, 2H, Ph), 7.35–7.27 (m, 4H, Ph), 7.25–7.18 (m, 2H, 
Ph), 5.57 (s, 1H, OH), 4.66 (q, J = 7.5 Hz, 1H, SCH(Me)COH), 3.21 (dq, J = 14.0, 7.5 
Hz, 1H, SCHMe), 2.40 (dq, J = 14.0, 7.5 Hz, 1H, SCHMe), 1.55 (d, J = 7.5 Hz, 3H, 
SCHMe), 1.45 (s, 9H, CMe3), 1.20 (t, J = 7.5 Hz, 3H, SCH2Me); 
13C NMR (100.6 MHz, 
CDCl3) δ 157.7 (C=O), 145.0 (ipso-Ph), 144.7 (ipso-Ph), 128.7 (Ph), 128.6 (Ph), 127.7 
(Ph), 127.3 (Ph), 125.9 (Ph), 125.0 (Ph), 80.5 (COH), 79.0 (CMe3), 65.0 (SCH), 47.5 
(SCH2), 28.2 (CMe3), 11.3 (SCHMe), 6.6 (SCH2Me); MS (ESI) m/z 404 [(M + H)
+] 
HRMS (ESI) m/z calcd for C22H29NO4S (M + H)
+ 404.1890, found 404.1885 (+1.3 ppm 
error). The stereochemistry of syn-128 was assigned by X-ray crystallography. 
X-ray crystal structure determination of syn-128 
C22H29NO4S, M = 403.52, monoclinic, a = 9.1428(3), b = 11.0946(3), c = 10.8364(3) Å, 
β = 100.753(3)°, U = 1079.90(5) Å3, T = 110.00(10) K, space group P21, Z = 2, μ(CuKα) 
= 1.548 mm-1, 14031 reflection measured, 2714 unique (Rint = 0.0143) which were used 
in calculation. The final R1 was 0.0260 (I≥2σ) and wR2 was 0.0664 (all data). 
Lab book reference: AH-1-26 
 
Ethyl(1-hydroxy-1,1-diphenylpropan-2-yl)imino-λ⁶-sulfanone anti-129 
 
TFA (0.18 mL, 2.2 mmol, 9.75 eq.) was added dropwise to a stirred solution of N-Boc 
sulfoximine anti-128 (90 mg, 0.23 mmol, 1.0 eq.) in CH2Cl2 (1.3 mL) at rt under Ar. The 
resulting solution was stirred at rt for 24 h. The solvent was evaporated under reduced 
pressure and the residue was dissolved in water (1.3 mL). Saturated Na2CO3(aq) (2.6 mL) 
was added and the aqueous mixture was extracted with CH2Cl2 (3 × 20 mL). The 
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combined organic extracts were dried (Na2SO4) and evaporated under reduced pressure 
to give the crude product. Purification by flash column chromatography on silica with 
EtOAc and then 9:1 EtOAc-MeOH as eluent gave NH sulfoximine anti-129 (21 mg, 30%) 
as a brown viscous oil, RF (9:1 EtOAc-MeOH) 0.53; IR (ATR) 2926, 1728, 1576, 1492, 
1458, 1205, 1134, 964, 750, 704, 471 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.62–7.50 (m, 
4H, Ph), 7.41–7.29 (m, 5H, Ph), 7.24–7.21 (m, 1H, Ph), 6.27 (br s, 1H, OH), 4.16 (q, J = 
7.0 Hz, 1H, SCH(Me)COH), 2.45 (dq, J = 14.0, 7.0 Hz, 1H, SCHMe), 2.24 (dq, J = 14.0, 
7.0 Hz, 1H, SCHMe), 1.53 (d, J = 7.0 Hz, 3H, SCHMe), 1.21 (t, J = 7.0 Hz, 3H, SCH2Me); 
13C NMR (100.6 MHz, CDCl3) δ 145.3 (ipso-Ph), 144.7 (ipso-Ph), 128.6 (Ph), 128.5 (Ph), 
127.6 (Ph), 127.3 (Ph), 126.2 (Ph), 125.6 (Ph), 79.0 (COH), 64.7 (SCH), 49.2 (SCH2), 
11.3 (SCHMe), 7.1 (SCH2Me); MS (ESI) m/z 304 [(M + H)
+] HRMS (ESI) m/z calcd for 
C17H21NO2S (M + H)
+ 304.1366, found 304.1363 (+0.9 ppm error).  
Lab book reference: AH-1-46 
 
2-{[(tert-Butyldimethylsilyl)imino](oxo)phenyl-λ⁶-sulfanyl}-1,1-diphenylpropan-1-
ol anti-130 and syn-130 
 
Using general procedure C, N-TBDMS sulfoximine 121 (142 mg, 0.5 mmol, 1.0 eq.), n-
BuLi (0.24 mL of a 2.3 M solution in hexanes, 0.55 mmol, 1.1 eq.) and benzophenone 
(0.25 mL of a 4 M solution in THF, 1.0 mmol, 2.0 eq.) in THF (5 mL) at ‒78 °C for 1 h 
gave the crude product which contained an 80:20 mixture of alcohols anti-130 and syn-
130 (by 1H NMR spectroscopy). Purification by flash column chromatography on silica 
with 97:3 and then 9:1 hexane-Et2O as eluent gave alcohol anti-130 (154 mg, 66%) as a 
white solid, mp 86–88 °C; RF (6:4 hexane-Et2O) 0.50; IR (ATR) 3401 (OH), 3061, 2953, 
2928, 2855, 1449, 1249, 1137, 1072, 774, 703, 693, 553 cm−1; 1H NMR (400 MHz, 
CDCl3) δ 7.59 (d, J = 7.5 Hz, 2H, Ph), 7.55 (d, J = 7.5 Hz, 2H, Ph), 7.49 (d, J = 7.5 Hz, 
2H, Ph), 7.44 (t, J = 7.5 Hz, 1H, Ph), 7.34 (dd, J = 7.5, 7.5 Hz, 2H, Ph), 7.24 (dd, J = 7.5, 
7.5 Hz, 2H, Ph), 7.18–7.06 (m, 4H, Ph), 6.76 (s, 1H, OH), 4.31 (q, J = 7.5 Hz, 1H, SCH), 
1.21 (d, J = 7.5 Hz, 3H, SCHMe), 0.88 (s, 9H, CMe3), −0.18 (s, 3H, SiMe), −0.21 (s, 3H, 
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SiMe); 13C NMR (100.6 MHz, CDCl3) δ 145.6 (ipso-Ph), 145.2 (ipso-Ph), 143.7 (ipso-
Ph), 132.2 (Ph), 128.6 (Ph), 128.44 (Ph), 128.36 (Ph), 127.8 (Ph), 126.9 (Ph), 126.8 (Ph), 
126.5 (Ph), 125.3 (Ph), 79.5 (COH), 67.9 (SCH), 26.0 (CMe3), 18.1 (CMe3), 13.5 
(SCHMe), −2.7 (SiMe), −2.9 (SiMe); MS (ESI) m/z 466 (M + H)+; HRMS (ESI) m/z calcd 
for C27H35NO2SSi (M + H)
+ 466.2231, found 466.2225 (+1.3 ppm error) and alcohol syn-
130 (39 mg, 17%) as a colourless oil, RF (9:1 hexane-Et2O) 0.15; IR (ATR) 3234 (OH), 
2952, 2855, 1447, 1246, 1135, 1074, 825, 776, 688, 578, 532 cm−1; 1H NMR (400 MHz, 
CDCl3) δ 7.48 (d, J = 7.5 Hz, 2H, Ph), 7.38–7.27 (m, 3H, Ph), 7.23 (dd, J = 7.5, 7.5 Hz, 
2H, Ph), 7.17–7.08 (m, 5H, Ph), 7.89–6.78 (m, 3H, Ph), 4.24 (q, J = 7.5 Hz, 1H, SCH), 
1.53 (d, J = 7.5 Hz, 3H, SCHMe), 0.95 (s, 9H, CMe3), −0.03 (s, 6H, SiMe2); 13C NMR 
(100.6 MHz, CDCl3) δ 145.9 (ipso-Ph), 144.9 (ipso-Ph), 131.6 (ipso-Ph), 128.6 (Ph), 
128.3 (Ph), 127.8 (Ph), 127.6 (Ph), 126.8 (Ph), 126.7 (Ph), 126.6 (Ph), 125.9 (Ph), 125.2 
(Ph), 78.3 (COH), 66.6 (SCH), 26.1 (CMe3), 18.2 (CMe3), 10.3 (SCHMe), −2.5 (SiMe), 
−2.6 (SiMe); MS (ESI) m/z 466 (M + H)+; HRMS (ESI) m/z calcd for C27H35NO2SSi (M 
+ H)+ 466.2231, found 466.2228 (+0.5 ppm error). The stereochemistry of anti-130 and 
syn-130 was assigned by analogy with related examples. 
Lab book reference: AH-1-20 
 
Attempted synthesis of (1-Hydroxy-1,1-diphenylpropan-2-yl)(imino)phenyl-λ⁶-
sulfanone anti-131 
 
TBAF (0.56 mL of a 1 M solution in THF, 0.56 mmol, 2.0 eq.) was added dropwise to a 
stirred solution of N-TBDMS sulfoximine anti-130 (130 mg, 0.28 mmol, 1.0 eq.) in THF 
(2 mL) at rt under Ar. The resulting solution was stirred at rt for 48 h. The solvent was 
evaporated under reduced pressure to give the crude product which contained none of the 
desired product anti-131. Purification by flash column chromatography on silica with 
EtOAc as eluent gave unsubstituted NH sulfoximine 98 (43 mg, 91%) as a yellow oil and 
none of the desired product anti-131. 
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Lab book reference: AH-1-45 
 
tert-Butyl[(tert-Butyldiphenylsilyl)imino](3-hydroxy-3-methylbutan-2-yl)-λ⁶-
sulfanone anti-133  
 
Using general procedure C, N-TBDPS sulfoximine 118 (128 mg, 0.33 mmol, 1.0 eq.), n-
BuLi (0.16 mL of a 2.2 M solution in hexanes, 0.36 mmol, 1.1 eq.) and acetone (0.05 mL, 
0.66 mmol, 2.0 eq.) in THF (5 mL) at ‒78 °C for 1 h gave the crude product which 
contained only alcohol anti-133 (by 1H NMR spectroscopy). Purification by flash column 
chromatography on silica with 95:5 hexane-Et2O as eluent gave alcohol anti-133 (73 mg, 
50%) as a white solid, mp 110–112 °C; RF (6:4 hexane-Et2O) 0.22; IR (ATR) 3467 (OH), 
3071, 2933, 2856, 1472, 1427, 1374, 1314, 1260, 1182, 1106, 949, 820, 729, 701, 627, 
595 498 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.78–7.73 (m, 4H, Ph), 7.31–7.41 (m, 6H, 
Ph), 5.04 (s, 1H, OH), 3.48 (q, J = 7.5 Hz, 1H, SCH), 1.28 (s, 9H, SCMe3), 1.26 (d, J = 
7.5 Hz, 3H, SCHMe), 1.18 (s, 3H, C(OH)Me), 1.13 (s, 3H, C(OH)Me), 1.09 (s, 9H, 
SiCMe3); 
13C NMR (100.6 MHz, CDCl3) δ 136.6 (ipso-Ph), 136.5 (ipso-Ph), 136.14 (Ph), 
136.12 (Ph), 129.18 (Ph), 129.15 (Ph), 127.42 (Ph), 127.35 (Ph), 73.2 (COH), 65.1 
(SCMe3), 63.3 (SCH), 30.2 (C(OH)Me), 27.6 (SiCMe3), 24.3 (C(OH)Me), 24.1 (SCMe3), 
20.0 (SiCMe3), 16.4 (SCHMe); MS (ESI) m/z 468 [(M + Na)
+] HRMS (ESI) m/z calcd 
for C25H39NO2SSi (M + Na)
+ 468.2363, found 468.2356 (+1.4 ppm error). The 
stereochemistry of anti-133 was assigned by conversion into anti-138. 
Lab book reference: AH-1-56 
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tert-Butyl[(tert-butyldiphenylsilyl)imino](3-hydroxy-3-methyl-1-phenylbutan-2-yl)-
λ⁶-sulfanone anti-134 
 
Using general procedure C, N-TBDPS sulfoximine 119 (232 mg, 0.5 mmol, 1.0 eq.), n-
BuLi (0.25 mL of a 2.2 M solution in hexanes, 0.55 mmol, 1.1 eq.) and acetone (0.07 mL, 
1.0 mmol, 2.0 eq.) in THF (5 mL) at ‒78 °C for 1 h gave the crude product which 
contained only alcohol anti-134 (by 1H NMR spectroscopy). Purification by flash column 
chromatography on silica with 95:5 hexane-Et2O as eluent gave alcohol anti-134 (187 
mg, 72%) as a white solid, mp 120–122 °C; RF (8:2 hexane-Et2O) 0.11; IR (ATR) 3458 
(OH), 2932, 2857, 1472, 1395, 1313, 1195, 1107, 908, 820, 731, 698, 632, 599, 545, 497, 
472 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.82–7.75 (m, 4H, Ph), 7.43–7.32 (m, 6H, Ph), 
7.22 (dd, J = 7.0, 7.0 Hz, 2H, Ph), 7.19–7.14 (m, 1H, Ph), 7.07 (d, J = 7.0 Hz, 2H, Ph), 
5.25 (s, 1H, OH), 3.77 (dd, J = 6.5, 5.0 Hz, 1H, SCH), 3.51 (dd, J = 16.5, 6.5 Hz, 1H, 
CHPh), 2.59 (dd, J = 16.5, 5.0 Hz, 1H, CHPh), 1.25 (s, 3H, C(OH)Me), 1.17 (s, 9H, 
SCMe3), 1.14 (s, 9H, SiCMe3), 1.09 (s, 3H, C(OH)Me);
 13C NMR (100.6 MHz, CDCl3) δ 
139.6 (ipso-Ph), 136.4 (ipso-Ph), 136.31 (Ph), 136.29 (Ph), 129.30 (Ph), 129.28 (Ph), 
128.7 (Ph), 128.5 (Ph), 127.5 (Ph), 127.4 (Ph), 126.6 (Ph), 73.8 (COH), 69.6 (SCH), 65.4 
(SCMe3), 35.6 (CH2Ph), 31.2 (C(OH)Me), 27.8 (SiCMe3), 25.1 (C(OH)Me), 24.2 
(SCMe3), 20.1 (SiCMe3) (one ipso-Ph resonance not resolved); MS (ESI) m/z 544 [(M + 
Na)+] HRMS (ESI) m/z calcd for C31H43NO2SSi (M + Na)
+ 544.2676, found 544.2676 
(−0.1 ppm error). The stereochemistry of anti-134 was assigned by analogy with related 
examples. 
Lab book reference: AH-1-51 
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[(tert-Butyldiphenylsilyl)imino](ethyl)(3-hydroxy-3-methylbutan-2-yl)-λ⁶-sulfanone 
anti-135 and syn-135 
 
Using general procedure C, N-TBDPS sulfoximine 86 (180 mg, 0.5 mmol, 1.0 eq.), n-
BuLi (0.25 mL of a 2.2 M solution in hexanes, 0.55 mmol, 1.1 eq.) and acetone (0.07 mL, 
1.0 mmol, 2.0 eq.) in THF (5 mL) at ‒78 °C for 1 h gave the crude product which 
contained an 80:20 mixture of alcohols anti-135 and syn-135 (by 1H NMR spectroscopy). 
Purification by flash column chromatography on silica with 95:5 hexane-Et2O as eluent 
gave an 85:15 mixture of alcohols anti-135 and syn-135 (171 mg, 82%) as a colourless 
oil, RF (8:2 hexane-Et2O) 0.33; IR (ATR) 3467 (OH), 3071, 2932, 2856, 1427, 1307, 
1258, 1181, 1107, 820, 733, 700, 631, 595 496 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.82–
7.70 (s, 4H, Ph), 7.44–7.32 (m, 6H, Ph), 6.56 (s, 0.15H, OH), 5.16 (s, 0.85H, OH), 3.22 
(q, J = 7.0 Hz, 0.15H, SCH(Me)COH), 3.16 (q, J = 7.0 Hz, 0.85H, SCH(Me)COH), 2.84 
(dq, J = 14.0, 7.0 Hz, 0.15H, SCHMe), 2.73 (dq, J = 14.0, 7.0 Hz, 0.85H, SCHMe), 2.47 
(dq, J = 14.0, 7.0 Hz, 0.85H, SCHMe), 2.05 (dq, J = 14.0, 7.0 Hz, 0.15H, SCHMe), 1.63 
(s, 0.45H, C(OH)Me), 1.51 (s, 2.55H, C(OH)Me), 1.40 (d, J = 7.0 Hz, 2.55H, SCHMe), 
1.37 (s, 2.55H, C(OH)Me), 1.32 (d, J = 7.0 Hz, 0.45H, SCHMe), 1.30 (s, 0.45H, 
C(OH)Me), 1.12–1.04 (s, 11.55H, SCH2Me, SiCMe3), 1.01 (t, J = 7.0 Hz, 0.45H, 
SCH2Me); 
13C NMR (100.6 MHz, CDCl3) δ 136.5 (ipso-Ph, anti-135), 136.1 (Ph, syn-
135), 136.0 (ipso-Ph, anti-135), 135.84 (Ph, anti-135), 135.79 (Ph, syn-135), 135.64 (Ph, 
anti-135), 135.55 (ipso-Ph, syn-135), 135.3 (ipso-Ph, syn-135), 129.6 (Ph, syn-135), 
129.5 (Ph, syn-135), 129.32 (Ph, anti-135), 129.27 (Ph, anti-135), 127.7 (Ph, syn-135), 
127.64 (Ph, syn-135), 127.56 (Ph, anti-135), 73.3 (COH, syn-135), 73.0 (COH, anti-135), 
65.3 (SCH, anti-135), 63.9 (SCH, syn-135), 51.8 (SCH2, anti-135), 49.1 (SCH2, syn-135), 
30.5 (C(OH)Me, syn-135), 30.2 (C(OH)Me, anti-135), 27.3 (CMe3, syn-135), 27.2 (CMe3, 
anti-135), 25.8 (C(OH)Me, anti-135), 24.9 (C(OH)Me, syn-135), 19.53 (CMe3, anti-135), 
19.47 (CMe3, syn-135), 13.9 (SCHMe, anti-135), 12.3 (SCHMe, syn-135), 8.9 (SCH2Me, 
syn-135), 8.5 (SCH2Me, anti-135) (one Ph resonance not resolved); MS (ESI) m/z 418 
[(M + H)+] HRMS (ESI) m/z calcd for C23H35NO2SSi (M + H)
+ 418.2231, found 418.2228 
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(+0.7 ppm error). The stereochemistry of anti-135 and syn-135 was assigned by analogy 
with related examples. 
Lab book reference: AH-1-47 
 
[(tert-Butyldiphenylsilyl)imino](3-hydroxy-3-methylbutan-2-yl)isopropyl-λ⁶-
sulfanone anti-136 and syn-136 
 
Using general procedure C, N-TBDPS sulfoximine 104 (187 mg, 0.5 mmol, 1.0 eq.), n-
BuLi (0.25 mL of a 2.2 M solution in hexanes, 0.55 mmol, 1.1 eq.) and acetone (0.07 mL, 
1.0 mmol, 2.0 eq.) in THF (5 mL) at ‒78 °C for 1 h gave the crude product which 
contained an 80:20 mixture of alcohols anti-136 and syn-136 (by 1H NMR spectroscopy). 
Purification by flash column chromatography on silica with 9:1 hexane-EtOAc as eluent 
gave an 80:20 mixture of alcohols anti-136 and syn-136 (110 mg of a 95:5 mixture of 
alcohol 136 and starting sulfoximine 104 i.e. 105 mg (49%) of 136) as a colourless oil, 
RF (6:4 hexane-Et2O) 0.36; IR (ATR) 3465 (OH), 3071, 2932, 2856, 1463, 1427, 1310, 
1257, 1181, 1106, 949, 820, 731, 700, 686, 597, 495 cm−1; 1H NMR (400 MHz, CDCl3) 
for anti-136 and syn-136 δ 7.83–7.71 (m, 4H, Ph), 7.43–7.30 (m, 6H, Ph), 6.43 (s, 0.2H, 
OH), 4.95 (s, 0.8H, OH), 3.31–3.20 (m, 1H, SCH(Me)COH), 2.88 (septet, J = 8.0 Hz, 
0.8H, SCHMe2), 2.81 (septet, J = 8.0 Hz, 0.2H, SCHMe2),1.59 (s, 0.6H, C(OH)Me), 1.36 
(s, 2.4H, C(OH)Me), 1.34 (s, 0.6H, C(OH)Me), 1.33–1.28 (m, 3H, SCH(Me)COH), 1.26 
(s, 2.4H, C(OH)Me), 1.17 (d, J = 8.0 Hz, 4.8H, SCHMe2), 1.14 (d, J = 8.0 Hz, 0.6H, 
SCHMe), 1.10 (s, 1.8H, CMe3), 1.08 (s, 7.2H, CMe3), 0.95 (d, J = 8.0 Hz, 0.6H, SCHMe); 
13C NMR (100.6 MHz, CDCl3) for anti-136 and syn-136 δ 136.6 (ipso-Ph, anti-136), 
136.29 (ipso-Ph, anti-136), 136.26 (Ph, syn-136), 136.0 (Ph, syn-136), 135.9 (Ph, anti-
136), 135.8 (Ph, anti-136), 129.4 (Ph, syn-136), 129.22 (Ph, syn-136), 129.19 (Ph, anti-
136), 127.7 (Ph, anti-136), 127.51 (Ph, syn-136), 127.47 (Ph, anti-136), 127.4 (Ph, syn-
136), 73.2 (COH, anti-136), 64.5 (SCHMe, anti-136), 64.1 (SCHMe, syn-136), 59.8 
(SCHMe2, anti-136), 58.4 (SCHMe2, syn-136), 30.6 (C(OH)Me, syn-136), 30.2 
(C(OH)Me, anti-136), 27.4 (CMe3, syn-136), 27.3 (CMe3, anti-136), 25.0 (C(OH)Me, 
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syn-136), 24.9 (C(OH)Me, anti-136), 19.8 (CMe3, anti-136), 19.7 (CMe3, syn-136), 18.0 
(SCHMe, syn-136), 16.8 (SCHMe, anti-136), 16.6 (SCHMe, anti-136), 16.0 (SCHMe, 
syn-136), 15.0 (SCH(Me)COH, anti-136), 13.2 (SCH(Me)COH, syn-136) (one COH, one 
Ph and two ipso-Ph resonances not resolved); MS (ESI) m/z 432 [(M + H)+] HRMS (ESI) 
m/z calcd for C24H37NO2SSi (M + H)
+ 432.2387, found 432.2380 (+1.5 ppm error). The 
stereochemistry of anti-136 and syn-136 was assigned by analogy with related examples. 
Lab book reference: AH-1-38 
 
tert-Butyl(3-hydroxy-3-methylbutan-2-yl)imino-λ⁶-sulfanone anti-137 
 
TBAF (0.23 mL of a 1 M solution in THF, 0.23 mmol, 2.0 eq.) was added dropwise to a 
stirred solution of N-TBDPS sulfoximine anti-133 (52 mg, 0.12 mmol, 1.0 eq.) in THF 
(1 mL) at rt under Ar. The resulting solution was stirred at rt for 64 h. The solvent was 
evaporated under reduced pressure to give the crude product. Purification by flash column 
chromatography on silica with EtOAc as eluent gave alcohol anti-137 (20 mg, 80%) as a 
white solid, mp 150–152 °C (dec); RF (9:1 EtOAc-MeOH) 0.43; IR (ATR) 3445 (OH), 
3276 (NH), 2988, 2937, 1467, 1391, 1184, 1070, 635, 578, 505 cm−1; 1H NMR (400 MHz, 
CDCl3) δ 5.04 (s, 1H, OH), 3.51 (q, J = 7.0 Hz, 1H, SCH), 2.35 (s, 1H, NH), 1.50 (s, 3H, 
C(Me)OH), 1.42 (s, 9H, SCMe3), 1.40 (d, J = 7.0 Hz, 3H, SCHMe), 1.29 (s, 3H, 
C(Me)OH); 13C NMR (100.6 MHz, CDCl3) δ 73.5 (COH), 63.3 (CMe3), 61.4 (SCH), 30.0 
(C(Me)OH), 24.3 (C(Me)OH), 23.9 (CMe3), 16.1 (SCHMe); MS (ESI) m/z 208 [(M + 
H)+] HRMS (ESI) m/z calcd for C9H21NO2S (M + H)
+ 208.1366, found 208.1369 (−1.6 
ppm error).  
Lab book reference: AH-1-77 
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4-Bromo-N-[tert-butyl(3-hydroxy-3-methylbutan-2-yl)oxo-λ⁶-
sulfanylidene]benzamide anti-138 
 
Et3N (0.02 mL, 0.15 mmol, 1.3 eq.) was added dropwise to a stirred solution of NH 
sulfoximine anti-137 (23 mg, 0.11 mmol, 1.0 eq.) and 4-bromobenzoyl chloride (25 mg, 
0.15 mmol, 1.3 eq.) in CH2Cl2 (1 mL) at 0 °C under Ar. The resulting solution was stirred 
at 0 °C for 1 h and then stirred at rt for 64 h. Then, water (5 mL) was added and the two 
layers were separated. The aqueous layer was extracted with CH2Cl2 (3 × 20 mL). The 
combined organic layers were dried (MgSO4) and evaporated under reduced pressure to 
give the crude product. Purification by flash column chromatography on silica with 
EtOAc as eluent gave impure alcohol anti-138 (25 mg of a 70:30 mixture of 4-
bromobenzoic acid and anti-138 i.e. 11 mg (26%) of anti-138) as a white solid, RF 
(EtOAc) 0.58; IR (ATR) 2976, 1785 (C=O), 1720 (C=O), 1632, 1586, 1480, 1395, 1288, 
1169, 1067, 1010, 793, 757, 737, 676, 626, 465 cm−1; 1H NMR (400 MHz, CDCl3) for 
anti-138 δ 7.96 (d, J = 8.5 Hz, 2H, Ar), 7.53 (d, J = 8.5 Hz, 2H, Ar), 4.24 (s, 1H, OH), 
3.80 (q, J = 7.0 Hz, 1H, SCH), 1.70 (s, 3H, C(Me)OH), 1.60 (s, 9H, CMe3), 1.47 (d, J = 
7.0 Hz, 3H, SCHMe), 1.40 (s, 3H, C(Me)OH); 13C NMR (100.6 MHz, CDCl3) for anti-
138 δ 172.5 (C=O), 131.8 (ipso-Ar), 131.4 (Ar), 131.0 (Ar), 126.9 (ipso-Ar), 74.1 (COH), 
65.8 (SCH), 64.7 (CMe3), 30.8 (C(Me)OH), 26.0 (C(Me)OH), 23.4 (CMe3), 14.7 
(SCHMe); MS (ESI) m/z 412 [(M (79Br) + Na)+] HRMS (ESI) m/z calcd for 
C16H24
79BrNO3S (M + Na)
+ 412.0552, found 412.0555 (−0.5 ppm error). The 
stereochemistry of anti-138 was assigned by X-ray crystallography. 
X-ray crystal structure determination of anti-138 
C16H24BrNO3S, M = 390.33, orthorhombic, a = 9.71496(17), b = 10.5508(2), c = 
35.0348(7) Å, β = 90°, U = 3591.10(12) Å3, T = 110.00(10) K, space group Pbca, Z = 8, 
μ(CuKα) = 4.302 mm-1, 7848 reflection measured, 3209 unique (Rint = 0.0177) which 
were used in calculation. The final R1 was 0.0241 (I≥2σ) and wR2 was 0.0628 (all data). 
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Lab book reference: AH-1-80 
 
Attempted synthesis tert-Butyl(3-hydroxy-3-methyl-1-phenylbutan-2-yl)imino-λ⁶-
sulfanone anti-139 
 
TBAF (0.42 mL of a 1 M solution in THF, 0.42 mmol, 2.0 eq.) was added dropwise to a 
stirred solution of N-TBDPS sulfoximine anti-134 (110 mg, 0.21 mmol, 1.0 eq.) in THF 
(2 mL) at rt under Ar. The resulting solution was stirred at rt for 64 h. The solvent was 
evaporated under reduced pressure to give the crude product which contained none of the 
desired product anti-139 (by 1H NMR spectroscopy). Purification by flash column 
chromatography on silica with EtOAc as eluent gave none of the desired product anti-
139 (by 1H NMR spectroscopy). 
Lab book reference: AH-1-78 
 
N-Methoxy-N-methylpyridine-3-carboxamide 141 
 
Et3N (3.14 mL, 22.5 mmol, 3.0 eq.) was added to a stirred solution of N,O-
dimethylhydroxylamine hydrochloride (730 mg, 7.5 mmol, 1.0 eq.) in CH2Cl2 (10 mL) at 
rt under Ar. The resulting solution was cooled to 0 °C and nicotinoyl chloride 
hydrochloride 140 (1.34 g, 7.5 mmol, 1.0 eq.) was added. The resulting solution was 
allowed to warm to rt and stirred at rt for 2 h. Saturated NH4Cl(aq) (20 mL) and saturated 
NaHCO3(aq) (20 mL) were added. The two layers were separated and the aqueous layer 
was extracted with CH2Cl2 (3 × 50 mL). The combined organic layers were dried 
(MgSO4) and evaporated under reduced pressure to give the crude product. Purification 
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by flash column chromatography on silica with EtOAc as eluent gave pyridinyl Weinreb 
amide 141 (800 mg, 64%) as a clear oil, RF (EtOAc) 0.26; IR (ATR) 2938, 1636 (C=O), 
1590, 1413, 1383, 978, 726 cm−1; 1H NMR (400 MHz, CDCl3) δ 8.94 (d, J = 1.5 Hz, 1H, 
2-py), 8.67 (dd, J = 5.0, 1.5 Hz, 1H, 6-py), 8.01 (ddd, J = 8.0, 1.5, 1.5 Hz, 1H, 4-py), 7.35 
(dd, J = 8.0, 5.0 Hz, 1H, 5-py), 3.55 (s, 3H, OMe), 3.38 (s, 3H, NMe); 13C NMR (100.6 
MHz, CDCl3) δ 167.6 (C=O), 151.5 (Ar), 149.4 (Ar), 136.3 (Ar), 130.0 (ipso-Ar), 123.1 
(Ar), 61.4 (OMe), 33.3 (NMe); MS (ESI) m/z 167 [(M + H)+] HRMS (ESI) m/z calcd for 
C8H10N2O2 (M + H)
+ 167.0815, found 167.0814 (+0.9 ppm error). Spectroscopic data are 
consistent with those reported in the literature.64 
Lab book reference: AH-1-4 
 
tert-Butyl[(tert-butyldiphenylsilyl)imino](1-oxo-1-phenylpropan-2-yl)-λ⁶-sulfanone 
anti-142 and syn-142  
 
Using general procedure C, N-TBDPS sulfoximine 118 (1.16 g, 3.0 mmol, 1.0 eq.), n-
BuLi (2.20 mL of a 1.5 M solution in hexanes, 3.3 mmol, 1.1 eq.) and N-methoxy-N-
methylbenzamide (0.60 mL, 3.9 mmol, 1.3 eq.) in THF (30 mL) at ‒78 °C for 1 h gave 
the crude product which contained a 97:3 mixture of ketones anti-142 and syn-142 (by 
1H NMR spectroscopy). Purification by flash column chromatography on silica with 95:5 
hexane-Et2O as eluent gave a 96:4 mixture of ketones anti-142 and syn-142 (1.28 g, 87%) 
as a white solid, mp 90–92 °C; RF (6:4 hexane-Et2O) 0.50, 0.52; IR (ATR) 3070, 2931, 
2856, 1684 (C=O), 1322, 1298, 1134, 1108, 948, 821, 734, 703, 501 cm−1; 1H NMR (400 
MHz, CDCl3) δ 7.88 (dd, J = 7.5, 1.0 Hz, 1.92H, Ph), 7.78–7.86 (m, 1.92H, Ph), 7.79 (dd, 
J = 7.5, 1.0 Hz, 0.08 Hz, Ph), 7.75 (dd, J = 7.5, 1.0 Hz, 1.92H, Ph), 7.72 (dd, J = 7.5, 1.0 
Hz, 0.08H, Ph), 7.66 (dd, J = 7.5, 1.0 Hz, 0.08H, Ph), 7.55–7.48 (m, 1H, Ph), 7.44–7.28 
(m, 8H, Ph), 5.21 (q, J = 7.0 Hz, 0.96H, SCH), 4.42 (q, J = 7.0 Hz, 0.04H, SCH), 1.62 (d, 
J = 7.0 Hz, 2.88H, SCHMe), 1.52 (d, J = 7.0 Hz, 0.12H, SCHMe), 1.40 (s, 0.36H, SCMe3), 
1.30 (s, 8.44H, SCMe3), 1.09 (s, 8.44H, SiCMe3), 1.05 (s, 0.36H, SiCMe3); 
13C NMR 
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(100.6 MHz, CDCl3) for anti-142 δ 194.0 (C=O), 137.8 (ipso-Ph), 136.6 (ipso-Ph), 136.4 
(ipso-Ph), 136.1 (Ph), 136.0 (Ph), 133.2 (Ph), 129.04 (Ph), 128.97 (Ph), 128.8 (Ph), 128.7 
(Ph), 127.4 (Ph), 127.3 (Ph), 66.5 (SCMe3), 60.9 (SCH), 27.3 (SiCMe3), 24.9 (SCMe3), 
19.9 (SiCMe3), 16.3 (SCHMe); MS (ESI) m/z 492 [(M + H)
+] HRMS (ESI) m/z calcd for 
C29H37NO2SSi (M + H)
+ 492.2387, found 492.2371 (+3.3 ppm error). The 
stereochemistry of anti-142 and syn-142 was assigned by analogy with related examples. 
Lab book reference: AH-2-43 
 
[(tert-Butyldiphenylsilyl)imino](ethyl)(1-oxo-1-phenylpropan-2-yl)-λ⁶-sulfanone 
syn-143 and anti-143 
 
Using general procedure C, N-TBDPS sulfoximine 86 (2.10 g, 6.0 mmol, 1.0 eq.), n-BuLi 
(2.87 mL of a 2.3 M solution in hexanes, 6.6 mmol, 1.1 eq.) and N-methoxy-N-
methylbenzamide (1.19 mL, 7.8 mmol, 1.3 eq.) in THF (60 mL) at ‒78 °C for 1 h gave 
the crude product which contained a 55:45 mixture of ketones syn-143 and anti-143 (by 
1H NMR spectroscopy). Purification by flash column chromatography on silica with 95:5 
hexane-Et2O gave ketone syn-143 (1.45 g, 52%) as a white solid, mp 98–100 °C; RF (8:2 
hexane-Et2O) 0.27; IR (ATR) 3069, 2931, 2856, 1675 (C=O), 1427, 1448, 1298, 1143, 
1109, 947, 821, 739, 702, 502 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.85–7.75 (m, 4H, 
Ph), 7.55–7.49 (m, 3H, Ph), 7.46–7.38 (m, 6H, Ph), 7.35 (dd, J = 7.5, 7.5 Hz, 2H, Ph), 
4.36 (q, J = 7.5 Hz, 1H, SCH(Me)COPh), 3.20–3.03 (m, 2H, SCH2), 1.52 (d, J = 7.5 Hz, 
3H, SCHMe), 1.38 (t, J = 7.5 Hz, 3H, SCH2Me), 1.09 (s, 9H, CMe3); 
13C NMR (100.6 
MHz, CDCl3) δ 195.3 (C=O), 136.6 (ipso-Ph), 136.3 (ipso-Ph), 136.1 (Ph), 135.9 (Ph), 
134.1 (ipso-Ph), 133.8 (Ph), 129.5 (Ph), 129.4 (Ph), 128.6 (Ph), 127.8 (Ph), 127.7 (Ph), 
65.8 (SCH), 45.7 (SCH2), 27.4 (CMe3), 18.9 (CMe3), 14.1 (SCHMe), 5.6 (SCH2Me) (one 
Ph resonance not resolved); MS (ESI) m/z 464 [(M + H)+] HRMS (ESI) m/z calcd for 
C27H33NO2SSi (M + H)
+ 464.2074, found 464.2074 (−0.0 ppm error) and a 93:7 mixture 
(by 1H NMR spectroscopy) of ketones anti-143 and syn-143 (262 mg, 9%) as a white 
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solid, mp 124–126 °C; RF (8:2 hexane-EtOAc) 0.16; IR (ATR) 3069, 2932, 2855, 1677, 
(C=O), 1584, 1449, 1427, 1301, 1144, 1108, 949, 821, 740, 702, 613, 503 cm−1; 1H NMR 
(400 MHz, CDCl3) for anti-143 δ 7.75 (dd, J = 8.0, 1.5 Hz, 2H, Ph), 7.60–7.53 (m, 4H, 
Ph), 7.48 (t, J = 8.0 Hz, 1H, Ph), 7.37–7.23 (m, 8H, Ph), 4.85 (q, J = 7.0 Hz, 1H, 
SCH(Me)COPh), 3.16 (dq, J = 14.0, 7.0 Hz, 1H, SCHMe), 3.08 (dq, J = 14.0, 7.0 Hz, 
1H, SCHMe), 1.66 (d, J = 7.0 Hz, 3H, SCHMe), 1.16 (t, J = 7.0 Hz, 3H, SCH2Me), 0.90 
(s, 9H, CMe3); 
13C NMR (100.6 MHz, CDCl3) for anti-143 δ 195.4 (C=O), 136.42 (ipso-
Ph), 136.37 (ipso-Ph), 136.1 (ipso-Ph), 135.71 (Ph), 135.65 (Ph), 133.9 (Ph), 129.3 (Ph), 
129.1 (Ph), 129.0 (Ph), 128.8 (Ph), 127.44 (Ph), 127.40 (Ph), 66.9 (SCH), 47.8 (SCH2), 
27.1 (CMe3), 19.4 (CMe3), 14.8 (SCHMe), 6.7 (SCH2Me); MS (ESI) m/z 464 [(M + H)
+] 
HRMS (ESI) m/z calcd for C23H33NO2SSi (M + H)
+ 464.2074, found 464.2073 (+0.3 ppm 
error) and a 75:25 mixture of ketones anti-143 and syn-143 (1.22 g, 32%) as a white solid. 
The stereochemistry of syn-143 was assigned by X-ray crystallography. 
X-ray crystal structure determination of syn-143 
C27H33NO2SSi, M = 463.69, orthorhombic, a = 29.3814(2), b = 14.75100(10), c = 
11.78790(10) Å, β = 90°, U = 5108.94(7) Å3, T = 110.00(10) K, space group Pccn, Z = 8, 
μ(CuKα) = 1.749 mm-1, 35804 reflection measured, 4931 unique (Rint = 0.0226) which 
were used in calculation. The final R1 was 0.0280 (I≥2σ) and wR2 was 0.0761 (all data). 
Lab book reference: AH-1-25 
 
[(tert-Butyldiphenylsilyl)imino](ethyl)[1-oxo-1-(pyridin-3-yl)propan-2-yl]-λ⁶-
sulfanone syn-145 and anti-145 
 
Using general procedure C, N-TBDPS sulfoximine 86 (180 mg, 0.5 mmol, 1.0 eq.), n-
BuLi (0.24 mL of a 2.3 M solution in hexanes, 0.55 mmol, 1.1 eq.) and N-methoxy-N-
methylpyridine-3-carboxamide (166 mg, 1.0 mmol, 2.0 eq.) in THF (5 mL) at ‒78 °C for 
1 h gave the crude product which contained a 65:35 mixture of ketones syn-145 and anti-
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145 (by 1H NMR spectroscopy). Purification by flash column chromatography on silica 
with 75:25 hexane-EtOAc as eluent gave a 70:30 mixture (by 1H NMR spectroscopy) of 
ketones syn-145 and anti-145 (153 mg, 66%) as a white solid. Further purification by 
flash column chromatography on silica with 9:1 and then 8:2 hexane-EtOAc gave a 90:10 
mixture of ketones syn-145 and anti-145 (51 mg, 22 %) as a white solid, RF (8:2 hexane-
EtOAc) 0.32, 0.18; IR (ATR) 2931, 2855, 1679 (C=O), 1584, 1426, 1304, 1143, 1108, 
943, 775, 601, 502 cm−1; 1H NMR (400 MHz, CDCl3) δ 8.97 (d, J = 1.5 Hz, 0.1H, Ar), 
8.79 (d, J = 1.5 Hz, 0.9H, Ar), 8.71 (dd, J = 5.0, 1.5 Hz, 0.9H, Ar), 8.65 (dd, J = 5.0, 1.5 
Hz, 0.1H, Ar), 7.93 (ddd, J = 8.0, 1.5, 1.5 H, 0.1H, Ar), 7.80 (ddd, J = 8.0, 8.0, 1.5 Hz, 
3.6H, Ar), 7.72 (ddd, J = 8.0, 1.5, 1.5 H, 0.9H, Ar), 7.60–7.55 (m, 0.4H, Ar), 7.50–7.40 
(m, 5.4H, Ar), 7.39–7.33 (m, 0.6H, Ar), 7.33–7.22 (m, 0.9H, Ar), 7.22–7.13 (m, 0.1H, 
Ar), 4.79 (q, J = 8.0 Hz, 0.1H, SCH(Me)COPy), 4.26 (q, J = 8.0 Hz, 0.9H, 
SCH(Me)COPy), 3.21–2.97 (m, 2H, SCH2), 1.68 (d, J = 8.0 Hz, 0.3H, SCHMe), 1.53 (d, 
J = 8.0 Hz, 2.7H, SCHMe), 1.40 (t, J = 8.0 Hz, 2.7H, SCH2Me), 1.22 (t, J = 8.0 Hz, 0.3H, 
SCH2Me), 1.11 (s, 8.1H, CMe3), 0.93 (s, 0.9H, CMe3); 
13C NMR (100.6 MHz, CDCl3) δ 
194.3 (C=O), 153.8 (Ar, anti-145), 153.7 (Ar, syn-145), 150.4 (Ar, syn-145), 150.3 (Ar, 
anti-145), 136.7 (Ar, syn-145), 136.5 (Ar, anti-145), 136.3 (ipso-Ar, syn-145), 136.0 
(ipso-Ar, syn-145), 135.9 (Ar, syn-145), 135.8 (Ar, syn-145), 135.6 (Ar, anti-145), 135.5 
(ipso-Ar, anti-145), 134.9 (ipso-Ar, anti-145), 132.0 (ipso-Ar, syn-145), 131.8 (ipso-Ar, 
anti-145), 129.6 (Ar, syn-145), 129.5 (Ar, syn-145), 129.2 (Ar, anti-145), 129.14 (Ar, 
anti-145), 129.11 (Ar, anti-145), 127.8 (Ar, syn-145), 127.7 (Ar, syn-145), 127.5 (Ar, 
anti-145), 127.4 (Ar, anti-145), 123.5 (Ar, anti-145), 123.3 (Ar, syn-145), 66.9 (SCH, 
anti-145), 66.0 (SCH, syn-145), 48.1 (SCH2, anti-145), 45.6 (SCH2, syn-145), 27.3 
(CMe3, syn-145), 27.0 (CMe3, anti-145), 19.5 (CMe3, syn-145), 19.5 (CMe3, anti-145), 
14.5 (SCHMe, anti-145), 13.6 (SCHMe, syn-145), 6.8 (SCH2Me, anti-145), 5.5 
(SCH2Me, syn-145) (one C=O resonance not resolved); MS (ESI) m/z 465 [(M + H)
+] 
HRMS (ESI) m/z calcd for C26H32N2O2SSi (M + H)
+ 465.2027, found 465.2026 (+0.1 
ppm error). The stereochemistry of syn-145 and anti-145 was assigned by analogy with 
related examples. 
Lab book reference: AH-1-6 
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[(tert-Butyldiphenylsilyl)imino](ethyl)(1-hydroxy-1-phenylpropan-2-yl)-λ⁶-
sulfanone anti,syn-146, anti,anti-146, syn,anti-146 and syn,syn-146 
 
Using general procedure C, N-TBDPS sulfoximine 86 (180 mg, 0.5 mmol, 1.0 eq.), n-
BuLi (0.24 mL of a 2.3 M solution in hexanes, 0.55 mmol, 1.1 eq.) and benzaldehyde 
(0.10 mL, 1.0 mmol, 2.0 eq.) in THF (5 mL) at −78 °C for 1 h gave the crude product 
which contained a 55:30:15 mixture of alcohols anti,anti-146, syn,syn-146 and anti,syn-
146 (by 1H NMR spectroscopy). Purification by flash column chromatography on silica 
with 98:2 and then 95:5 hexane-EtOAc as eluent gave alcohol anti,syn-146 (17 mg, 7%) 
as a colourless oil, RF (8:2 hexane-EtOAc) 0.41; IR (ATR) 3432 (OH), 2931, 2856, 1452, 
1427, 1309, 1137, 1109, 740, 702, 505 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.67 (dd, J 
= 7.0, 2.0 Hz, 2H, Ph), 7.63 (dd, J = 7.0, 2.0 Hz, 2H, Ph), 7.31–7.10 (m, 11H, Ph), 5.62 
(s, 1H, CHOH), 4.15 (d, J = 1.0 Hz, 1H, CHOH), 2.91 (qd, J = 7.5, 1.0 Hz, 1H, 
SCH(Me)CHOH), 2.67 (qd, J = 15.0, 7.5 Hz, 1H, SCHMe), 2.50 (dq, J = 15.0, 7.5 Hz, 
1H, SCHMe), 1.14 (d, J = 7.0 Hz, 3H, SCHMe), 1.01–0.94 (m, 12H, CMe3, SCH2Me); 
13C NMR (100.6 MHz, CDCl3) δ 140.9 (ipso-Ph), 136.3 (ipso-Ph), 135.91 (Ph), 135.85 
(ipso-Ph), 135.7 (Ph), 129.5 (Ph), 128.5 (Ph), 127.8 (Ph), 127.73 (Ph), 127.67 (Ph), 125.9 
(Ph), 69.7 (CHOH), 62.9 (SCH), 48.6 (SCH2), 27.3 (CMe3), 19.5 (CMe3), 8.2 (SCHMe), 
7.2 (SCH2Me) (one Ph resonance not resolved); MS (ESI) m/z 466 [(M + H)
+] HRMS 
(ESI) m/z calcd for C27H35NO2SSi (M + H)
+ 466.2231, found 466.2231 (‒0.1 ppm error) 
and a 60:40 mixture of alcohols anti,anti-146 and syn,syn-146 (186 mg, 80%) as a white 
solid, RF (8:2 hexane-EtOAc) 0.32; IR (ATR) 3441 (OH), 2931, 2855, 1453, 1427, 1309, 
1134, 1108, 740, 701, 502 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.77–7.70 (m, 4H, Ph), 
7.40-7.15 (m, 11H, Ph), 5.49 (s, 0.4H, CHOH), 5.09 (s, 0.6H, CHOH), 4.81 (d, J = 7.0 
Hz, 0.6H, CHOH), 4.34 (s, 0.4H, CHOH), 3.20 (quintet, J = 7.0 Hz, 0.6H, SCHMe), 3.02 
(q, J = 7.0 Hz, 0.4H, SCH(Me)CHOH), 2.96–2.78 (m, 2H, SCH2Me), 1.24–1.07 (m, 
13.2H, CMe3, SCH2Me, SCHMe), 0.87 (d, J = 7.0 Hz, 1.8H, SCHMe); 
13C NMR (100.6 
MHz, CDCl3) δ 140.6 (ipso-Ph), 140.5 (ipso-Ph), 136.5 (ipso-Ph), 136.2 (ipso-Ph), 136.1 
(ipso-Ph), 135.83 (Ph), 135.80 (Ph), 135.71 (Ph), 135.68 (Ph), 129.4 (Ph), 129.3 (Ph), 
128.6 (Ph), 128.5 (Ph), 128.4 (Ph), 127.7 (Ph), 127.63 (Ph), 127.58 (Ph), 127.3 (Ph), 125.7 
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(Ph), 73.8 (CHOH, anti,anti-146), 70.0 (CHOH, syn,syn-146), 64.4 (SCH, anti,anti-146), 
63.0 (SCH, syn,syn-146), 50.1 (SCH2, anti,anti-146), 49.0 (SCH2, syn,syn-146), 27.4 
(CMe3, anti,anti-146), 27.3 (CMe3, syn,syn-146), 19.6 (CMe3, anti,anti-146), 19.5 (CMe3, 
syn,syn-146), 13.9 (SCHMe, anti,anti-146), 8.0 (SCHMe, syn,syn-146), 7.5 (SCH2Me, 
anti,anti-146), 5.3 (SCH2Me, syn,syn-146) (one ipso-Ph and four Ph resonances not 
resolved); MS (ESI) m/z 488 [(M + Na)+] HRMS (ESI) m/z calcd for C27H35NO2SSi (M 
+ Na)+ 488.2050, found 488.2042 (+1.7 ppm error). The stereochemistry of anti,anti-146, 
syn,syn-146 and anti,syn-146 was tentatively assigned as described in Chapter 2.2.1.  
Lab book reference: AH-1-5 
 
L-selectride® (0.32 mL of a 1.0 M solution in THF, 0.32 mmol, 1.5 eq.) was added 
dropwise to a stirred solution of ketone syn-143 (100 mg, 0.22 mmol, 1.0 eq.) in THF (5 
mL) at −78 C under Ar. The resulting solution was stirred at −78 C for 5.5 h. Then, 
MeOH (5 mL) was added dropwise (caution: vigorous effervescence). 20% Rochelle’s 
salt(aq) (15 mL) and Et2O (15 mL) were added and the resulting mixture was allowed to 
warm to rt and stirred vigorously for 2 h. The two layers were separated and the aqueous 
layer was extracted with Et2O (3  20 mL). The combined organics were washed with 
water (20 mL), dried (MgSO4) and evaporated under reduced pressure to give the crude 
product which contained only alcohol syn,anti-146 (by 1H NMR spectroscopy). 
Purification by flash column chromatography on silica with 9:1 hexane-Et2O as eluent 
gave alcohol syn,anti-146 (87 mg, 85%) as a white solid, mp 98–100 °C; RF (1:1 hexane-
Et2O) 0.43; IR (ATR) 3442 (OH), 2931, 2855, 1453, 1427, 1109, 740, 701, 504 cm
−1; 1H 
NMR (400 MHz, CDCl3) δ 7.82–7.76 (m, 4H, Ph), 7.45–7.27 (m, 11H, Ph), 5.29 (d, J = 
2.0 Hz, 1H, CHOH), 4.99 (dd, J = 9.0, 2.0 Hz, 1H, CHOH), 3.18 (dq, J = 9.0, 7.0 Hz, 1H, 
SCH(Me)CHOH), 2.88 (dq, J = 14.5, 7.5 Hz, 1H, SCHMe), 2.59 (dq, J = 14.5, 7.5 Hz, 
1H, SCHMe), 1.18 (t, J = 7.5 Hz, 3H, SCH2Me), 1.12 (s, 9H, CMe3), 0.91 (d, J = 7.0 Hz, 
3H, SCHMe); 13C NMR (100.6 MHz, CDCl3) δ 140.8 (ipso-Ph), 136.1 (ipso-Ph), 136.0 
(ipso-Ph), 135.9 (Ph), 135.8 (Ph), 129.5 (Ph), 128.7 (Ph), 128.5 (Ph), 127.72 (Ph), 127.65 
(Ph), 127.2 (Ph), 74.5 (CHOH), 63.2 (SCH), 49.3 (SCH2), 27.4 (CMe3), 19.4 (CMe3), 
12.3 (SCHMe), 7.9 (SCH2Me) (one Ph resonance not resolved); MS (ESI) m/z 466 [(M + 
H)+] HRMS (ESI) m/z calcd for C27H35NO2SSi (M + H)
+ 466.2231, found 466.2223 (+1.7 
ppm error). 
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Lab book reference: AH-2-33 
 
Red-Al® (0.07 mL of a ≥60 wt. % in toluene, 0.22 mmol, 1.0 eq.) was added dropwise to 
a stirred solution of ketone syn-143 (100 mg, 0.22 mmol) in CH2Cl2 (1 mL) at 0 C under 
Ar. The resulting solution was stirred at 0 C for 4 h. Then, 20% Rochelle’s salt(aq) (5 mL) 
was added and the two layers were separated and the aqueous layer was extracted with 
Et2O (3  20 mL). The combined organics were washed with 20% Rochelle’s salt(aq) (20 
mL), dried (MgSO4) and evaporated under reduced pressure to give the crude product 
which contained an 80:20 mixture of alcohols syn,anti-146 and syn,syn-146 (by 1H NMR 
spectroscopy). Purification by flash column chromatography on silica with 9:1 hexane-
Et2O as eluent gave an 85:15 mixture of alcohols syn,anti-146 and syn,syn-146 (50 mg, 
49%) as a white solid. 
Lab book reference: AH-2-22 
 
tert-Butyl[(tert-butyldiphenylsilyl)imino][1-phenyl-1-(phenylamino)propan-2-yl]-
λ⁶-sulfanone 147  
 
Using general procedure C, N-TBDPS sulfoximine 86 (194 mg, 0.5 mmol, 1.0 eq.), n-
BuLi (0.37 mL of a 1.5 M solution in hexanes, 0.55 mmol, 1.1 eq.) and N-
benzylideneaniline (0.25 mL of a 4 M solution in THF, 1.0 mmol, 2.0 eq.) in THF (5 mL) 
at ‒78 °C for 1 h gave the crude product which contained a 40:30:20:10 mixture of 
diastereomeric amines 147a, 147b, 147c and 147d (by 1H NMR spectroscopy). 
Purification by flash column chromatography on silica with 7:3 CH2Cl2-hexane gave a 
92:6:2 mixture of diastereomeric amines 147b, 147d and 147a (78 mg, 27%) as a pale 
brown solid, mp 190–192 °C; RF (1:1 CH2Cl2-hexane) 0.40; 1H NMR (400 MHz, CDCl3) 
for 147b δ 7.78–7.73 (m, 4H, Ph), 7.42–7.34 (m, 2H, Ph), 7.34–7.24 (m, 4H, Ph), 7.24–
7.13 (m, 3H, Ph), 7.10–7.04 (m, 2H, Ph), 7.04–6.96 (m, 2H, Ph), 6.64 (t, J = 7.5 Hz 1H, 
Ph), 6.36 (d, J = 7.5 Hz, 2H, Ph), 5.88 (br s, 1H, NH), 4.17 (d, J = 8.5 Hz, 1H, CHNH), 
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3.52 (dq, J = 8.5, 7.0 Hz, 1H, SCH), 1.38 (s, 9H, SCMe3), 1.07 (s, 9H, SiCMe3), 0.95 (d, 
J = 7.0 Hz, 3H, SCHMe); 13C NMR (100.6 MHz, CDCl3) for 147b δ 147.6 (ipso-Ph), 
141.5 (ipso-Ph), 137.0 (ipso-Ph), 136.6 (ipso-Ph), 136.1 (Ph), 129.2 (Ph), 129.1 (Ph), 
128.7 (Ph), 128.6 (Ph), 128.1 (Ph), 127.6 (Ph), 127.53 (Ph), 127.45 (Ph), 118.1 (Ph), 115.3 
(Ph), 65.1 (SCMe3), 61.5 (SCH), 59.9 (CHNH), 27.5 (SiCMe3), 24.9 (SCMe3), 19.9 
(SiCMe3), 17.2 (SHCMe) (one Ph resonance not resolved) and a mixture of impure 
diastereomeric amines 147. Further purification by flash column chromatography on 
silica with 95:5 hexane-Et2O as eluent gave a 75:15:5:5 mixture of diastereomeric amines 
147a, 147d, 147b and 147c (149 mg, 52%) as a pale brown solid, RF (6:4 hexane-Et2O) 
0.56; IR (ATR) 3361 (NH), 3051, 2931, 2856, 1602, 1503, 1308, 1182, 1129, 1106, 909, 
820, 729, 701, 603, 501 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.85–7.68 (m, 4H, Ph), 
7.43–7.11 (m, 10.6H, Ph), 7.09–6.89 (m, 2.3H, Ph), 6.76 (tt, J = 7.5, 1.0 Hz, 0.05H, Ph), 
6.71–6.59 (m, 1H, Ph), 6.56 (tt, J = 7.5, 1.0 Hz, 0.05H, Ph), 6.53 (s, 0.05H, NH), 6.43 
(dd, J = 8.5, 1.0 Hz, 0.1H, Ph), 6.36 (dd, J = 8.5, 1.0 Hz, 0.1H, Ph), 6.34 (dd, J = 8.5, 1.0 
Hz, 1.5H, Ph), 6.14 (dd, J = 8.5, 1.0 Hz, 0.3H, Ph), 5.89 (s, 0.05H, NH), 5.70 (s, 0.15H, 
NH), 5.20 (dd, J = 4.0, 2.5 Hz, 0.75H, CHNH), 5.09 (d, J = 2.5 Hz, 0.15H, CHNH), 4.60 
(d, J = 4.0 Hz, 0.75H, NH), 4.31 (dd, J = 10.0, 2.5 Hz, 0.05H, CHNH), 4.16 (d, J = 8.5 
Hz, 0.05H, CHNH), 3.69–3.46 (m, 0.95H, SCH), 2.56 (dq, J = 10.0, 7.5 Hz, 0.05H, SCH), 
1.46 (s, 0.45H, SCMe3), 1.38 (s, 0.45H, SCMe3), 1.37 (d, J = 7.0 Hz, 0.45H, SCHMe), 
1.30 (s, 6.75H, SCMe3), 1.29 (s, 1.35H, SCMe3), 1.26 (d, J = 7.0 Hz, 2.25H, SCHMe), 
1.15 (s, 1.35H, SiCMe3), 1.10 (s, 0.45H, SiCMe3), 1.08 (s, 6.75H, SiCMe3), 1.06 (s, 
0.45H, SiCMe3), 0.99-0.93 (m, 0.3H, SCHMe); 
13C NMR (100.6 MHz, CDCl3) δ 146.8 
(ipso-Ph, 147a), 146.7 (ipso-Ph), 146.5 (ipso-Ph), 142.8 (ipso-Ph), 141.2 (ipso-Ph, 147a), 
140.4 (ipso-Ph), 136.7 (ipso-Ph, 147a), 136.7 (ipso-Ph, 147a), 136.3 (Ph), 136.4 (Ph), 
136.1 (ipso-Ph), 136.02 (Ph, 147a), 135.99 (Ph, 147a), 135.9 (ipso-Ph), 129.23 (Ph), 
129.16 (Ph, 147a), 129.11 (Ph, 147a), 129.94 (Ph, 147a), 129.88 (Ph, 147a), 128.79 (Ph), 
128.76 (Ph), 128.7 (Ph), 128.1 (Ph), 127.7 (Ph), 127.6 (Ph), 127.52 (Ph, 147a), 127.50 
(Ph, 147a), 127.47 (Ph, 147a), 127.0 (Ph, 147a), 126.8 (Ph), 118.0 (Ph, 147a), 117.9 (Ph), 
114.71 (Ph), 114.67 (Ph, 147a), 65.2 (SCMe3), 65.0 (SCMe3), 64.9 (SCMe3, 147a), 62.8 
(SCH), 62.5 (SCH), 60.7 (SCH, 147a), 59.9 (CHNH, 147a), 59.7 (CHNH), 27.6 (SiCMe3, 
147a), 27.5 (SiCMe3), 25.6 (SCMe3), 25.5 (SCMe3), 25.0 (SCMe3), 24.8 (SCMe3, 147a), 
20.08 (SiCMe3, 147a), 20.05 (SiCMe3), 11.0 (SCHMe, 147a), 8.1 (SHCMe); MS (ESI) 
m/z 569 [(M + H)+] HRMS (ESI) m/z calcd for C35H44N2OSSi (M + H)
+ 569.3016, found 
569.3006 (+1.8 ppm error). 
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Lab book reference: AH-2-38 
 
n-BuLi (0.37 mL of a 1.5 M solution in hexanes, 0.55 mmol, 1.1 eq.) was added dropwise 
to a stirred solution of N-TBDPS sulfoximine 86 (194 mg, 0.5 mmol, 1.0 eq.) in THF (5 
mL) at ‒78 °C under Ar. The resulting solution was stirred at ‒78 °C for 20 min. In a 
separate flask, BF3•Et2O (0.12 mL, 1.0 mmol, 1.0 eq.) was added dropwise to a stirred 
solution of N-benzylideneaniline (181 mg, 1.0 mmol, 2.0 eq.) in THF (2 mL) at ‒78 °C 
under Ar to give a 2 M solution of N-benzylideneaniline BF3•Et2O in THF. The N-
benzylideneaniline BF3•Et2O solution (0.5 mL of a 2 M solution in THF, 1.0 mmol, 2.0 
eq.) was added dropwise to the lithiated N-TBDPS sulfoximine. The resulting solution 
was stirred at ‒78 °C for 1 h then allowed to warm to rt. Then, water (5.0 mL) was added 
and the two layers were separated. The aqueous layer was extracted with CH2Cl2 (3 × 20 
mL). The combined organic layers were dried (MgSO4) and evaporated under reduced 
pressure to give the crude product which contained a 35:30:25:10 mixture of 
diastereomeric amines 147b, 147a, 147d and 147c (by 1H NMR spectroscopy). 
Purification by flash column chromatography on silica with 95:5 CH2Cl2-Et2O gave a 
35:30:25:10 mixture of diastereomeric amines 147b, 147a, 147d and 147c (175 mg, 62%) 
as a pale brown solid. 
Lab book reference: AH-2-50 
 
[Adamantan-1-yl(oxo)(1-phenylpropan-2-yl)-λ⁶-sulfanylidene](tert-
butyldiphenylsilyl)amine anti-148 
 
Using general procedure C, N-TBDPS sulfoximine 107 (212 mg, 0.5 mmol, 1.0 eq.), n-
BuLi (0.24 mL of a 2.3 M solution in hexanes, 0.55 mmol, 1.1 eq.) and benzyl bromide 
(0.12 mL, 1.0 mmol, 2.0 eq.) in THF (5 mL) at ‒78 °C for 1 h gave the crude product 
which contained only anti-148 (by 1H NMR spectroscopy). Purification by flash column 
chromatography on silica with 95:5 hexane-Et2O as eluent gave sulfoximine anti-148 
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(191 mg, 69%) as a white solid, mp 128–130 °C; RF (8:2 hexane-Et2O) 0.30; IR (ATR) 
2910, 2853, 1454, 1320, 1285, 1253, 1142, 1106, 1043, 908, 820, 729, 698, 646, 605, 498 
cm−1; 1H NMR (400 MHz, CDCl3) δ 7.88–7.84 (m, 4H, Ph), 7.42–7.35 (m, 6H, Ph), 7.25–
7.20 (m, 2H, Ph), 7.19–7.14 (m, 1H, Ph), 6.90 (d, J = 7.0 Hz, 2H, Ph), 3.39–3.31 (m, 1H, 
SCH), 3.28 (dd, J = 13.0, 3.0 Hz, 1H, CHPh), 2.16–2.10 (m, 3H, CH), 2.09–2.04 (m, 6H, 
CH2), 1.80 (dd, J = 13.0, 11.5 Hz, 1H, CHPh), 1.74–1.66 (m, 3H, CH), 1.66–1.58 (m, 3H, 
CH), 1.14 (s, 9H, CMe3), 1.03 (d, J = 7.0 Hz, 3H, SCHMe); 
13C NMR (100.6 MHz, 
CDCl3) δ 139.2 (ipso-Ph), 137.5 (ipso-Ph), 137.4 (ipso-Ph), 136.20 (Ph), 136.17 (Ph), 
129.4 (Ph), 129.1 (Ph), 129.0 (Ph), 128.5 (Ph), 127.44 (Ph), 127.41 (Ph), 126.4 (Ph), 65.3 
(SC), 56.4 (SCH), 36.2 (CH2), 36.1 (CH2), 35.4 (CH2Ph), 29.0 (CH), 27.7 (CMe3), 20.0 
(CMe3), 16.7 (SCHMe); MS (ESI) m/z 556 [(M + H)
+] HRMS (ESI) m/z calcd for 
C435H45NOSSi (M + H)
+ 556.3064, found 556.3060 (+0.2 ppm error). The 
stereochemistry of anti-148 was assigned by conversion into anti-153. 
Lab book reference: AH-2-7  
 
tert-Butyl[(tert-butyldiphenylsilyl)imino](1-phenylpropan-2-yl)-λ⁶-sulfanone anti-
149 and syn-149 
 
Using general procedure C, N-TBDPS sulfoximine 118 (194 mg, 0.5 mmol, 1.0 eq.), n-
BuLi (0.25 mL of a 2.2 M solution in hexanes, 0.55 mmol, 1.1 eq.) and benzyl bromide 
(0.12 mL, 1.0 mmol, 2.0 eq.) in THF (5 mL) at ‒78 °C for 1 h gave the crude product 
which contained a 97:3 mixture of sulfoximines anti-149 and syn-149 (by 1H NMR 
spectroscopy). Purification by flash column chromatography on silica with 95:5 hexane-
Et2O as eluent gave a 97:3 mixture of sulfoximines anti-149 and syn-149 (228 mg, 96%) 
as a white solid, mp 102–104 °C; RF (8:2 hexane-Et2O) 0.37; IR (ATR) 3069, 2930, 2855, 
1445, 1290, 1129, 1107, 820, 742, 699, 661, 599, 499 cm−1; 1H NMR (400 MHz, CDCl3) 
for anti-149 δ 7.87–7.80 (m, 4H, Ph), 7.44–7.34 (m, 6H, Ph), 7.22 (dd, J = 7.5, 7.5 Hz, 
2H, Ph), 7.18 (t, J = 7.5 Hz, 1H, Ph), 6.89 (d, J = 7.5 Hz, 2H, Ph), 3.43–3.33 (m, 1H, 
SCH), 3.29 (dd, J = 13.5, 3.0 Hz, 1H, CHPh), 1.80 (dd, J = 13.5, 12.0 Hz, 1H, CHPh), 
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1.43 (s, 9H, SCMe3), 1.13 (s, 9H, SiCMe3), 1.04 (d, J = 7.0 Hz, 3H, SCHMe);
 13C NMR 
(100.6 MHz, CDCl3) for anti-149 δ 139.1 (ipso-Ph), 137.3 (ipso-Ph), 137.2 (ipso-Ph), 
136.2 (Ph), 136.1 (Ph), 129.3 (Ph), 129.1 (Ph), 129.0 (Ph), 128.6 (Ph), 127.5 (Ph), 127.4 
(Ph), 126.4 (Ph), 63.7 (SCMe3), 57.8 (SCH), 35.6 (CH2Ph), 27.6 (SiCMe3), 25.1 (SCMe3), 
20.0 (SiCMe3), 16.5 (SCHMe); MS (ESI) m/z 478 [(M + H)
+] HRMS (ESI) m/z calcd for 
C29H39NOSSi (M + H)
+ 478.2594, found 478.2591 (+0.7 ppm error). The stereochemistry 
of anti-149 and syn-149 was assigned by analogy with related examples. 
Lab book reference: AH-1-49 
 
Using general procedure C, N-TBDPS sulfoximine 119 (3.47 g, 7.5 mmol, 1.0 eq.), n-
BuLi (3.32 mL of a 2.5 M solution in hexanes, 8.3 mmol, 1.1 eq.) and methyl iodide (0.87 
mL, 14.0 mmol, 2.0 eq.) in THF (75 mL) at ‒78 °C for 1 h gave the crude product which 
contained a 98:2 mixture of sulfoximines syn-149 and anti-149 (by 1H NMR 
spectroscopy). Purification by flash column chromatography on silica with 9:1 hexane-
Et2O as eluent gave a 98:2 mixture of sulfoximines syn-149 and anti-149 (3.46 g, 96%) 
as a white solid, mp 116–118 °C; RF (8:2 hexane-Et2O) 0.31; IR (ATR) 3070, 2931, 2855, 
1455, 1427, 1299, 1187, 1128, 1106, 909, 820, 731, 698, 598, 497 cm−1; 1H NMR (400 
MHz, CDCl3) for syn-149 δ 7.83–7.92 (m, 4H, Ph), 7.48–7.36 (m, 6H, Ph), 7.29–7.16 (m, 
3H, Ph), 6.92 (d, J = 7.0 Hz, 2H, Ph), 3.48–3.37 (m, 1H, SCH), 3.33 (dd, J = 13.5, 3.5 
Hz, 1H, CHPh), 2.30 (dd, J = 13.5, 12.0 Hz, 1H, CHPh), 1.51 (s, 9H, SCMe3), 1.16 (s, 
9H, SiCMe3), 0.96 (d, J = 7.0 Hz, 3H, SCHMe);
 13C NMR (100.6 MHz, CDCl3) for syn-
149 δ 138.7 (ipso-Ph), 137.2 (ipso-Ph), 136.1 (Ph), 136.0 (Ph), 129.1 (Ph), 129.0 (Ph), 
128.6 (Ph), 127.4 (Ph), 126.6 (Ph), 63.9 (SCMe3), 57.9 (SCH), 39.3 (CH2Ph), 27.6 
(SiCMe3), 25.1 (SCMe3), 20.0 (SiCMe3), 13.5 (SCHMe) (one ipso-Ph and two Ph 
resonances not resolved); MS (ESI) m/z 500 [(M + H)+] HRMS (ESI) m/z calcd for 
C29H39NOSSi (M + Na)
+ 500.2414, found 500.2412 (+0.4 ppm error). The 
stereochemistry of syn-149 and anti-149 was assigned by analogy with related examples. 
Lab book reference: AH-1-61 
 
n-BuLi (0.22 mL of a 2.5 M solution in hexanes, 0.55 mmol, 1.1 eq.) was added dropwise 
to a stirred solution of N-TBDPS sulfoximine syn-149 (239 mg, 0.5 mmol, 1.0 eq.) in 
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THF (5 mL) at −78 °C under Ar. The resulting solution was stirred at −78 °C for 20 min 
and then saturated NH4Cl(aq) (5 mL) was added. The resulting solution was stirred at −78 
°C for 1 h and then allowed to warm to rt. Then, water (5 mL) was added and the two 
layers were separated. The aqueous layer was extracted with CH2Cl2 (3 × 20 mL). The 
combined organic layers were dried (MgSO4) and evaporated under reduced pressure to 
give the crude product which contained a 90:10 mixture of sulfoximines syn-149 and anti-
149 (by 1H NMR spectroscopy). Purification by flash column chromatography on silica 
with 95:5 hexane-Et2O as eluent gave a 90:10 mixture of sulfoximines syn-149 and anti-
149 (112 mg, 47%) as a white solid. The stereochemistry of syn-149 and anti-149 was 
assigned by analogy with related examples. 
Lab book reference: AH-1-68 
 
[(tert-Butyldiphenylsilyl)imino](isopropyl)(1-phenylpropan-2-yl)-λ⁶-sulfanone anti-
150 and syn-150 
 
Using general procedure C, N-TBDPS sulfoximine 104 (187 mg, 0.5 mmol, 1.0 eq.), n-
BuLi (0.24 mL of a 2.3 M solution in hexanes, 0.55 mmol, 1.1 eq.) and benzyl bromide 
(0.12 mL, 1.0 mmol, 2.0 eq.) in THF (5 mL) at ‒78 °C for 1 h gave the crude product 
which contained a 70:30 mixture of sulfoximines anti-150 and syn-150 (by 1H NMR 
spectroscopy). Purification by flash column chromatography on silica with 95:5 hexane-
Et2O as eluent gave a 70:30 mixture of sulfoximines anti-150 and syn-150 (218 mg, 94%) 
as a colourless oil, RF (8:2 hexane-Et2O) 0.30; IR (ATR) 3069, 2931, 2855, 1456, 1427, 
1323, 1142, 1107, 821, 700, 601, 500 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.87–7.84 (m, 
0.6H, Ph), 7.83–7.78 (m, 3.4H, Ph), 7.44–7.31 (m, 6H, Ph), 7.27–7.15 (m, 3H, Ph), 6.98 
(dd, J = 7.0, 3.0 Hz, 1.4H, Ph), 6.83 (dd, J = 7.0, 3.0 Hz, 0.6H, Ph), 3.34 (dd, J = 13.0, 
3.0 Hz, 0.7H, CHPh), 3.30–3.11 (m, 2.3H, CHPh, SCH(Me)CH2Ph, SCHMe2), 2.44 (dd, 
J = 13.0, 11.0 Hz, 0.3H, CHPh), 2.31 (dd, J = 13.0, 11.0 Hz, 0.7H, CHPh), 1.32–1.21 (m, 
6H, SCHMe2), 1.13–1.06 (m, 12H, CMe3, SCH(Me)CH2Ph); 13C NMR (100.6 MHz, 
CDCl3) δ 138.4 (ipso-Ph, anti-150), 138.1 (ipso-Ph, syn-150), 137.2 (ipso-Ph, syn-150), 
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137.1 (ipso-Ph, anti-150), 137.0 (ipso-Ph, anti-150), 136.7 (ipso-Ph, syn-150), 136.0 
(Ph), 135.93 (Ph, anti-150), 135.89 (Ph, anti-150), 135.8 (Ph), 129.4 (Ph, anti-150), 129.3 
(Ph), 129.07 (Ph), 129.06 (Ph), 128.7 (Ph), 128.6 (Ph, anti-150), 127.6 (Ph), 127.49 (Ph, 
anti-150), 127.46 (Ph, anti-150), 126.7 (Ph), 59.3 (SCH, anti-150), 59.2 (SCH, syn-150), 
53.5 (SCHMe2, anti-150), 53.0 (SCHMe2, syn-150), 35.4 (CH2Ph, syn-150), 35.0 
(CH2Ph, anti-150), 27.5 (CMe3, anti-150), 27.4 (CMe3, syn-150), 20.0 (CMe3, syn-150), 
19.9 (CMe3, anti-150), 16.7 (SCHMe, syn-150), 16.6 (SCHMe, anti-150), 16.0 (SCHMe, 
anti-150), 15.4 (SCHMe, syn-150), 13.7 (SCH(Me)CH2Ph, anti-150), 12.9 
(SCH(Me)CH2Ph, syn-150) (four Ph resonances not resolved); MS (ESI) m/z 464 [(M + 
H)+] HRMS (ESI) m/z calcd for C28H37NOSSi (M + H)
+ 464.2438, found 464.2444 (+0.4 
ppm error). The stereochemistry of anti-150 and syn-150 was assigned by analogy with 
related examples. 
Lab book reference: AH-1-13 
 
(tert-Butyldiphenylsilyl)[oxo(phenyl)(1-phenylpropan-2-yl)-λ⁶-sulfanylidene]amine 
anti-151 and syn-151  
 
Using general procedure C, N-TBDPS sulfoximine 87 (204 mg, 0.5 mmol, 1.0 eq.), n-
BuLi (0.24 mL of a 2.3 M solution in hexanes, 0.55 mmol, 1.1 eq.) and benzyl bromide 
(0.12 mL, 1.0 mmol, 2.0 eq.) in THF (5 mL) at ‒78 °C for 1 h gave the crude product 
which contained a 60:40 mixture of sulfoximines anti-151 and syn-151 (by 1H NMR 
spectroscopy). Purification by flash column chromatography on silica with 9:1 hexane-
Et2O as eluent gave a 60:40 mixture of sulfoximines anti-151 and syn-151 (209 mg, 84%) 
as a colourless oil, RF (9:1 hexane-Et2O) 0.21; IR (ATR) 3067, 2930, 2855, 1427, 1295, 
1148, 1106, 1109, 733, 699, 603, 499 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.94–7.84 (m, 
4H, Ph), 7.84–7.78 (m, 2H, Ph), 7.55–7.49 (m, 1H, Ph), 7.46–7.20 (m, 11H, Ph), 7.04 (d, 
J = 7.0 Hz, 0.8H, Ph), 7.02 (d, J = 7.0 Hz, 1.2H, Ph), 3.56 (dd, J = 13.0, 3.0 Hz, 0.4H, 
CHPh), 3.48 (dd, J = 13.0, 3.0 Hz, 0.6H, CHPh), 3.29–3.17 (m, 1H, SCH), 2.49 (dd, J = 
13.0, 12.0 Hz, 0.4H, CHPh), 2.40 (dd, J = 13.0, 12.0 Hz, 0.6H, CHPh), 1.21 (s, 9H, 
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CMe3), 1.17 (d, J = 7.0 Hz, 1.8H, SCHMe), 1.10 (d, J = 7.0 Hz, 1.2H, SCHMe); 
13C NMR 
(100.6 MHz, CDCl3) δ 140.73 (ipso-Ph), 140.71 (ipso-Ph), 138.1 (ipso-Ph), 138.0 (ipso-
Ph), 136.7 (ipso-Ph), 136.6 (ipso-Ph), 136.5 (ipso-Ph), 136.4 (ipso-Ph), 135.8 (Ph, anti-
151), 135.7 (Ph), 132.3 (Ph), 129.1 (Ph, anti-151), 129.0 (Ph), 128.9 (Ph), 128.83 (Ph), 
128.76 (Ph), 128.6 (Ph, anti-151), 127.4 (Ph, anti-151), 127.3 (Ph, anti-151), 126.6 (Ph), 
65.1 (SCH, anti-151), 65.0 (SCH, syn-151), 36.0 (CH2Ph, syn-151), 35.9 (CH2Ph, anti-
151), 27.4 (CMe3), 19.7 (CMe3), 13.4 (SCHMe, anti-151), 13.0 (SCHMe, syn-151) (one 
CMe3, one CMe3 and twelve Ph resonances not resolved); MS (ESI) m/z 498 [(M + H)
+] 
HRMS (ESI) m/z calcd for C31H35NOSSi (M + H)
+ 498.2281, found 498.2280 (+0.3 ppm 
error). The stereochemistry of anti-151 and syn-151 was assigned by analogy with related 
examples. 
Lab book reference: AH-1-10 
 
Using general procedure C, N-TBDPS sulfoximine 117 (242 mg, 0.5 mmol, 1.0 eq.), n-
BuLi (0.24 mL of a 2.3 M solution in hexanes, 0.55 mmol, 1.1 eq.) and methyl iodide 
(0.06 mL, 1.0 mmol, 2.0 eq.) in THF (5 mL) at ‒78 °C for 1 h gave the crude product 
which contained a 65:35 mixture of sulfoximines syn-151 and anti-151 (by 1H NMR 
spectroscopy). Purification by flash column chromatography on silica with 95:5 hexane-
Et2O as eluent gave a 65:35 mixture of sulfoximines syn-151 and anti-151 (201 mg of a 
54:42 mixture of 151 and toluene i.e. 176 mg (71%) of 151) as a yellow oil. 
Lab book reference: AH-1-15 
 
Adamantan-1-yl(imino)(1-phenylpropan-2-yl)-λ⁶-sulfanone anti-152 
 
TBAF (0.34 mL of a 1 M solution in THF, 0.34 mmol, 2.0 eq.) was added dropwise to a 
stirred solution of N-TBDPS sulfoximine anti-148 (95 mg, 0.17 mmol, 1.0 eq.) in THF 
(1 mL) at rt under Ar. The resulting solution was stirred at rt for 48 h. The solvent was 
evaporated under reduced pressure to give the crude product. Purification by flash column 
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chromatography on silica with 1:1 hexane-EtOAc as eluent gave sulfoximine anti-152 
(50 mg, 93%) as a yellow oil, RF (EtOAc) 0.37; IR (ATR) 3272 (NH), 2907, 2851, 1453, 
1195, 1180, 1103, 950, 750, 730, 703, 598, 546, 506, 459 cm−1; 1H NMR (400 MHz, 
CDCl3) δ 7.31 (dd, J = 7.0, 7.0 Hz, 2H, Ph), 7.24 (t, J = 7.0 Hz, 1H, Ph), 7.20 (d, J = 7.0 
Hz, 2H, Ph), 3.55 (dd, J = 13.5, 3.0 Hz 1H, CHPh), 3.46–3.34 (m, 1H, SCH), 2.64 (dd, J 
= 13.5, 11.5 Hz 1H, CHPh), 2.25 (s, 1H, NH), 2.23–2.17 (m, 3H, CH), 2.15–2.10 (m, 6H, 
CH), 1.79–1.66 (m, 6H, CH), 1.27 (d, J = 7.0 Hz, 3H, SCHMe); 13C NMR (100.6 MHz, 
CDCl3) δ 138.3 (ipso-Ph), 129.5 (Ph), 128.8 (Ph), 126.9 (Ph), 64.1 (SC), 54.9 (SCH), 36.1 
(CH2), 35.99 (CH2), 35.96 (CH2Ph), 28.8 (CH), 15.9 (SCHMe); MS (ESI) m/z 318 [(M + 
H)+] HRMS (ESI) m/z calcd for C19H27NOS (M + H)
+ 318.1886, found 318.1885 (+0.2 
ppm error).  
Lab book reference: AH-2-19  
 
N-[Adamantan-1-yl(oxo)(1-phenylpropan-2-yl)-λ⁶-sulfanylidene]-4-
bromobenzamide anti-153 
 
Et3N (0.03 mL, 0.21 mmol, 1.3 eq.) was added dropwise to a stirred solution of NH 
sulfoximine anti-152 (50 mg, 0.16 mmol, 1.0 eq.) and 4-bromobenzoyl chloride (42 mg, 
0.21 mmol, 1.3 eq.) in CH2Cl2 (1 mL) at 0 °C under Ar. The resulting solution was stirred 
at 0 °C for 1 h and then stirred at rt for 64 h. Then, water (5 mL) was added and the two 
layers were separated. The aqueous layer was extracted with CH2Cl2 (3 × 20 mL). The 
combined organic layers were dried (MgSO4) and evaporated under reduced pressure to 
give the crude product. Purification by flash column chromatography on silica with 9:1 
hexane-EtOAc as eluent gave sulfoximine anti-153 (67 mg, 84%) as a white solid, mp 
156–158 °C; RF (8:2 hexane-EtOAc) 0.36; IR (ATR) 2910, 2854, 1623 (C=O), 1586, 
1454, 1308, 1281, 1197, 1167, 1136, 1011, 829, 757, 735, 701, 592, 544 cm−1; 1H NMR 
(400 MHz, CDCl3) δ 8.02 (d, J = 8.5 Hz, 2H, Ar), 7.54 (d, J = 8.5 Hz, 2H, Ar), 7.33 (dd, 
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J = 7.0, 1.5 Hz, 2H, Ar), 7.28–7.22 (m, 3H, Ar), 3.87–3.80 (m, 1H, SCH), 3.77 (dd, J = 
13.5, 3.0 Hz 1H, CHPh), 3.14 (dd, J = 13.5, 11.5 Hz 1H, CHPh), 2.31–2.23 (m, 6H, CH), 
2.22–2.15 (m, 3H, CH), 1.85–1.71 (m, 6H, CH), 1.34 (d, J = 7.0 Hz, 3H, SCHMe); 13C 
NMR (100.6 MHz, CDCl3) δ 173.9 (C=O), 138.7 (ipso-Ar), 135.5 (ipso-Ar), 131.3 (Ar), 
131.1 (Ar), 129.5 (Ar), 128.9 (Ar), 127.0 (Ar), 126.7 (ipso-Ar), 65.2 (SC), 56.4 (SCH), 
37.5 (CH2), 35.9 (CH2), 35.1 (CH2Ph), 28.7 (CH), 15.8 (SCHMe); MS (ESI) m/z 500 [(M 
(79Br) + H)+] HRMS (ESI) m/z calcd for C26H30
79BrNO2S (M + H)
+ 500.1253, found 
500.1254 (−0.1 ppm error). The stereochemistry of anti-153 was assigned by X-ray 
crystallography. 
X-ray crystal structure determination of anti-153 
C26H30NO2SBr, M = 500.48, monoclinic, a = 10.6638(4), b = 22.7301(5), c = 11.0915(4) 
Å, β = 118.538(5)°, U = 2361.80(16) Å3, T = 110.00(10) K, space group P21/c, Z = 4, 
μ(CuKα) = 3.372 mm-1, 8750 reflection measured, 4210 unique (Rint = 0.0175) which 
were used in calculation. The final R1 was 0.0233 (I≥2σ) and wR2 was 0.0601 (all data). 
Lab book reference: AH-2-25 
 
 [(tert-Butyldiphenylsilyl)imino](ethyl)(1-phenylpropan-2-yl)-λ⁶-sulfanone anti-154 
and syn-154 and [(tert-Butyldiphenylsilyl)imino]bis(1-phenylpropan-2-yl)-λ⁶-
sulfanone 155 
 
Using general procedure C, N-TBDPS sulfoximine 86 (180 mg, 0.5 mmol, 1.0 eq.), n-
BuLi (0.24 mL of a 2.3 M solution in hexanes, 0.55 mmol, 1.1 eq.) and benzyl bromide 
(0.12 mL, 1.0 mmol, 2.0 eq.) in THF (5 mL) at ‒78 °C for 1 h gave the crude product 
which contained an unquantifiable mixture of products (by 1H NMR spectroscopy). 
Purification by flash column chromatography on silica with 95:5 hexane-EtOAc as eluent 
gave an unknown mixture of diastereomeric N-TBDPS sulfoximines 155 (70 mg, 26%) 
as a white solid, RF (8:2 hexane-EtOAc) 0.49; IR (ATR) 3027, 2932, 2855, 1455, 1427, 
1331, 1145, 1107, 821, 744, 700, 501 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.94–7.77 (m, 
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4H, Ph), 7.45–7.33 (m, 6H, Ph), 7.31–7.16 (m, 6H, Ph), 7.07–6.83 (m, 4H, Ph), 3.48–
3.16 (m, 4H, CHPh), 2.62–2.34 (m, 2H, SCH), 1.22–1.10 (m, 15H, CMe3, SCHMe); 13C 
NMR (100.6 MHz, CDCl3) δ 138.23 (ipso-Ph), 138.18 (ipso-Ph), 138.1 (ipso-Ph), 137.2 
(ipso-Ph), 137.0 (ipso-Ph), 136.7 (ipso-Ph), 136.0 (Ph), 135.93 (Ph), 135.86 (Ph), 129.5 
(Ph), 129.4 (Ph), 129.3 (Ph), 129.2 (Ph), 129.1 (Ph), 128.70 (Ph), 128.66 (Ph), 127.7 (Ph), 
127.64 (Ph), 127.59 (Ph), 127.5 (Ph), 126.7 (Ph), 60.0 (SCH), 59.9 (SCH), 59.40 (SCH), 
59.36 (SCH), 35.9 (CH2Ph), 35.8 (CH2Ph), 34.9 (CH2Ph), 34.6 (CH2Ph), 27.51 (CMe3), 
27.46 (CMe3), 20.0 (CMe3), 19.9 (CMe3), 13.8 (SCHMe), 13.6 (SCHMe), 13.4 (SCHMe), 
12.6 (SCHMe); MS (ESI) m/z 540 [(M + H)+] HRMS (ESI) m/z calcd for C34H41NOSSi 
(M + H)+ 540.2751, found 540.2743 (+1.4 ppm error) and a 75:25 mixture of sulfoximines 
anti-154 and syn-154 (102 mg, 45%) as a white solid, RF (8:2 hexane-EtOAc) 0.40; IR 
(ATR) 2931, 2855, 1456, 1427, 1314, 1145, 1108, 821, 738, 701, 502 cm−1; 1H NMR 
(400 MHz, CDCl3) δ 7.89–7.80 (m, 4H, Ph), 7.48–7.37 (m, 6H, Ph), 7.36–7.23 (m, 2H, 
Ph), 7.11 (d, J = 7.5 Hz, 0.5H, Ph), 7.08 (d, J = 7.5 Hz, 1.5H, Ph), 3.55–3.42 (m, 1H, 
CHPh), 3.21–3.09 (m, 1H, SCH), 2.96–2.73 (m, 2H, SCH2), 2.63 (dd, J = 13.5, 11.0 Hz, 
0.25H, CHPh), 2.52 (dd, J = 13.5, 11.0 Hz, 0.75H, CHPh), 1.30–1.22 (m, 6H, SMe, 
SCHMe), 1.17 (s, 9H, CMe3); 
13C NMR (100.6 MHz, CDCl3) δ 138.13 (ipso-Ph, anti-
154), 138.08 (ipso-Ph, syn-154), 137.1 (ipso-Ph, anti-154), 136.9 (ipso-Ph, syn-154), 
136.84 (ipso-Ph, syn-154), 136.80 (ipso-Ph, anti-154), 135.83 (Ph, anti-154), 135.79 
(Ph), 135.76 (Ph, anti-154), 129.33 (Ph, anti-154), 129.26 (Ph, syn-154), 129.1 (Ph), 
128.74 (Ph, syn-154), 128.69 (Ph, anti-154), 127.5 (Ph, anti-154), 126.8 (Ph, syn-154), 
126.7 (Ph), 60.8 (SCH, anti-154), 60.5 (SCH, syn-154), 47.9 (CH2Ph, syn-154), 47.8 
(CH2Ph, anti-154), 36.1 (SCH2, syn-154), 35.0 (SCH2, anti-154), 27.4 (CMe3), 19.6 
(CMe3), 13.8 (SCHMe, anti-154), 12.7 (SCHMe, syn-154), 7.7 (SCH2Me, syn-154), 7.4 
(SCH2Me, anti-154) (CMe3, CMe3 and seven Ph resonances not resolved); MS (ESI) m/z 
450 [(M + H)+] HRMS (ESI) m/z calcd for C27H35NOSSi (M + H)
+ 450.2281, found 
450.2278 (+0.8 ppm error). The stereochemistry of anti-154 and syn-154 was assigned 
by analogy with related examples. 
Lab book reference: AH-1-3 
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tert-Butyl[(tert-butyldiphenylsilyl)imino](1-phenylbutan-2-yl)-λ⁶-sulfanone anti-158 
and syn-158 
 
Using general procedure C, N-TBDPS sulfoximine 119 (200 mg, 0.5 mmol, 1.0 eq.), n-
BuLi (0.24 mL of a 2.3 M solution in hexanes, 0.55 mmol, 1.1 eq.) and ethyl iodide (0.08 
mL, 1.0 mmol, 2.0 eq.) in THF (5 mL) at ‒78 °C for 1 h gave the crude product which 
contained a 97:3 mixture of sulfoximines anti-158 and syn-158 (by 1H NMR 
spectroscopy). Purification by flash column chromatography on silica with 95:5 hexane-
Et2O as eluent gave a 97:3 mixture of sulfoximines anti-158 and syn-158 (115 mg, 47%) 
as a pale orange solid, mp 126–128 °C; RF (8:2 hexane-Et2O) 0.43, IR (ATR) 3069, 2931, 
2855, 1454, 1427, 1294, 1130, 1106, 909, 820, 730, 698, 657, 598, 497 cm−1; 1H NMR 
(400 MHz, CDCl3) for anti-158 δ 7.88–7.82 (m, 4H, Ph), 7.44–7.35 (m, 6H, Ph), 7.29–
7.23 (m, 2H, Ph), 7.22–7.17 (m, 1H, Ph), 6.98 (d, J = 7.5 Hz, 2H, Ph), 3.34–3.23 (m, 2H, 
SCH, CHPh), 2.36 (dd, J = 15.0, 12.0 Hz, 1H, CHPh), 1.74 (ddq, J = 14.0, 7.5, 7.5 Hz, 
1H, CHMe), 1.46 (s, 9H, SCMe3), 1.33–1.22 (m, 1H, CHMe), 1.15 (s, 9H, SiCMe3), 0.73 
(t, J = 7.5 Hz, 3H, CH2Me); 
13C NMR (100.6 MHz, CDCl3) for anti-158 δ 139.1 (ipso-
Ph), 137.3 (ipso-Ph), 137.2 (ipso-Ph), 136.14 (Ph), 136.09 (Ph), 129.04 (Ph), 128.98 (Ph), 
128.9 (Ph), 128.7 (Ph), 127.4 (Ph), 126.6 (Ph), 63.7 (SCMe3), 63.1 (SCH), 38.7 (CH2Ph), 
27.7 (SiCMe3), 24.8 (SCMe3), 21.6 (CH2Me), 20.0 (SiCMe3), 13.4 (CH2Me) (one Ph 
resonance not resolved); MS (ESI) m/z 492 [(M + H)+] HRMS (ESI) m/z calcd for 
C30H41NOSSi (M + H)
+ 492.2751, found 492.2752 (‒0.1 ppm error). Diagnostic signals 
for alcohol syn-158: 1H NMR (400 MHz, CDCl3) δ 2.10 (dd, J = 14.0, 8.0 Hz, 1H, CHPh), 
0.65 (t, J = 7.5 Hz, 3H, CH2Me). The stereochemistry of anti-158 and syn-158 was 
assigned by analogy with related examples. 
Lab book reference: AH-1-76 
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tert-Butyl[(tert-butyldiphenylsilyl)imino](1-²H₁)ethyl-λ⁶-sulfanone 118-d 
 
n-BuLi (0.42 mL of a 1.3 M solution in hexanes, 0.55 mmol, 1.1 eq.) was added dropwise 
to a stirred solution of N-TBDPS sulfoximine 118 (194 mg, 0.5 mmol, 1.0 eq.) in THF (5 
mL) at ‒78 °C under Ar. The resulting solution was stirred at ‒78 °C for 20 min. Then, 
CD3OD (0.04 mL, 1.0 mmol, 2.0 eq.) was added. Then, water (5 mL) was added and the 
two layers were separated. The aqueous layer was extracted with CH2Cl2 (3 × 50 mL). 
The combined organic layers were dried (MgSO4) and evaporated under reduced pressure 
to give a 60:40 mixture of sulfoximines 118-d (176 mg, 91%) as a white solid, RF (6:4 
hexane-Et2O) 0.30; IR (ATR) 3070, 2930, 2855, 1427, 1306, 1138, 1106, 820, 736, 700, 
608, 501 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.88–7.82 (m, 2H, Ph), 7.82–7.75 (m, 2H, 
Ph), 7.43–7.32 (m, 6H, Ph), 2.88 (br q, J = 7.5 Hz, 0.4H, SCH), 2.78 (br q, J = 7.5 Hz, 
0.6H, SCH), 1.43 (s, 9H, SiCMe3), 1.10 (s, 9H, SCMe3), 1.01 (d, J = 7.5 Hz, 3H, SCHMe); 
13C NMR (100.6 MHz, CDCl3) δ 137.2 (ipso-Ph), 136.9 (ipso-Ph), 135.9 (Ph), 135.7 (Ph), 
129.0 (Ph), 127.43 (Ph), 127.39 (Ph), 61.4 (SCMe3), 43.9 (1:1:1 triplet, J = 21.0 Hz, 
SHCD), 27.4 (SiCMe3), 24.3 (SCMe3), 19.9 (SiCMe3), 6.8 (SCHMe) (one Ph resonance 
not resolved); MS (ESI) m/z 411 [(M + Na)+] HRMS (ESI) m/z calcd for C22H32DNOSSi 
(M + Na)+ 411.2007, found 411.1998 (+2.1 ppm error).  
Lab book reference: AH-2-35 
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3-Benzyl-4-tert-butyl-2,2,7,7-tetramethyl-6,6-diphenyl-4λ⁶-thia-5-aza-2,6-disilaoct-
4-en-4-one anti-159 
 
Using general procedure C, N-TBDPS sulfoximine 119 (232 mg, 0.5 mmol, 1.0 eq.), n-
BuLi (0.25 mL of a 2.2 M solution in hexanes, 0.55 mmol, 1.1 eq.) and TMS−Cl (0.13 
mL, 1.0 mmol, 2.0 eq.) in THF (5 mL) at ‒78 °C for 1 h gave the crude product which 
contained only sulfoximine anti-159 (by 1H NMR spectroscopy). Purification by flash 
column chromatography on silica with 95:5 hexane-Et2O as eluent gave sulfoximine anti-
159 (242 mg, 90%) as a colourless oil, RF (8:2 hexane-Et2O) 0.51; IR (ATR) 3070, 2959, 
2856, 1472, 1392, 1313, 1248, 1132, 1107, 846, 762, 700, 524, 498 cm−1; 1H NMR (400 
MHz, CDCl3) δ 7.89–7.79 (m, 4H, Ph), 7.45–7.34 (m, 6H, Ph), 7.29–7.15 (m, 3H, Ph), 
7.10 (d, J = 7.0 Hz, 2H, Ph), 3.58 (dd, J = 16.0, 4.5 Hz, 1H, CHPh), 3.41 (dd, J = 7.0, 4.5 
Hz, 1H, SCH), 2.87 (dd, J = 16.0, 7.0 Hz, 1H, CHPh), 1.21–1.13 (m, 18H, SiCMe3, 
SCMe3), 0.14 (s, 9H, SiMe3); 
13C NMR (100.6 MHz, CDCl3) δ 140.8 (ipso-Ph), 137.2 
(ipso-Ph), 137.1 (ipso-Ph), 136.31 (Ph), 136.27 (Ph), 128.99 (Ph), 128.95 (Ph), 128.5 
(Ph), 128.4 (Ph), 127.4 (Ph), 127.3 (Ph), 126.3 (Ph), 64.3 (SCMe3), 52.1 (SCH) 34.4 
(CH2Ph), 27.9 (SiCMe3), 24.4 (SCMe3), 20.1 (SiCMe3), 0.04 (SiMe3); MS (ESI) m/z 536 
[(M + H)+] HRMS (ESI) m/z calcd for C31H45NOSSi2 (M + H)
+ 536.2833, found 536.2814 
(+0.2 ppm error). The stereochemistry of anti-159 was assigned by analogy with related 
examples. 
Lab book reference: AH-1-52 
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4-Ethyl-2,2,3,7,7-pentamethyl-6,6-diphenyl-4λ⁶-thia-5-aza-2,6-disilaoct-4-en-4-one 
anti-160 and syn-160 and 4-Ethyl-2,2,3,7,7-pentamethyl-6,6-diphenyl-3-
(trimethylsilyl)-4λ⁶-thia-5-aza-2,6-disilaoct-4-en-4-one 161 
 
Using general procedure C, N-TBDPS sulfoximine 86 (180 mg, 0.5 mmol, 1.0 eq.), n-
BuLi (0.24 mL of a 2.3 M solution in hexanes, 0.55 mmol, 1.1 eq.) and TMS−Cl (0.13 
mL, 1.0 mmol, 2.0 eq.) in THF (5 mL) at ‒78 °C for 1 h gave the crude product which 
contained a 67:33 mixture of monosubstituted sulfoximines 160 (80:20 mixture of anti-
160 and syn-160) and disubstituted sulfoximine 161 (by 1H NMR spectroscopy). 
Purification by flash column chromatography on silica with 98:2 and then 95:5 hexane-
EtOAc as eluent gave an 80:20 mixture of monosubstituted N-TBDPS sulfoximines anti-
160 and syn-160 (128 mg, 59%) as a white solid, RF (8:2 hexane-EtOAc) 0.47; IR (ATR) 
3070, 2932, 2855, 1427, 1292, 1248, 1136, 1106, 841, 770, 729, 700, 626, 603, 566, 498 
cm−1; 1H NMR (400 MHz, CDCl3) δ 7.82 (dd, J = 7.5, 2.0 Hz, 2H, Ph), 7.76 (dd, J = 7.5, 
2.0 Hz, 2H, Ph), 7.42–7.31 (m, 6H, Ph), 2.88 (dq, J = 14.0, 7.5 Hz, 0.2H, SCHMe), 2.69 
(dq, J = 14.0, 7.5 Hz, 0.8H, SCHMe), 2.61 (q, J = 7.5 Hz, 0.8H, SCH(Me)SiMe3), 2.52 
(q, J = 7.5 Hz, 0.2H, SCH(Me)SiMe3), 2.34–2.18 (m, 1H, SCHMe), 1.40 (d, J = 7.5 Hz, 
2.4H, SCHMe), 1.30 (d, J = 7.5 Hz, 0.6H, SCHMe), 1.09 (s, 9H, CMe3), 1.04 (t, J = 7.5 
Hz, 3H, SCH2Me), 0.30 (s, 7.2H SiMe3), 0.24 (s, 1.8H SiMe3); 
13C NMR (100.6 MHz, 
CDCl3) δ 137.4 (ipso-Ph, anti-160), 137.1 (ipso-Ph, syn-160), 136.92 (ipso-Ph, anti-160), 
136.90 (ipso-Ph, syn-160), 136.0 (Ph, anti-160), 135.9 (Ph), 135.8 (Ph, anti-160), 129.1 
(Ph, syn-160), 129.02 (Ph), 128.98 (Ph), 127.5 (Ph, anti-160), 127.43 (Ph, anti-160), 
127.39 (Ph), 49.9 (SCH2, anti-160), 49.5 (SCH2, syn-160), 48.0 (SCH, syn-160), 47.3 
(SCH, anti-160), 27.6 (CMe3, syn-160), 27.4 (CMe3, anti-160), 19.6 (CMe3, anti-160), 
19.5 (CMe3, syn-160), 12.7 (SCHMe, anti-160), 11.7 (SCHMe, syn-160), 9.2 (SCH2Me, 
anti-160), 8.1 (SCH2Me, syn-160), −0.9 (SiMe3, syn-160), −1.0 (SiMe3, anti-160) (three 
Ph resonances not resolved); MS (ESI) m/z 432 [(M + H)+] HRMS (ESI) m/z calcd for 
C23H37NOSSi2 (M + H)
+ 432.2207, found 432.2209 (−1.2 ppm error) and disubstituted 
N-TBDPS sulfoximine 161 (60 mg, 24%) as a colourless oil, RF (8:2 hexane-EtOAc) 0.58; 
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IR (ATR) 3071, 2955, 2855, 1427, 1246, 1136, 1105, 834, 785, 732, 700, 615, 502 cm−1; 
1H NMR (400 MHz, CDCl3) δ 7.83 (dd, J = 7.5, 2.0 Hz, 2H, Ph), 7.75 (dd, J = 7.5, 2.0 
Hz, 2H, Ph), 7.40–7.29 (m, 6H, Ph), 2.87 (dq, J = 14.0, 7.5 Hz, 1H, SCHMe), 2.72 (dq, J 
= 14.0, 7.5 Hz, 1H, SCHMe), 1.39 (s, 3H, SCMe), 1.08 (s, 9H, CMe3), 0.92 (t, J = 7.5 Hz, 
3H, SCH2Me), 0.26 (s, 9H SiMe3), 0.25 (s, 9H SiMe3); 
13C NMR (100.6 MHz, CDCl3) δ 
137.4 (ipso-Ph), 137.1 (ipso-Ph), 136.3 (Ph), 136.1 (Ph), 128.91 (Ph), 128.86 (Ph), 127.3 
(Ph), 127.2 (Ph), 52.1 (SCH2), 51.3 (SCMe), 27.7 (CMe3), 19.9 (CMe3), 15.9 (SCMe), 
7.8 (SCH2Me), 1.0 (SiMe3), 0.9 (SiMe3); MS (ESI) m/z 504 [(M + H)
+] HRMS (ESI) m/z 
calcd for C26H45NOSSi3 (M + H)
+ 504.2602, found 504.2602 (+1.9 ppm error). The 
stereochemistry of anti-160 and syn-160 was assigned by analogy with related examples. 
Lab book reference: AH-1-16 
 
[(tert-Butyldiphenylsilyl)imino](2-hydroxy-1,2-diphenylethyl)methyl-λ⁶-sulfanone 
44 
 
Using general procedure C, N-TBDPS sulfoximine 43 (204 mg, 0.5 mmol, 1.0 eq.), n-
BuLi (0.37 mL of a 1.5 M solution in hexanes, 0.55 mmol, 1.1 eq.) and benzaldehyde 
(0.10 mL, 1.0 mmol, 2.0 eq.) in THF (5 mL) at ‒78 °C for 2 h gave the crude product 
which contained a 70:25:5 mixture of diastereomeric alcohols 44a, 44b and 44c (by 1H 
NMR spectroscopy). Purification by flash column chromatography on silica with 95:5 
hexane-Et2O as eluent gave alcohol 44b (33 mg, 13%) as a white solid, mp 126–128 °C; 
RF (6:4 hexane-EtOAc) 0.33; IR (ATR) 3431 (OH), 3068, 2929, 2855, 1427, 1316, 1288, 
1133, 1108, 1060, 820, 738, 697, 596, 500 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.80–
7.74 (m, 4H, Ph), 7.44–7.27 (m, 10H, Ph), 7.25–7.20 (m, 1H, Ph), 7.15–7.11 (m, 3H, Ph), 
6.95–6.89 (m, 2H, Ph), 6.08 (dd, J = 2.0, 2.0 Hz, 1H, CHOH), 4.02 (d, J = 2.0 Hz, 1H, 
SCH), 3.98 (d, J = 2.0 Hz, 1H, CHOH), 2.46 (s, 3H, SMe), 1.16 (s, 9H, CMe3); 
13C NMR 
(100.6 MHz, CDCl3) δ 140.2 (ipso-Ph), 136.1 (ipso-Ph), 135.9 (ipso-Ph), 135.8 (Ph), 
135.7 (Ph), 130.4 (ipso-Ph), 131.4 (Ph), 129.5 (Ph), 128.9 (Ph), 128.3 (Ph), 128.1 (Ph), 
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127.82 (Ph), 127.76 (Ph), 127.6 (Ph), 126.1 (Ph), 78.4 (SCH), 70.9 (CHOH), 44.1 (SMe), 
27.3 (CMe3), 19.5 (CMe3) (one Ph resonance not resolved); MS (ESI) m/z 466 [(M + 
Na)+] HRMS (ESI) m/z calcd for C31H35NO2SSi (M + Na)
+ 536.2050, found 536.2049 
(+0.2 ppm error) and a 95:5 mixture of alcohols 44a and 44c (103 mg, 40%) as a white 
solid, mp 110–112 °C; RF (6:4 hexane-EtOAc) 0.21, IR (ATR) 3389 (OH), 3052, 2930, 
2857, 1427, 1265, 1142, 1109, 820, 734, 697, 599, 547, 501 cm−1; 1H NMR (400 MHz, 
CDCl3) for 44a δ 7.87–7.78 (m, 4H, Ph), 7.49–7.32 (m, 7H, Ph), 7.28–7.18 (m, 3H, Ph), 
7.18–7.06 (m, 6H, Ph), 6.18 (d, J = 1.0 Hz, 1H, CHOH), 5.81 (d, J = 9.5 Hz, 1H, CHOH), 
4.42 (d, J = 9.5 Hz, 1H, SCH), 2.29 (s, 3H, SMe), 1.19 (s, 9H, CMe3); 
13C NMR (100.6 
MHz, CDCl3) for 44a δ 140.13 (ipso-Ph), 135.9 (Ph), 135.7 (Ph) 135.6 (ipso-Ph), 135.3 
(ipso-Ph), 132.0 (ipso-Ph), 130.3 (Ph), 129.62 (Ph), 129.58 (Ph), 128.7 (Ph), 128.5 (Ph), 
128.1 (Ph), 127.93 (Ph), 127.86 (Ph), 127.8 (Ph), 127.5 (Ph), 77.8 (SCH), 74.4 (CHOH), 
43.6 (SMe), 27.2 (CMe3), 19.3 (CMe3); MS (ESI) m/z 514 [(M + H)
+] HRMS (ESI) m/z 
calcd for C31H35NO2SSi (M + H)
+ 514.2231, found 514.2233 (‒0.4 ppm error). 
Diagnostic signals for alcohol 44c: 1H NMR (400 MHz, CDCl3) δ 5.67 (dd, J = 9.5, 1.0 
Hz, 1H, CHOH), 4.57 (d, J = 9.5 Hz, 1H, SCH), 2.52 (s, 3H, SMe), 1.15 (s, 9H, CMe3).   
Lab book reference: AH-2-30 
 
[(tert-Butyldiphenylsilyl)imino][1,2-diphenyl-2-(phenylamino)ethyl]methyl-λ⁶-
sulfanone 46  
 
Using general procedure C, N-TBDPS sulfoximine 43 (204 mg, 0.5 mmol, 1.0 eq.), n-
BuLi (0.37 mL of a 1.5 M solution in hexanes, 0.55 mmol, 1.1 eq.) and N-
benzylideneaniline (0.25 mL of a 4 M solution in THF, 1.0 mmol, 2.0 eq.) in THF (5 mL) 
at ‒78 °C for 1 h gave the crude product which contained a 50:35:10:5 mixture of amines 
46a, 46b, 46c and 46d (by 1H NMR spectroscopy). Purification by flash column 
chromatography on silica with 95:5 hexane-Et2O gave amine 46b (23 mg, 8%) as a pale 
brown oil, RF (6:4 hexane- Et2O) 0.47; IR (ATR) 3348 (NH), 3030, 2929, 2856, 1602, 
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1499, 1427, 1316, 1287, 1132, 1109, 910, 821, 740, 700, 503 cm−1; 1H NMR (400 MHz, 
CDCl3) δ 7.70 (dd, J = 8.0, 1.0 Hz, 2H, Ph), 7.66 (dd, J = 8.0, 1.0 Hz, 2H, Ph), 7.42–7.27 
(m, 6H, Ph), 7.25–7.14 (m, 7H, Ph), 7.13–6.98 (m, 5H, Ph), 6.65 (t, J = 7.5 Hz, 1H, Ph), 
6.56 (d, J = 7.5 Hz, 2H, Ph), 6.37 (s, 1H, NH), 5.30 (d, J = 9.0 Hz, 1H, CHNH), 4.36 (d, 
J = 9.0 Hz, 1H, SCH), 2.26 (s, 3H, SMe), 1.12 (s, 9H, CMe3); 
1H NMR (400 MHz, d6-
acetone) δ 7.73-7.65 (m, 4H, Ph), 7.41–7.30 (m, 6H, Ph), 7.29–7.22 (m, 4H, Ph), 7.21–
7.11 (m, 3H, Ph), 7.09–6.93 (m, 5H, Ph), 6.70 (d, J = 7.5 Hz, 2H, Ph), 6.59 (t, J = 7.5 Hz, 
1H, Ph), 6.14 (d, J = 8.0 Hz, 1H, NH), 5.58 (dd, J = 9.0, 8.0 Hz, 1H, CHNH), 4.80 (d, J 
= 9.0 Hz, 1H, SCH), 2.77 (s, 3H, SMe), 1.09 (s, 9H, CMe3); 
13C NMR (100.6 MHz, 
CDCl3) δ 136.2 (ipso-Ph), 135.9 (Ph), 135.8 (Ph), 133.4 (ipso-Ph), 130.4 (Ph), 129.4 (Ph), 
129.1 (Ph), 128.9 (Ph), 128.7 (Ph), 128.3 (Ph), 127.83 (Ph), 127.78 (Ph), 127.7 (Ph), 127.5 
(Ph), 118.0 (Ph), 114.3 (Ph), 78.3 (SCH), 60.2 (CHNH), 44.5 (SMe), 27.4 (CMe3), 19.5 
(CMe3) (three ipso-Ph and one Ph resonances not resolved); 
13C NMR (100.6 MHz, d6-
acetone) δ 146.8 (ipso-Ph), 141.2 (ipso-Ph), 136.6 (ipso-Ph), 136.4 (ipso-Ph), 135.9 (Ph), 
135.8 (Ph), 133.0 (ipso-Ph), 131.2 (Ph), 129.1 (Ph), 129.0 (Ph), 128.9 (Ph), 128.24 (Ph), 
128.15 (Ph), 127.9 (Ph), 127.8 (Ph), 127.5 (Ph), 127.4 (Ph), 126.9 (Ph), 117.6 (Ph), 114.3 
(Ph), 77.4 (SCH), 59.6 (CHNH), 46.5 (SMe), 26.9 (CMe3), 19.2 (CMe3); (ESI) m/z 589 
[(M + H)+] HRMS (ESI) m/z calcd for C37H40N2OSSi (M + H)
+ 589.2703, found 589.2698 
(+1.0 ppm error) and a mixture of impure diastereomeric amines 46. Further purification 
by flash column chromatography on silica with 1:1 hexane-CH2Cl2 as eluent gave an 
80:15:5 mixture of diastereomeric amines 46a, 46c and 46d (111 mg, 38%) as a pale 
brown solid, RF (1:1 CH2Cl2-hexane) 0.43; IR (ATR) 3375 (NH), 3051, 2929, 2856, 1601, 
1498, 1314, 1264, 1124, 1109, 820, 735, 698, 643, 501 cm−1; 1H NMR (400 MHz, d6-
acetone) δ 7.74–7.86 (m, 0.2H, Ph), 7.73–7.57 (m, 4.2H, Ph), 7.57–7.43 (m, 1.6H, Ph), 
7.42–7.12 (m, 12H, Ph), 7.11–6.96 (m, 4H, Ph), 6.71–6.55 (m, 3H, Ph), 6.43 (d, J = 4.0 
Hz, 0.8H, NH), 5.86–5.77 (m, 0.2H, CHNH, NH), 5.72–5.63 (m, 0.2H, CHNH, NH), 5.44 
(dd, J = 10.0, 4.0 Hz, 0.8H, CHNH), 4.84–4.75 (m, 1H, SCH), 2.47 (s, 0.15H, SMe), 2.44 
(s, 0.45H, SMe), 2.41 (s, 2.4H, SMe), 1.07-0.98 (m, 9H, CMe3); 
13C NMR (100.6 MHz, 
d6-acetone) for 46a and 46c δ 148.13 (ipso-Ph, 46a), 148.08 (ipso-Ph, 46c), 142.1 (ipso-
Ph, 46a), 142.0 (ipso-Ph, 46c), 137.4 (ipso-Ph, 46a), 137.2 (ipso-Ph, 46c), 137.14 (ipso-
Ph, 46a), 137.08 (ipso-Ph, 46c), 136.5 (Ph, 46a), 136.5 (Ph, 46a), 135.6 (ipso-Ph, 46c), 
134.5 (ipso-Ph, 46a), 132.9 (Ph, 46c), 132.5 (Ph), 132.24 (Ph), 132.19 (Ph), 131.5 (Ph), 
129.92 (Ph, 46a), 129.87 (Ph), 129.8 (Ph, 46a), 129.60 (Ph), 129.58 (Ph, 46a), 129.4 (Ph, 
46a), 129.00 (Ph, 46a), 128.98 (Ph, 46a), 128.88 (Ph), 128.75 (Ph, 46a), 128.39 (Ph), 
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128.35 (Ph), 128.3 (Ph, 46a), 128.2 (Ph), 128.13 (Ph, 46a), 128.05 (Ph, 46c), 127.8 (Ph, 
46a), 118.6 (Ph, 46c), 118.2 (Ph), 118.1 (Ph, 46a), 115.29 (Ph), 115.26 (Ph, 46c), 114.8 
(Ph, 46a), 77.2 (SCH, 46a), 77.1 (SCH, 46c), 60.8 (CHNH, 46a), 58.3 (CHNH, 46c), 46.2 
(SMe, 46a), 44.8 (SMe, 46c), 27.6 (CMe3, 46c), 27.5 (CMe3, 46a), 19.8 (CMe3, 46c), 19.8 
(CMe3, 46a); MS (ESI) m/z 589 [(M + H)
+] HRMS (ESI) m/z calcd for C37H40N2OSSi (M 
+ H)+ 589.2703, found 589.2707 (−0.5 ppm error). 
Lab book reference: AH-2-23 
 
n-BuLi (0.37 mL of a 1.5 M solution in hexanes, 0.55 mmol, 1.1 eq.) was added dropwise 
to a stirred solution of N-TBDPS sulfoximine 43 (204 mg, 0.5 mmol, 1.0 eq.) in THF (5 
mL) at ‒78 °C under Ar. The resulting solution was stirred at ‒78 °C for 20 min. In a 
separate flask, BF3•Et2O (0.12 mL, 1.0 mmol, 1.0 eq.) was added dropwise to a stirred 
solution of N-benzylideneaniline (181 mg, 1.0 mmol, 2.0 eq.) in THF (2 mL) at ‒78 °C 
under Ar to give a 2 M solution of N-benzylideneaniline BF3•Et2O in THF. The N-
benzylideneaniline BF3•Et2O solution (0.5 mL of a 2 M solution in THF, 1.0 mmol, 2.0 
eq.) was added dropwise to the lithiated N-TBDPS sulfoximine. The resulting solution 
was stirred at ‒78 °C for 1 h then allowed to warm to rt. Then, water (5.0 mL) was added 
and the two layers were separated. The aqueous layer was extracted with CH2Cl2 (3 × 20 
mL). The combined organic layers were dried (MgSO4) and evaporated under reduced 
pressure to give the crude product which contained a 50:20:15:15 mixture of amines 46c, 
46b, 46d and 46a (by 1H NMR spectroscopy). Purification by flash column 
chromatography on silica with 1:1 CH2Cl2-hexane gave a 90:5:5 mixture of amines 46d, 
46a and 46c (52 mg, 18%) as a brown oil RF (6:4 hexane- Et2O) 0.34; IR (ATR) 3372 
(NH), 2929, 2855, 1601, 1498, 1279, 1141, 1108, 820, 739, 698, 603, 500 cm−1; 1H NMR 
(400 MHz, d6-acetone) for 46d δ 7.77 (dd, J = 8.0, 1.0 Hz, 2H, Ph), 7.69 (dd, J = 8.0, 1.0 
Hz, 2H, Ph), 7.48 (dd, J = 8.0, 1.0 Hz, 2H, Ph), 7.42–7.21 (m, 10H, Ph), 7.20–7.12 (m, 
4H, Ph), 7.06–6.97 (m, 2H, Ph), 6.69–6.52 (m, 3H, Ph), 5.85–5.78 (m, 1H, CHNH), 5.67 
(d, J = 4.0 Hz, 1H, NH), 4.77 (d, J = 4.0 Hz, 1H, SCH), 2.47 (s, 3H, SMe), 1.05 (s, 9H, 
CMe3); 
13C NMR (100.6 MHz, d6-acetone) for 46d δ 148.3 (ipso-Ph), 141.9 (ipso-Ph), 
136.6 (Ph), 136.5 (Ph), 132.4 (ipso-Ph), 132.3 (Ph), 130.0 (Ph), 129.9 (Ph), 129.63 (ipso-
Ph), 129.56 (Ph), 129.4 (Ph), 129.1 (Ph), 128.9 (Ph), 128.4 (Ph), 128.23 (Ph), 128.15 (Ph), 
128.1 (Ph), 120.2 (ipso-Ph), 118.5 (Ph), 115.3 (Ph), 77.1 (SCH), 57.7 (CHNH), 44.8 
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(SMe), 27.6 (CMe3), 19.9 (CMe3); MS (ESI) m/z 589 [(M + Na)
+] HRMS (ESI) m/z calcd 
for C37H40N2OSSi (M + Na)
+ 611.2523, found 611.2513 (+0.7 ppm error) and a 75:25 
mixture of diastereomeric amines 46 (75:25 mixture of 46c and 46a) and starting 
sulfoximine 46 (154 mg of a 75:25 mixture of 46 and starting material 43 i.e. 128 mg 
(44%) of 46) as a brown oil. 
Lab book reference: AH-2-49 
 
Benzyl[(tert-butyldiphenylsilyl)imino](2-hydroxy-2,2-diphenylethyl)-λ⁶-sulfanone 
165 
 
Using general procedure C, N-TBDPS sulfoximine 43 (204 mg, 0.5 mmol, 1.0 eq.), n-
BuLi (0.24 mL of a 2.3 M solution in hexanes, 0.55 mmol, 1.1 eq.) and benzophenone 
(0.25 mL of a 4 M solution in THF, 1.0 mmol, 2.0 eq.) in THF (5 mL) at ‒78 °C for 1 h 
gave the crude product. Purification by flash column chromatography on silica with 95:5 
hexane-Et2O as eluent gave starting sulfoximine 43 (74 mg, 36%) as a white solid, impure 
alcohol 165 and no desired alcohol 164. Further purification of impure alcohol 165 by 
flash column chromatography on silica with 1:1 hexane-CH2Cl2 as eluent gave impure 
alcohol 165 (7 mg of a 70:30 mixture of 165 and tert-butyldiphenylsilanol i.e. 5.9 mg 
(2%) of 165) as a white solid, RF (1:1 hexane-CH2Cl2) 0.14; IR (ATR) 3292 (OH), 3069, 
2930, 2856, 1427, 1265, 1240, 1110, 821, 740, 699, 607, 505 cm−1; 1H NMR (400 MHz, 
CDCl3) for 165 δ 7.61 (dd, J = 8.0, 1.5 Hz, 2H, Ph), 7.49 (dd, J = 8.0, 1.5 Hz, 4H, Ph), 
7.43–7.30 (m, 6H, Ph), 7.30–7.25 (m, 7H, Ph), 7.24–7.18 (m, 4H, Ph), 7.02 (d, J = 7.0 
Hz, 2H, Ph), 3.74 (d, J = 14.5 Hz, 1H, CHPh), 3.66 (d, J = 14.5 Hz, 1H, CHPh), 3.42 (s, 
2H, SCH2COH), 0.98 (s, 9H, CMe3); 
13C NMR (100.6 MHz, CDCl3) for 165 δ 145.4 
(ipso-Ph), 144.6 (ipso-Ph), 136.0 (Ph), 135.7 (ipso-Ph), 135.5 (ipso-Ph), 131.1 (Ph), 129.8 
(Ph), 129.4 (Ph), 129.1 (Ph), 128.7 (Ph), 128.6 (Ph), 128.43 (Ph), 128.41 (Ph), 127.82 
(Ph), 127.75 (Ph), 127.6 (Ph), 127.5 (Ph), 126.7 (Ph), 126.1 (Ph), 65.3 (COH), 62.7 
(CH2Ph), 31.1 (SCH2COH), 27.1 (CMe3), 19.2 (CMe3) (one ipso-Ph resonance not 
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resolved); MS (ESI) m/z 590 [(M + H)+] HRMS (ESI) m/z calcd for C37H39NO2SSi (M + 
H)+ 590.2544, found 590.2548 (‒0.8 ppm error). 
Lab book reference: AH-2-10 
 
[(tert-Butyldiphenylsilyl)imino](methyl)(1-phenylethyl)-λ⁶-sulfanone syn-166 and 
anti-166 and [(tert-Butyldiphenylsilyl)imino](ethyl)(1-phenylethyl)-λ⁶-sulfanone 167  
 
Using general procedure C, N-TBDPS sulfoximine 43 (204 mg, 0.5 mmol, 1.0 eq.), n-
BuLi (0.39 mL of a 1.4 M solution in hexanes, 0.55 mmol, 1.1 eq.) and methyl iodide 
(0.06 mL, 1.0 mmol, 2.0 eq.) in THF (5 mL) at ‒78 °C for 2 h gave the crude product 
which contained an 85:15 mixture of monosubstituted sulfoximines 166 (as a 90:10 
mixture of syn-166 and anti-166) and disubstituted sulfoximines 167 (as a 60:40 mixture 
of 167a and 167b) (by 1H NMR spectroscopy). Purification by flash column 
chromatography on silica with 9:1 hexane-Et2O as eluent gave sulfoximine 167a (18 mg, 
8%) as a colourless oil, RF (6:4 hexane-Et2O) 0.46; IR (ATR) 3069, 2931, 2855, 1427, 
1310, 1146, 1108, 821, 778, 740, 700, 501 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.75 (dd, 
J = 7.5, 1.5 Hz, 2H, Ph), 7.72 (dd, J = 7.5, 1.5 Hz, 2H, Ph), 7.44–7.29 (m, 11H, Ph), 4.14 
(q, J = 7.5 Hz, 1H, SCH(Me)Ph), 2.55 (dq, J = 14.0, 7.0 Hz, 1H, SCHMe), 2.47 (dq, J = 
14.0, 7.0 Hz, 1H, SCHMe), 1.68 (d, J = 7.5 Hz, 3H, SCHMe), 1.06 (s, 9H, CMe3), 1.02 
(t, J = 7.0 Hz, 3H, SCH2Me); 
13C NMR (100.6 MHz, CDCl3) δ 136.77 (ipso-Ph), 136.75 
(ipso-Ph), 136.1 (ipso-Ph), 135.7 (Ph), 134.9 (Ph), 129.3 (Ph), 129.0 (Ph), 128.7 (Ph), 
128.6 (Ph), 127.8 (Ph), 127.44 (Ph), 127.42 (Ph), 65.1 (SCH), 47.9 (SCH2), 27.3 (CMe3), 
19.6 (CMe3), 14.4 (SCHMe), 7.9 (SCH2Me); MS (ESI) m/z 458 [(M + Na)
+] HRMS (ESI) 
m/z calcd for C26H33NOSSi (M + Na)
+ 458.1944, found 458.1941 (+0.8 ppm error), a 94:6 
mixture of syn-166 and 167b (155 mg, i.e. 146 mg (69%) of syn-166 and 9 mg (4%) of 
167b) as a colourless oil, RF (6:4 hexane-Et2O) 0.34; IR (ATR) 3068, 2930, 2855, 1427, 
1315, 1295, 1144, 1107, 945, 821, 781, 738, 697, 604, 528, 499 cm−1; 1H NMR (400 
MHz, CDCl3) δ 7.76–7.65 (m, 4H, Ph), 7.46–7.29 (m, 11H, Ph), 4.20 (q, J = 7.0 Hz, 
Chapter Four: Experimental 
 
139 
 
0.06H, SCH(Me)Ph), 4.14 (q, J = 7.0 Hz, 0.94H, SCH(Me)Ph), 2.63–2.54 (m, 0.12H, 
SCHMe), 2.38 (s, 2.82H, SMe), 1.80 (d, J = 7.0 Hz, 2.82H, SCHMe), 1.72 (d, J = 7.0 Hz, 
0.18H, SCHMe), 1.09 (s, 8.46H, CMe3), 1.08 (s, 0.54H, CMe3), 1.04 (t, J = 7.0 Hz, 0.18H, 
SCH2Me); 
13C NMR (100.6 MHz, CDCl3) δ 136.7 (ipso-Ph, syn-166), 136.5 (ipso-Ph, 
syn-166), 135.9 (Ph, 167b), 135.82 (Ph, syn-166), 135.79 (Ph, syn-166), 135.7 (Ph, syn-
166), 129.6 (Ph, 167b), 129.5 (Ph, syn-166), 129.2 (Ph, syn-166), 129.1 (Ph, syn-166), 
129.03 (Ph, 167b), 129.01 (Ph, 167b), 128.74 (Ph, syn-166), 128.70 (Ph, syn-166), 128.63 
(Ph, 167b), 128.56 (Ph, 167b), 127.6 (Ph, syn-166), 127.5 (Ph, 167b), 127.40 (Ph, 167b), 
127.38 (Ph, 167b), 68.3 (SCH, syn-166), 64.8 (SCH, 167b), 48.0 (SCH2, 167b), 41.6 
(SMe, syn-166), 27.34 (CMe3, 167b), 27.25 (CMe3, syn-166), 19.6 (CMe3, 167b), 19.5 
(CMe3, syn-166), 14.5 (SCHMe, syn-166), 14.2 (SCHMe, 167b), 7.7 (SCH2Me, 167b) 
(four ipso-Ph resonances not resolved); MS (ESI) m/z 444 [(M + Na)+] HRMS (ESI) m/z 
calcd for C25H31NOSSi (M + Na)
+ 444.1788, found 444.1789 (−0.2 ppm error) and 
sulfoximine anti-166 (20 mg, 10%) as a white solid, mp 78–80 °C; RF (6:4 hexane-Et2O) 
0.26; IR (ATR) 3069, 2929, 2855, 1427, 1316, 1292, 1142, 1108, 947, 821, 773, 742, 
700, 501 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.64 (dd, J = 7.5, 1.5 Hz, 2H, Ph), 7.59 
(dd, J = 7.5, 1.5 Hz, 2H, Ph), 7.45–7.39 (m, 2H, Ph), 7.39–7.26 (m, 9H, Ph), 4.18 (q, J = 
7.0 Hz, 1H, SCH(Me)Ph), 2.38 (s, 3H, SMe), 1.78 (d, J = 7.0 Hz, 3H, SCHMe), 1.05 (s, 
9H, CMe3); 
13C NMR (100.6 MHz, CDCl3) δ 136.7 (ipso-Ph), 136.5 (ipso-Ph), 136.1 
(ipso-Ph), 135.84 (Ph), 135.76 (Ph), 129.7 (Ph), 129.14 (Ph), 129.08 (Ph), 128.8 (Ph), 
128.6 (Ph), 127.49 (Ph), 127.47 (Ph), 67.7 (SCH), 41.8 (SMe), 27.3 (CMe3), 19.5 (CMe3), 
13.9 (SCHMe); MS (ESI) m/z 444 [(M + Na)+] HRMS (ESI) m/z calcd for C25H31NOSSi 
(M + Na)+ 444.1788, found 444.1784 (+0.9 ppm error). The stereochemistry of anti-166 
was assigned by X-ray crystallography. 
X-ray crystal structure determination of anti-166 
C25H31NOSiS, M = 421.66, monoclinic, a = 9.4105(2), b = 35.5159(9), c = 7.4138(2) Å, 
β = 111.167(3)°, U = 2310.68(11) Å3, T = 110.00(10) K, space group Pc, Z = 4, μ(CuKα) 
= 1.850 mm-1, 12399 reflection measured, 5722 unique (Rint = 0.0408) which were used 
in calculation. The final R1 was 0.0708 (I≥2σ) and wR2 was 0.1891 (all data). 
Lab book reference: AH-2-21 
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tert-Butyl[(tert-butyldiphenylsilyl)imino][phenyl(²H₁)methyl]-λ⁶-sulfanone 110-d 
 
Using general procedure C, N-TBDPS sulfoximine 110 (225 mg, 0.5 mmol, 1.0 eq.), n-
BuLi (0.24 mL of a 2.3 M solution in hexanes, 0.55 mmol, 1.1 eq.) and CD3OD (0.04 
mL, 1.0 mmol, 2.0 eq.) in THF (5 mL) at ‒78 °C for 1 h gave the crude product which 
contained a 65:35 mixture of diastereomeric sulfoximines 110-da and 110-db (222 mg, 
99%) as a white solid, RF (9:1 hexane-EtOAc) 0.37; IR (ATR) 3069, 2930, 2855, 1427, 
1302, 1196, 1131, 1107, 820, 742, 699, 502 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.75 
(dd, J = 7.5, 1.5 Hz, 2H, Ph), 7.68 (dd, J = 7.5, 1.5 Hz, 2H, Ph), 7.45–7.30 (m, 6H, Ph), 
7.29–7.17 (m, 5H, Ph), 4.19 (br s, 0.65H, SCH), 4.01 (br s, 0.35H, SCH), 1.35 (s, 9H, 
SCMe3), 1.02 (s, 9H, SiCMe3); 
13C NMR (100.6 MHz, CDCl3) δ 137.1 (ipso-Ph), 136.8 
(ipso-Ph), 135.91 (Ph), 135.89 (Ph), 131.5 (Ph), 129.7 (ipso-Ph), 129.0 (Ph), 128.9 (Ph), 
128.4 (Ph), 128.3 (Ph), 127.40 (Ph), 127.37 (Ph), 63.1 (SCMe3), 57.4 (triplet 1:1:1, J = 
21.5 Hz, SCHD, 110-db), 57.3 (triplet 1:1:1, J = 20.0 Hz, SCHD, 110-da), 27.4 (SiCMe3), 
24.6 (SCMe3), 19.7 (SiCMe3); MS (ESI) m/z 451 [(M + H)
+] HRMS (ESI) m/z calcd for 
C27H34DNOSSi (M + H)
+ 451.2344, found 451.2335 (+2.1 ppm error).  
Lab book reference: AH-2-15 
 
tert-Butyl[(tert-butyldiphenylsilyl)imino](2-hydroxy-1,2-diphenylethyl)-λ⁶-
sulfanone anti,anti-170 and syn,syn-170 
 
Using general procedure C, N-TBDPS sulfoximine 110 (225 mg, 0.5 mmol, 1.0 eq.), n-
BuLi (0.42 mL of a 1.3 M solution in hexanes, 0.55 mmol, 1.1 eq.) and benzaldehyde 
(0.10 mL, 1.0 mmol, 2.0 eq.) in THF (5 mL) at ‒78 °C for 2 h gave the crude product 
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which contained an 85:15 mixture of alcohols anti,anti-170 and syn,syn-170 (by 1H NMR 
spectroscopy). Purification by flash column chromatography on silica with 95:5 hexane-
EtOAc as eluent gave alcohol anti,anti-170 (213 mg, 77%) as a white solid, mp 148–150 
°C; RF (6:4 hexane-EtOAc) 0.59; IR (ATR) 3428 (OH), 3053, 2932, 2858, 1308, 1264, 
1103, 733, 698, 667, 501 cm−1; 1H NMR (400 MHz, CDCl3) δ 8.00–7.93 (m, 2H, Ph), 
7.87–7.79 (m, 2H, Ph), 7.50–7.35 (m, 7H, Ph), 7.03 (tt, J = 7.5, 1.5 Hz, 1H, Ph), 7.00–
6.90 (m, 6H, Ph), 6.80–6.75 (m, 2H, Ph), 5.59 (s, 1H, CHOH), 4.90 (d, J = 9.5 Hz, 1H, 
CHOH), 4.66 (d, J = 9.5 Hz, 1H, SCH), 1.22 (s, 9H, SCMe3), 1.20 (s, 9H, SiCMe3); 
13C 
NMR (100.6 MHz, CDCl3) δ 139.9 (ipso-Ph), 136.6 (ipso-Ph), 136.4 (Ph), 136.1 (Ph), 
136.0 (ipso-Ph), 133.4 (ipso-Ph), 130.7 (Ph), 129.6 (Ph), 129.4 (Ph), 128.0 (Ph), 127.8 
(Ph), 127.7 (Ph), 127.6 (Ph), 127.51 (Ph), 127.48 (Ph), 74.2 (CHOH), 73.0 (SCH), 66.8 
(SCMe3), 27.7 (SiCMe3), 24.8 (SCMe3), 20.2 (SiCMe3) (one Ph resonance not resolved); 
MS (ESI) m/z 556 [(M + H)+] HRMS (ESI) m/z calcd for C34H41NO2SSi (M + H)
+ 
556.2700, found 556.2692 (+1.5 ppm error) and alcohol syn,syn-170 (18 mg, 6%) as a 
white solid, mp 126–128 °C; RF (6:4 hexane-EtOAc) 0.59, IR (ATR) 3551 (OH), 3069, 
2930, 2855, 1427, 1321, 1187, 1124, 1107, 820, 701, 603, 503 cm−1; 1H NMR (400 MHz, 
CDCl3) δ 8.03–7.96 (m, 2H, Ph), 7.96–7.90 (m, 2H, Ph), 7.49–7.44 (m, 3H, Ph), 7.38–
7.44 (m, 3H, Ph), 7.19–7.27 (m, 4H, Ph), 7.14 (t, J = 7.5 Hz, 1H, Ph), 6.99 (tt, J = 7.5, 
1.0 Hz, 1H, Ph), 6.95–6.88 (m, 2H, Ph), 6.36 (d, J = 7.5 Hz, 2H, Ph), 5.70 (dd, J = 2.0, 
2.0 Hz, 1H, CHOH), 4.10 (d, J = 2.0 Hz, 1H, SCH), 3.18 (d, J = 2.0 Hz, 1H, CHOH), 
1.16 (s, 9H, SCMe3), 1.12 (s, 9H, SiCMe3); 
13C NMR (100.6 MHz, CDCl3) δ 140.0 (ipso-
Ph), 136.5 (ipso-Ph), 136.0 (Ph), 135.9 (Ph), 135.7 (ipso-Ph), 131.9 (Ph), 131.4 (ipso-Ph), 
129.6 (Ph), 129.5 (Ph), 128.4 (Ph), 127.89 (Ph), 127.86 (Ph), 127.8 (Ph), 127.6 (Ph), 127.1 
(Ph), 126.0 (Ph), 73.5 (SCH), 70.8 (CHOH), 66.8 (SCMe3), 27.3 (SiCMe3), 25.2 (SCMe3), 
20.3 (SiCMe3); MS (ESI) m/z 578 [(M + Na)
+] HRMS (ESI) m/z calcd for C34H41NO2SSi 
(M + Na)+ 578.2519, found 578.2532 (+1.5 ppm error). The stereochemistry of anti,anti-
170 and syn,syn-170 was assigned by X-ray crystallography. 
X-ray crystal structure determination of anti,anti-170 
C34H41NO2SSi, M = 555.83, triclinic, a = 9.8480(4), b = 10.3406(5), c = 16.8725(6) Å, β 
= 92.595(3)°, U = 1570.44(12) Å3, T = 110.05(10) K, space group P-1, Z = 2, μ(CuKα) = 
1.503 mm-1, 10170 reflection measured, 5608 unique (Rint = 0.0175) which were used in 
calculation. The final R1 was 0.0319 (I≥2σ) and wR2 was 0.0828 (all data). 
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X-ray crystal structure determination of syn,syn-170 
C34H41NO2SSi, M = 555.83, monoclinic, a = 10.52130(10), b = 14.25640(10), c = 
20.4833(2) Å, β = 95.5430(10)°, U = 3058.04(5) Å3, T = 109.9(2) K, space group P21/c, 
Z = 4, μ(CuKα) = 1.544 mm-1, 20253 reflection measured, 5465 unique (Rint = 0.0240) 
which were used in calculation. The final R1 was 0.0309 (I≥2σ) and wR2 was 0.0841 (all 
data). 
Lab book reference: AH-2-29 
 
Attempted synthesis of tert-Butyl[(tert-butyldiphenylsilyl)imino](2-hydroxy-1,2,2-
triphenylethyl)-λ⁶-sulfanone 171 
 
Using general procedure C, N-TBDPS sulfoximine 110 (225 mg, 0.5 mmol, 1.0 eq.), n-
BuLi (0.24 mL of a 2.3 M solution in hexanes, 0.55 mmol, 1.1 eq.) and benzophenone 
(0.25 mL of a 4 M solution in THF, 1.0 mmol, 2.0 eq.) in THF (5 mL) at ‒78 °C for 1 h 
gave the crude product which contained only starting sulfoximine 110 and none of the 
desired product 171 (by 1H NMR spectroscopy). Purification by flash column 
chromatography on silica with 95:5 hexane-Et2O as eluent gave starting sulfoximine 171 
(202 mg, 85%) as a white solid and none of the desired product 171. 
Lab book reference: AH-2-3 
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Attempted synthesis of tert-Butyl[(tert-butyldiphenylsilyl)imino][1,2-diphenyl-2-
(phenylamino)ethyl]-λ⁶-sulfanone 172  
 
Using general procedure C, N-TBDPS sulfoximine 110 (225 mg, 0.5 mmol, 1.0 eq.), n-
BuLi (0.37 mL of a 1.5 M solution in hexanes, 0.55 mmol, 1.1 eq.) and N-
benzylideneaniline (0.25 mL of a 4 M solution in THF, 1.0 mmol, 2.0 eq.) in THF (5 mL) 
at ‒78 °C for 1 h gave the crude product which contained none of the desired product 172 
(by 1H NMR spectroscopy). Purification by flash column chromatography on silica with 
1:1 CH2Cl2-hexane gave none of the desired product 172. 
Lab book reference: AH-2-31 
 
tert-Butyl[(tert-butyldiphenylsilyl)imino](1-phenylethyl)-λ⁶-sulfanone 173 
 
Using general procedure C, N-TBDPS sulfoximine 110 (225 mg, 0.5 mmol, 1.0 eq.), n-
BuLi (0.39 mL of a 1.4 M solution in hexanes, 0.55 mmol, 1.1 eq.) and methyl iodide 
(0.06 mL, 1.0 mmol, 2.0 eq.) in THF (5 mL) at ‒78 °C for 2 h gave the crude product 
which contained a 50:50 mixture of sulfoximines 173a and 173b (by 1H NMR 
spectroscopy). Purification by flash column chromatography on silica with 9:1 CH2Cl2-
hexane as eluent gave sulfoximine 173a (109 mg, 47%) as a colourless oil, RF (9:1 
CH2Cl2-hexane) 0.46; IR (ATR) 3069, 2930, 2855, 1427, 1308, 1196, 1136, 1105, 909, 
820, 770, 699, 502 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.86 (dd, J = 7.5, 2.0 Hz, 2H, 
Ph), 7.78 (dd, J = 7.5, 2.0 Hz, 2H, Ph), 7.42–7.32 (m, 6H, Ph), 7.31–7.22 (m, 5H, Ph), 
4.35 (q, J = 7.0 Hz, 1H, SCH), 1.50 (d, J = 7.0 Hz, 3H, SCHMe), 1.22 (s, 9H, SCMe3), 
1.06 (s, 9H, SiCMe3); 
13C NMR (100.6 MHz, CDCl3) δ 137.3 (ipso-Ph), 137.1 (ipso-Ph), 
136.9 (ipso-Ph), 136.0 (Ph), 135.9 (Ph), 129.6 (Ph), 128.97 (Ph), 128.96 (Ph), 128.4 (Ph), 
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128.2 (Ph), 127.41 (Ph), 127.39 (Ph), 64.8 (SCMe3), 63.2 (SCH), 27.5 (SiCMe3), 25.2 
(SCMe3), 20.1 (SiCMe3), 18.0 (SCHMe); MS (ESI) m/z 464 [(M + H)
+] HRMS (ESI) m/z 
calcd for C28H37NOSSi (M + H)
+ 464.2438, found 464.2428 (+2.2 ppm error) and a 96:4 
mixture of sulfoximines 173b and 173a (95 mg, 41%) as a white solid, mp 98–100 °C; 
RF (9:1 CH2Cl2-hexane) 0.38; IR (ATR) 3070, 2931, 2855, 1427, 1297, 1122, 1107, 909, 
820, 729, 698, 608, 492 cm−1; 1H NMR (400 MHz, CDCl3) for 173b δ 7.86 (dd, J = 7.5, 
2.0 Hz, 2H, Ph), 7.82 (dd, J = 7.5, 2.0 Hz, 2H, Ph), 7.42–7.32 (m, 8H, Ph), 7.30–7.20 (m, 
3H, Ph), 4.38 (q, J = 7.0 Hz, 1H, SCH), 1.45 (d, J = 7.0 Hz, 3H, SCHMe), 1.12 (s, 9H, 
SCMe3), 1.09 (s, 9H, SiCMe3); 
13C NMR (100.6 MHz, CDCl3) for 173b δ 138.1 (ipso-
Ph), 136.9 (ipso-Ph), 136.8 (ipso-Ph), 136.3 (Ph), 136.2 (Ph), 129.3 (Ph), 129.0 (Ph), 
128.5 (Ph), 128.3 (Ph), 127.8 (Ph), 127.4 (Ph), 127.3 (Ph), 64.9 (SCMe3), 63.2 (SCH), 
27.6 (SiCMe3), 25.1 (SCMe3), 20.2 (SiCMe3), 16.9 (SCHMe); MS (ESI) m/z 464 [(M + 
H)+] HRMS (ESI) m/z calcd for C28H37NOSSi (M + H)
+ 464.2438, found 464.2440 (−0.5 
ppm error). 
Lab book reference: AH-2-20 
 
tert-Butyl[(tert-butyldiphenylsilyl)imino][1-phenyl(2-²H)propan-2-yl]-λ⁶-sulfanone 
syn-149-d and anti-149-d 
 
Using general procedure C, N-TBDPS sulfoximine syn-149 (239 mg, 0.5 mmol, 1.0 eq.), 
n-BuLi (0.24 mL of a 2.3 M solution in hexanes, 0.55 mmol, 1.1 eq.) and CD3OD (0.04 
mL, 1.0 mmol, 2.0 eq.) in THF (5 mL) at ‒78 °C for 1 h gave the crude product which 
contained an 85:15 mixture of sulfoximines syn-149-d and anti-149-d (by 1H NMR 
spectroscopy). Purification by flash column chromatography on silica with 95:5 and then 
9:1 hexane-Et2O as eluent gave an 85:15 mixture of sulfoximines syn-149-d and anti-
149-d (212 mg, 89%) as a white solid, RF (8:2 hexane-Et20) 0.27; IR (ATR) 2931, 2855, 
1455, 1427, 1296, 1136, 1106, 1090, 908, 820, 730, 698, 649, 497 cm−1; 1H NMR (400 
MHz, CDCl3) δ 7.92–7.84 (m, 4H, Ph), 7.46–7.36 (m, 6H, Ph), 7.28–7.16 (m, 3H, Ph), 
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6.92 (d, J = 7.0 Hz, 2H, Ph), 3.33 (d, J = 13.5 Hz, 1H, CHPh), 2.30 (d, J = 13.5 Hz, 0.85H, 
CHPh), 1.85 (d, J = 13.5 Hz, 0.15H, CHPh), 1.51 (s, 7.65H, SCMe3), 1.46 (s, 1.35H, 
SCMe3), 1.17 (s, 9H, SiCMe3), 1.08 (s, 0.45H, SCDMe), 0.96 (s, 2.55H, SCDMe);
 13C 
NMR (100.6 MHz, CDCl3) δ 139.0 (ipso-Ph, anti-149-d), 138.7 (ipso-Ph, syn-149-d), 
137.3 (ipso-Ph, anti-149-d), 137.19 (ipso-Ph, syn-149-d), 137.16 (ipso-Ph, anti-149-d), 
136.14 (Ph), 136.11 (Ph, syn-149-d), 136.0 (Ph, syn-149-d), 134.9 (Ph, anti-149-d), 129.3 
(Ph), 129.1 (Ph), 129.0 (Ph, syn-149-d), 128.6 (Ph, syn-149-d), 128.5 (Ph), 127.7 (Ph, 
anti-149-d), 127.4 (Ph, syn-149-d), 126.6 (Ph), 126.4 (Ph, anti-149-d), 63.9 (SCMe3, syn-
149-d), 63.6 (SCMe3, anti-149-d), 57.5 (1:1:1 triplet, J = 20.5 Hz, SCD), 39.2 (CH2Ph, 
anti-149-d), 39.1 (CH2Ph, syn-149-d), 27.6 (SiCMe3), 25.1 (SCMe3, syn-149-d), 25.0 
(SCMe3, anti-149-d), 20.0 (SiCMe3), 13.5 (SCDMe, anti-149-d), 13.4 (SCDMe, syn-149-
d) (one SCD, one SiCMe3, one SiCMe3, one ipso-Ph and five Ph resonances not resolved); 
MS (ESI) m/z 479 [(M + H)+] HRMS (ESI) m/z calcd for C29H38DNOSSi (M + H)
+ 
479.2657, found 479.2657 (−0.1 ppm error). The stereochemistry of anti-149-d and syn-
149-d was assigned by analogy with anti-149 and syn-149. 
Lab book reference: AH-1-67 
 
Attempted synthesis of tert-Butyl[(tert-butyldiphenylsilyl)imino](1-hydroxy-2-
methyl-1,1,3-triphenylpropan-2-yl)-λ⁶-sulfanone 175 
 
Using general procedure C, N-TBDPS sulfoximine syn-149 (239 mg, 0.5 mmol, 1.0 eq.), 
n-BuLi (0.24 mL of a 2.3 M solution in hexanes, 0.55 mmol, 1.1 eq.) and benzophenone 
(0.25 mL of a 4 M solution in THF, 1.0 mmol, 2.0 eq.) in THF (5 mL) at ‒78 °C for 1 h 
gave the crude product which contained a 65:35 mixture of starting sulfoximines syn-149 
and anti-149 (by 1H NMR spectroscopy). Purification by flash column chromatography 
on silica with 95:5 hexane-Et2O as eluent gave a 65:35 mixture of starting sulfoximines 
syn-149 and anti-149 (118 mg, 49%) as a white solid and none of the desired product 175. 
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Lab book reference: AH-1-64 
 
n-BuLi (0.24 mL of a 2.3 M solution in hexanes, 0.55 mmol, 1.1 eq.) was added dropwise 
to a stirred solution of N-TBDPS sulfoximine syn-149 (239 mg, 0.5 mmol, 1.0 eq.) in 
THF (5 mL) at ‒78 °C under Ar. The resulting solution was stirred at ‒78 °C for 20 min. 
Then, benzophenone (0.25 mL of a 4 M solution in THF, 1.0 mmol, 2.0 eq.) was added. 
The resulting solution was allowed to warm to rt and stirred for 16 h. Then, water (5.0 
mL) was added and the two layers were separated. The aqueous layer was extracted with 
CH2Cl2 (3 × 20 mL). The combined organic layers were dried (MgSO4) and evaporated 
under reduced pressure to give the crude product which contained a 65:35 mixture of 
starting sulfoximines syn-149 and anti-149 (by 1H NMR spectroscopy). Purification by 
flash column chromatography on silica with 97:3 hexane-Et2O as eluent gave a 65:35 
mixture of starting sulfoximines syn-149 and anti-149 (165 mg, 69%) as a white solid and 
none of the desired product 175. 
Lab book reference: AH-1-66 
 
Attempted synthesis of (2-Benzyl-1-oxo-1-phenylpropan-2-yl)(tert-butyl)[(tert-
butyldiphenylsilyl)imino]-λ⁶-sulfanone 176 
 
Using general procedure C, N-TBDPS sulfoximine syn-149 (239 mg, 0.5 mmol, 1.0 eq.), 
n-BuLi (0.24 mL of a 2.3 M solution in hexanes, 0.55 mmol, 1.1 eq.) and N-Methoxy-N-
methylbenzamide (0.10 mL, 0.65 mmol, 1.3 eq.) in THF (5 mL) at ‒78 °C for 2 h gave 
the crude product which contained a 65:35 mixture of starting sulfoximines syn-149 and 
anti-149 (by 1H NMR spectroscopy). Purification by flash column chromatography on 
silica with 95:5 hexane-Et2O as eluent gave a 65:35 mixture of starting sulfoximines syn-
149 and anti-149 (179 mg, 75%) as a white solid and none of the desired product 176. 
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Lab book reference: AH-1-70 
 
Attempted synthesis of tert-Butyl[(tert-butyldiphenylsilyl)imino](2-fluoro-1-
phenylpropan-2-yl)-λ⁶-sulfanone 177 
 
Using general procedure C, N-TBDPS sulfoximine syn-149 (239 mg, 0.5 mmol, 1.0 eq.), 
n-BuLi (0.24 mL of a 2.3 M solution in hexanes, 0.55 mmol, 1.1 eq.) and N-
fluorobenzenesulfonimide (0.25 mL of a 4 M solution in THF, 1.0 mmol, 2.0 eq.) in THF 
(5 mL) at ‒78 °C for 3 h gave the crude product which contained a 65:35 mixture of 
starting sulfoximines syn-149 and anti-149 (by 1H NMR spectroscopy). Purification by 
flash column chromatography on silica with 95:5 hexane-Et2O as eluent gave an impure 
65:35 mixture of starting sulfoximines syn-149 and anti-149 (124 mg) as a yellow solid 
and none of the desired product 177. 
Lab book reference: AH-1-91 
 
n-BuLi (0.24 mL of a 2.3 M solution in hexanes, 0.55 mmol, 1.1 eq.) was added dropwise 
to a stirred solution of N-TBDPS sulfoximine syn-149 (239 mg, 0.5 mmol, 1.0 eq.) in 
THF (5 mL) at ‒78 °C under Ar. The resulting solution was stirred at ‒78 °C for 20 min. 
Then, N-fluorobenzenesulfonimide (0.25 mL of a 4 M solution in THF, 1.0 mmol, 2.0 
eq.) was added. The resulting solution was allowed to warm to rt and stirred for 16 h. 
Then water (5.0 mL) was added and the two layers were separated. The aqueous layer 
was extracted with CH2Cl2 (3 × 20 mL). The combined organic layers were dried 
(MgSO4) and evaporated under reduced pressure to give the crude product which 
contained a 65:35 mixture of starting sulfoximines syn-149 and anti-149 as a brown solid 
and none of the desired product 177 (by 1H NMR spectroscopy).  
Lab book reference: AH-2-5 
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tert-Butyl[(tert-butyldiphenylsilyl)imino](2-methyl-1-phenylpropan-2-yl)-λ⁶-
sulfanone 178 
 
Using general procedure C, N-TBDPS sulfoximine syn-149 (239 mg, 0.5 mmol, 1.0 eq.), 
n-BuLi (0.22 mL of a 2.5 M solution in hexanes, 0.55 mmol, 1.1 eq.) and methyl iodide 
(0.06 mL, 1.0 mmol, 2.0 eq.) in THF (5 mL) at ‒78 °C for 2 h gave the crude product 
which contained an 80:20 mixture of sulfoximine 178 and starting sulfoximines syn-149 
and anti-149 (as an 85:15 mixture of diastereomers) (by 1H NMR spectroscopy). 
Purification by flash column chromatography on silica with 98:2 hexane-Et2O as eluent 
gave an 80:20 mixture of sulfoximine 178 and starting sulfoximines syn-149 and anti-
149 (as an 85:15 mixture of diastereomers) (245 mg of a 80:20 mixture of 178 and starting 
sulfoximines syn-149 and anti-149 i.e. 196 mg (80%) of 178) as a white solid, RF (8:2 
hexane-Et2O) 0.74; IR (ATR) 3070, 2931, 2855, 1441, 1105, 908, 820, 731, 699, 664, 
599, 484 cm−1; 1H NMR (400 MHz, CDCl3) for 178 δ 7.97–7.86 (m, 5H, Ph), 7.48–7.37 
(m, 6H, Ph), 7.31–7.17 (m, 3H, Ph), 6.91 (dd, J = 7.0, 2.5 Hz, 2H, Ph), 3.20 (d, J = 12.5 
Hz, 1H, CHPh), 3.12 (d, J = 12.5 Hz, 1H, CHPh), 1.55 (s, 9H, SCMe3), 1.32 (s, 3H, 
SCMe), 1.25 (s, 3H, SCMe), 1.18 (s, 9H, SiCMe3); 
13C NMR (100.6 MHz, CDCl3) for 
178 δ 137.5 (ipso-Ph), 137.0 (ipso-Ph), 136.4 (ipso-Ph), 136.2 (Ph), 136.1 (Ph), 131.2 
(Ph), 129.0 (Ph), 128.9 (Ph), 128.6 (Ph), 128.0 (Ph), 127.4 (Ph), 126.6 (Ph), 72.2 
(SCMe3), 68.8 (SC), 42.2 (CH2Ph), 27.7 (SiCMe3), 27.3 (SCMe3), 23.0 (SCMe), 22.7 
(SCMe), 20.3 (SiCMe3); MS (ESI) m/z 514 [(M + Na)
+] HRMS (ESI) m/z calcd for 
C30H41NOSSi (M + Na)
+ 514.2570, found 514.2575 (−1.0 ppm error).  
Lab book reference: AH-1-69 
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tert-Butyl[(tert-butyldiphenylsilyl)imino](2-methyl-1-phenylbutan-2-yl)-λ⁶-
sulfanone 179 
 
Using general procedure C, N-TBDPS sulfoximine syn-149 (239 mg, 0.5 mmol, 1.0 eq.), 
n-BuLi (0.24 mL of a 2.3 M solution in hexanes, 0.55 mmol, 1.1 eq.) and ethyl iodide 
(0.08 mL, 1.0 mmol, 2.0 eq.) in THF (5 mL) at ‒78 °C for 2 h gave the crude product 
which contained a 65:35 mixture of starting sulfoximines anti-149 and syn-149 (as a 
55:45 mixture of diastereomers) and sulfoximines 179a and 179b (as a 75:25 mixture of 
diastereomers) (by 1H NMR spectroscopy). Purification by flash column chromatography 
on silica with 95:5 hexane-Et2O as eluent gave impure sulfoximine 179. Further 
purification by flash column chromatography on silica with 1:1 hexane-CH2Cl2 gave an 
80:20 mixture of diastereomeric sulfoximines 179a and 179b (78 mg of a 90:10 mixture 
of 179 and starting sulfoximine anti-149 i.e. 71 mg (28%) of 179) as a white solid, RF 
(9:1 CH2Cl2-hexane) 0.43; IR (ATR) 2931, 2855, 1454, 1427, 1304, 1136, 1106, 909, 
820, 732, 700, 600, 498 cm−1; 1H NMR (400 MHz, CDCl3) for 179a and 179b δ 7.90–
7.83 (m, 4H, Ph), 7.42–7.33 (m, 6H, Ph), 7.25–7.17 (m, 3H, Ph), 6.96 (dd, J = 8.0, 2.0 
Hz, 2H, Ph), 3.32 (d, J = 13.0 Hz, 0.2H, CHPh), 3.22 (d, J = 13.0 Hz, 0.8H, CHPh), 3.16 
(d, J = 13.0 Hz, 0.8H, CHPh), 3.10 (d, J = 13.0 Hz, 0.2H, CHPh), 2.02–1.93 (m, 1H, 
CHMe), 1.85–1.76 (m, 0.2H, CHMe), 1.59–1.52 (m, 0.8H, CHMe), 1.49 (s, 7.2H, 
SCMe3), 1.42 (s, 1.8H, SCMe3), 1.32 (s, 2.4H, SC(Me)CH2Ph), 1.18 (s, 0.6H, 
SC(Me)CH2Ph), 1.14 (s, 7.2H, SiCMe3), 1.12 (s, 1.8H, SiCMe3), 0.73 (t, J = 7.5 Hz, 2.4H, 
CH2Me), 0.72 (t, J = 7.5 Hz, 0.6H, CH2Me);
 13C NMR (100.6 MHz, CDCl3) for 179a and 
179b δ 137.42 (ipso-Ph, 179b), 137.39 (ipso-Ph, 179a), 137.17 (ipso-Ph, 179b), 137.15 
(ipso-Ph, 179a), 137.0 (ipso-Ph, 179b), 136.7 (ipso-Ph, 179a), 136.21 (Ph, 179a), 136.17 
(Ph, 179a), 136.1 (Ph), 135.92 (Ph), 135.90 (Ph), 131.1 (Ph, 179a), 129.5 (Ph), 129.3 
(Ph), 128.9 (Ph, 179a), 128.4 (Ph), 128.1 (Ph, 179a), 128.0 (Ph), 127.5 (Ph), 127.4 (Ph, 
179a), 127.3 (Ph), 127.2 (Ph), 126.7 (Ph), 126.6 (Ph, 179b), 76.0 (SCMe3, 179b), 75.7 
(SCMe3, 179a), 69.5 (SC, 179a), 69.4 (SC, 179b), 42.6 (CH2Ph, 179b), 41.6 (CH2Ph, 
179a), 28.6 (CH2Me, 179b), 28.1 (CH2Me, 179a), 27.8 (SiCMe3), 27.4 (SCMe3), 27.3 
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(SiCMe3), 24.4 (SCMe3), 20.6 (SiCMe3, 179a), 20.3 (SC(Me)CH2Ph, 179a), 19.8 
(SiCMe3, 179b), 19.4 (SC(Me)CH2Ph, 179b), 9.8 (CH2Me) (one Me resonance not 
resolved); MS (ESI) m/z 528 [(M + Na)+] HRMS (ESI) m/z calcd for C31H43NOSSi (M + 
Na)+ 528.2727, found 528.2721 (+1.1 ppm error).  
Lab book reference: AH-1-74 
 
tert-Butyl[(tert-butyldiphenylsilyl)imino](1-hydroxy-2-methyl-1,3-diphenylpropan-
2-yl)-λ⁶-sulfanone 180  
 
Using general procedure C, N-TBDPS sulfoximine syn-149 (749 mg, 1.57 mmol, 1.0 eq.), 
n-BuLi (1.15 mL of a 1.5 M solution in hexanes, 1.73 mmol, 1.1 eq.) and benzaldehyde 
(0.32 mL, 3.14 mmol, 2.0 eq.) in THF (15 mL) at ‒78 °C for 2 h gave the crude product 
which contained a 95:5 mixture of diastereomeric alcohols 180a and 180b (by 1H NMR 
spectroscopy). Purification by flash column chromatography on silica with 95:5 hexane-
Et2O as eluent gave impure sulfoximine 180. Further purification by flash column 
chromatography on silica with 6:4 CH2Cl2-hexane gave a single diastereomeric alcohol 
180a (616 mg, 67%) as a white solid, mp 122–124 °C; RF (8:2 CH2Cl2-hexane) 0.43; IR 
(ATR) 3294 (OH), 2932, 2857, 1453, 1427, 1316, 1246, 1125, 1106, 908, 819, 729, 699, 
644, 599, 497 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.96 (dd, J = 8.0, 1.5 Hz, 2H, Ph), 
7.89 (dd, J = 8.0, 1.5 Hz, 2H, Ph), 7.50 (dd, J = 8.0, 1.5 Hz, 2H, Ph), 7.46–7.36 (m, 10H, 
Ph), 7.12–7.02 (m, 3H, Ph), 6.73 (dd, J = 8.0, 1.5 Hz, 2H, Ph), 6.54 (s, 1H, CHOH), 5.61 
(s, 1H, CHOH), 3.87 (d, J = 15.5 Hz, 1H, CHPh), 3.43 (d, J = 15.5 Hz, 1H, CHPh), 1.48 
(s, 9H, SCMe3), 1.24 (s, 9H, SiCMe3), 1.14 (s, 3H, SC(Me)CHOH);
 13C NMR (100.6 
MHz, CDCl3) δ 138.8 (ipso-Ph), 137.2 (ipso-Ph), 136.5 (Ph), 136.3 (Ph), 136.0 (ipso-Ph), 
135.7 (ipso-Ph), 131.4 (Ph), 129.4 (Ph), 129.3 (Ph), 128.5 (Ph), 128.3 (Ph), 128.0 (Ph), 
127.7 (Ph), 127.5 (Ph), 127.4 (Ph), 126.2 (Ph), 78.1 (CHOH), 71.4 (SCMe3), 33.3 
(CH2Ph), 27.8 (SiCMe3), 27.3 (SCMe3), 26.7 (SCMe), 22.3 (SCMe), 20.5 (SiCMe3); MS 
(ESI) m/z 606 [(M + Na)+] HRMS (ESI) m/z calcd for C36H45NO2SSi (M + Na)
+ 606.2832, 
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found 606.2840 (−1.2 ppm error). Alcohol 180b was not isolated. Diagnostic signals for 
alcohol 180b: 1H NMR (400 MHz, CDCl3) δ 6.16 (d, J = 7.0 Hz, 1H, CHOH), 5.30 (d, J 
= 7.0 Hz, 1H, CHOH). 
Lab book reference: AH-2-52 
 
Using general procedure C, N-TBDPS sulfoximine anti-149 (239 mg, 0.5 mmol, 1.0 eq.), 
n-BuLi (0.24 mL of a 2.3 M solution in hexanes, 0.55 mmol, 1.1 eq.) and benzaldehyde 
(0.10 mL, 1.0 mmol, 2.0 eq.) in THF (5 mL) at ‒78 °C for 2 h gave the crude product 
which contained a 90:10 mixture of alcohols 180a and 180b (as a 95:5 mixture of 
diastereomers) and starting sulfoximine anti-149 (by 1H NMR spectroscopy). Purification 
by flash column chromatography on silica with 1:1 hexane-CH2Cl2 as eluent gave a 90:10 
mixture of single diastereomeric alcohol 180a and starting sulfoximine anti-149 (215 mg 
of a 90:10 mixture of 180a and anti-149 i.e. 199 mg (68%) of 180a) as a white solid. 
Alcohol 180b was not isolated.  
Lab book reference: AH-1-87 
 
Attempted synthesis of tert-Butyl(1-hydroxy-2-methyl-1,3-diphenylpropan-2-
yl)imino-λ⁶-sulfanone 181 
 
TBAF (0.35 mL of a 1 M solution in THF, 0.35 mmol, 2.0 eq.) was added dropwise to a 
stirred solution of N-TBDPS sulfoximine 180a (103 mg, 0.18 mmol, 1.0 eq.) in THF (2 
mL) at rt under Ar. The resulting solution was stirred at rt for 64 h. The solvent was 
evaporated under reduced pressure to give the crude product which contained none of the 
desired product 181 (by 1H NMR spectroscopy and mass spectrometry).  
Lab book reference: AH-2-51 
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AcCl (2 µL, 0.02 mmol, 0.15 eq.) was added to a stirred solution of N-TBDPS 
sulfoximine 180a (59 mg, 0.1 mmol, 1.0 eq.) in dry MeOH (1 mL) at 0 °C under Ar. The 
resulting solution was stirred at rt for 24 h. Then, saturated NH4Cl(aq) (5 mL) was added 
and the two layers were separated. The aqueous layer was extracted with CH2Cl2 (3 × 20 
mL). The combined organic layers were dried (MgSO4) and evaporated under reduced 
pressure to give the crude product which contained none of the desired product 181 (by 
1H NMR spectroscopy and mass spectrometry). 
Lab book reference: AH-2-55 
 
Acetic acid (0.01 mL, 0.15 mmol, 1.5 eq.) was added to a stirred solution of N-TBDPS 
sulfoximine 180a (59 mg, 0.1 mmol, 1.0 eq.) in THF (1 mL) at rt under Ar. Then, TBAF 
(0.15 mL of a 1 M solution in THF, 0.15 mmol, 1.5 eq.) was added dropwise to the 
solution at rt under Ar. The resulting solution was stirred at rt for 96 h. Then, brine (5 
mL) was added and the two layers were separated. The aqueous layer was extracted with 
Et2O (3 × 20 mL). The combined organic layers were dried (MgSO4) and evaporated 
under reduced pressure to give the crude product which contained none of the desired 
product 181 (by 1H NMR spectroscopy and mass spectrometry). 
Lab book reference: AH-2-56 
 
Attempted synthesis of 2-Benzyl-2-{tert-butyl[(tert-butyldiphenylsilyl)imino]oxo-λ⁶-
sulfanyl}-1-phenylpropyl 4-bromobenzoate 182  
 
Et3N (0.02 mL, 0.13 mmol, 1.3 eq.) was added dropwise to a stirred solution of N-TBDPS 
sulfoximine 180a (59 mg, 0.1 mmol, 1.0 eq.) and 4-bromobenzoyl chloride (29 mg, 0.13 
mmol, 1.3 eq.) in CH2Cl2 (1 mL) at 0 °C under Ar. The resulting solution was stirred at 0 
°C for 1 h and then stirred at rt for 96 h. Then, water (5 mL) was added and the two layers 
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were separated. The aqueous layer was extracted with CH2Cl2 (3 × 20 mL). The combined 
organic layers were dried (MgSO4) and evaporated under reduced pressure to give the 
crude product which contained starting sulfoximine 180a and none of the desired product 
182 (by 1H NMR spectroscopy and mass spectrometry). 
Lab book reference: AH-2-53 
 
Et3N (0.02 mL, 0.15 mmol, 1.5 eq.) was added dropwise to a stirred solution of N-TBDPS 
sulfoximine 180a (59 mg, 0.1 mmol, 1.0 eq.), DMAP (3 mg, 0.025 mmol, 0.25 eq.) and 
4-bromobenzoyl chloride (25 mg, 0.11 mmol, 1.1 eq.) in CH2Cl2 (1 mL) at 0 °C under 
Ar. The resulting solution was stirred at rt for 48 h. Then, water (5 mL) was added and 
the two layers were separated. The aqueous layer was extracted with CH2Cl2 (3 × 20 mL). 
The combined organic layers were dried (MgSO4) and evaporated under reduced pressure 
to give the crude product which contained starting sulfoximine 180a and none of the 
desired product 182 (by 1H NMR spectroscopy and mass spectrometry). 
Lab book reference: AH-2-54 
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